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Summary 
Bovine tuberculosis (BTB) is a chronic, infectious disease found in domestic livestock and 
wildlife, and has serious biodiversity, economic and public health implications. African 
buffalo act as a wildlife reservoir of BTB, maintaining and transmitting the disease within the 
environment. The research presented in this thesis addresses the role of host genetic variation 
in resistance to BTB infection in African buffalo, and reviews the possible practical 
application of such information. Annual BTB prevalence within the African buffalo 
population in Hluhluwe iMfolozi Park, South Africa, was evaluated over a seven year period 
in order to define the extent of M. bovis infection. Prevalence changes over time suggest that 
the test and cull operation currently in place is performing successfully with respect to the 
original aims of the programme. A review of genetic studies of BTB in livestock and wildlife 
collated previous findings in this field and provided a collection of possible candidate genes 
and variants. It also highlighted a lack of research in wildlife, and the limitations of working 
with species with insufficient genetic data. To overcome the absence of whole-genome data, 
next-generation sequencing was performed on nine African buffalo, in order to identify novel 
genetic variants in this species. Upwards of 76 000 novel SNPs within gene regions were 
identified, and subsequent fluorescent genotyping of 173 SNPs showed a 57% validation rate. 
From the validated set, 69 SNPs located in genes related to the immune system were selected 
for association testing with BTB status in African buffalo, and were fluorescently genotyped 
in 868 individuals. Three SNPs, in the Solute Carrier family 7, member A13 (SLC7A13), 
Deleted in Malignant Brain Tumour-1 (DMBT1) and Interleukin 1 alpha (IL1α) genes, were 
identified as significantly associated with BTB status. Very little sequence information of the 
NRAMP1 (SLC11A1) gene was obtained from the next-generation sequencing performed, 
and this gene has been associated with brucellosis, salmonella and paratuberculosis in other 
animal species, making it an excellent candidate for BTB resistance. To characterise this gene 
in African buffalo, Sanger sequencing was performed to generate the complete coding region, 
and partially sequence the 5’UTR, intronic and 3’UTR regions. Fifteen novel polymorphisms 
and three microsatellites were identified within the gene.  Finally, a review was prepared to 
assess the applicability of genetic information on BTB resistance to selective breeding 
programmes for African buffalo. Phenotypic, marker-assisted and genomic breeding 
strategies were discussed, with particular emphasis on their suitability to African buffalo. 
Identifying genes and variants involved in BTB resistance in African buffalo provides 
potential targets for drug or vaccine development, as well as information that could be 
incorporated into selective breeding programmes. This may support new management options 
for controlling the BTB epidemic in the game parks of South Africa, as an alternative to, or in 
conjunction with, lethal control. 
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Opsomming 
Beestuberkulose (BTB) is ‘n chroniese, aansteeklike siekte wat in vee en wild voorkom en 
wat ernstige gevolge vir die ekonomie, biodiversiteit en openbare gesondheid inhou. Die 
Kaap-buffel is ‘n wild reservoir vir BTB wat die siekte onderhou en versprei in die 
omgewing. Die navorsing wat in hierdie tesis aangebied word fokus op die rol van gasheer 
genetiese variasie in die weerstand teen BTB infeksie in Kaap-buffels en gee ‘n oorsig van 
die moontlike praktiese toepassing van die resultate. Die jaarlikse BTB voorkomsyfer in die 
Kaap-buffel bevolking in die Hluhluwe iMfolozi Park in Suid-Afrika is oor ‘n tydperk van 
sewe jaar geëvalueer om die omvang van M. bovis infeksie te bepaal. Die verandering in 
voorkomsyfer oor tyd dui daarop dat die toets-en-slag operasie wat tans gebruik word die 
oorspronklike doelwitte van die program suksesvol bereik. ‘n Oorsig en vergelyking van 
vorige genetiese studies van BTB in vee en wild het ‘n versameling van moontlike 
kandidaatgene en –variante verskaf. Dit het ook die gebrek aan navorsing in wildediere 
uitgewys en die navorsingsbeperkinge wanneer ‘n spesie met onvoldoende genetiese data 
bestudeer word benadruk. Aangesien daar nie heel genoom data beskikbaar is nie, is 
volgende-generasie volgordebepaling van 9 Kaap-buffels gedoen om nuwe genetiese 
variasies in hierdie spesie te identifiseer. Meer as 76 000 nuwe enkel-nukleotied 
polimorfismes (ENPs) binne geen-areas is geïdentifiseer en die daaropvolgende genotipering 
van 173 ENPs het ‘n bevestigingskoers van 57% gehad. Vanuit die bevestigde stel ENPs is 
69 gekies vir assosiasietoetse met BTB status in die Kaap-buffel en genotipering van 868 
individue is gedoen. Drie ENPs, in die Solute Carrier family 7, member A13 (SLC7A13), 
Deleted in Malignant Brain Tumour-1 (DMBT1) en Interleukin 1 alpha (IL1α) gene, was 
beduidend geassosieer met BTB status. Baie min volgorde inligting van die NRAMP1 
(SLC11A1) geen is verkry uit die volgende-generasie volgordebepaling. Aangesien hierdie 
geen voorheen met brucellose, salmonella en paratuberkulose in ander dierespesies 
geassosieer is, is dit ‘n uitstekende kandidaat vir BTB weerstand. Hierdie geen is in Kaap-
buffels gekarakteriseer deur Sanger volgordebepaling van die volledige koderende, 
gedeeltelike 5’UTR, introniese en 3’UTR areas te doen. Vyftien nuwe polimorfismes en drie 
mikrosatelliete is geïdentifiseer. Ten slotte is ‘n oorsigstudie gedoen om die toepaslikheid van 
BTB genetiese weerstandsdata in selektiewe telingsprogramme van Kaap-buffels te evalueer. 
Fenotipiese, merkerbemiddelde en genomiese teling strategieë is bespreek, met spesifieke 
klem op die geskiktheid van die metodes vir Kaap-buffels. Identifisering van gene en variante 
wat betrokke is by BTB weerstand in die Kaap-buffel bied potensiële teikens vir medikasie of 
entstof ontwikkeling, sowel as inligting wat in selektiewe telingsprogramme gebruik kan 
word. Dit kan nuwe bestuursopsies vir die beheer van die BTB-epidemie in die parke van 
Suid-Afrika bied as 'n alternatief vir, of in samewerking met, dodelike beheermetodes.
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ANP  Addo National Park 
BCG  Bacille Calmette-Guerin  
BTB  Bovine tuberculosis 
CA  Brucellosis 
CD  Corridor disease 
CMI  Cell-mediated immunity  
DNA  Deoxyribonucleic acid 
FMD  Foot and mouth disease  
GLTP  Greater Limpopo Transfrontier Park 
HIP  Hluhluwe iMfolozi Park 
HIV  Human immunodeficiency virus  
IGRA  Interferon gamma release assay  
IFNγ  Interferon gamma  
IUCN  International Union for the Conservation of Nature 
KNP  Kruger National Park  
MHC  Major Histocompatibility Complex 
NRAMP1 Natural resistance-associated macrophage protein 1 
PPD  Purified protein derivative  
QTL  Quantitative trait locus  
RFLP  Restriction fragment length polymorphism 
SCITT  Single comparative intradermal tuberculin test 
SNP  Single nucleotide polymorphism 
TB  Tuberculosis 
VNTR  Variable number of tandem repeats  
YBP  Years before present 
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1. African buffalo (Syncerus caffer) 
 
1.1 General 
Buffalo are one of the most abundant and ecologically important species of megafauna in the 
savannah ecosystem. They are gregarious grazers that, because of their size, can process taller 
grasses than most other species, thus fulfilling a potentially facilitative role for the smaller 
grazers [1]. They inhabit most vegetation types where permanent water is found, and are 
considered a riverine species, preferring areas close to rivers or lakes. They are an important 
prey species, and host a vast array of nematodes, pathogens and infectious diseases [1,2]. 
Population reductions or loss in this species would thus have significant consequences for the 
ecological balance of the ecosystem, as the African buffalo can be considered a keystone 
species in the savannah biome.  
Buffalo become sexually mature at around 3 years of age, and cows may have their first calf 
as early as 4 years old. Due to the age dominance hierarchy of the herd, male buffalo are 
unlikely to mate before 7 or 8 years of age [3]. The gestation period for buffalo is around 11 
months, and evidence suggests that mating and/or parturition may be timed with arrival of the 
wet season, taking advantage of the emergence of new grass with high protein content [4]. 
The main factors influencing buffalo mortality are drought and predation, primarily by lions, 
and their maximum life expectancy under natural conditions is suggested be around 20 years 
[3]. 
1.2 Population Biology 
African buffalo are found in herds ranging from a few hundred to several thousand 
individuals. Herd size varies between geographical areas, and is influenced by vegetation 
density, food abundance and water availability [4]. During the breeding season large mixed 
herds are seen, while smaller mixed herds and bachelor groups are more common during the 
remainder of the year. Buffalo herds have home ranges that range from 5-100 km2 in size, 
and display a predominantly male-dominated hierarchy, although adult female buffalo form 
the core of the herd. Short and long-range dispersal is undertaken by both male and female 
buffalo at all times of the year [1,4,5].  
Numerous studies have investigated the population differentiation and genetic diversity in 
African buffalo populations from eastern and southern Africa, using markers such as 




microsatellites, MHC, mitochondrial DNA and Y chromosomal loci [2,6–8]. Population 
differentiation is consistently very low and comparable with other migratory species, which 
suggests that there is significant dispersal and migration between herds and/or populations in 
buffalo. Simonsen et al. (1998) found microsatellite and mitochondrial diversity to be 
comparably high across buffalo populations within a number of African countries, and 
significant genetic differentiation could be consistently detected only at a continental level. 
Buffalo also showed comparable heterozygosity when compared to five other African bovid 
species, and the highest within population nucleotide diversity [5]. Overall, buffalo show low 
population differentiation and high levels of genetic variability for the MHC DRB3 gene, 
microsatellites and mitochondrial DNA. 
1.3 History and Distribution 
The high genetic diversity exhibited by African buffalo suggests that the ancestral population 
size was extremely large. Evidence of a massive population decline of 75-95% in the East 
African buffalo population was found for the mid-Holocene period, approximately 4500 
YBP, which coincides with the aridification of Africa [9]. This shift in climatic conditions is 
suggested to be the cause of this enormous population decline, as buffalo have been shown to 
be extremely sensitive to drought conditions [2]. The concurrent Neolithic expansion of 
humans and their cattle in Africa, characterised by a shift to pastoralism and agriculture, may 
also have contributed to the decline in the buffalo population as a result of the farmers‟ 
acquisition of land and the introduction of cattle-borne diseases [10].  
Prior to the arrival of European settlers, the distribution of the African buffalo extended 
across the majority of southern Africa, Angola, central and East Africa to the southern 
borders of Ethiopia and Sudan [11,12]. In 1889, rinderpest (a virus carried by cattle) was 
introduced into north-eastern Africa by humans and led to a continent-wide pandemic that 
killed 90-95% of the buffalo population. This situation was exacerbated by a foot and mouth 
outbreak, and resulted in the isolation of the remaining buffalo in South Africa into three 
remnant populations in the Kruger National Park (KNP), Hluhluwe iMfolozi Park (HiP) and 
Addo National Park (ANP) [11,13]. Despite this historical population crash, no evidence of a 
genetic bottleneck has been found in buffalo from South Africa or other African countries. 
This suggests that either the rinderpest epidemic was not as devastating as previously 
thought, or that factors such as rapid growth, gene flow and high genetic diversity masked the 
detrimental effects [2,5,11] 




The current distribution of African buffalo extends throughout much of sub-Saharan Africa, 
although within this range the distribution is fragmented and largely confined to protected 
areas (Figure 1). The International Union for the Conservation of Nature (IUCN) SSC 
Antelope Specialist Group classified African buffalo as „Least Concern‟ in 2008, which 
reflects an improvement in status since the 1996 „Lower Risk/Conservation Dependant‟ 
designation. This is a result of their widespread distribution and global population size, which 
was estimated at approximately 900 000 individuals in 1999, with savannah buffalo 
accounting for around 830 000, and forest buffalo about 60 000 individuals [14]. The two 
largest free-ranging buffalo populations in South Africa at present are those found in the 
KNP/Greater Limpopo Transfrontier Park (GLTP), and HiP. 
 
 
Figure 1: Extant distribution of the African buffalo (Syncerus caffer) [14]. 
 
1.4 Phylogeny 
African buffalo belong to the family Bovidae (Mammalia, Artiodactyla, Ruminantia), which 
comprises more than 137 extant species classified into 45 genera [15]. The Bovidae family is 
a diverse group which includes domestic animals such as goats, sheep and cattle, large plains 
antelopes, and small forest dwellers. A conservative approach proposes that the 12 recognised 
tribes within the Bovidae family be grouped into six subfamilies, namely Bovinae, 




Cephalophinae, Hippotraginae, Alcelaphinae, Antilopinae and Caprinae. Phylogenetic 
evidence suggests that these subfamilies form two distinct clades, a Bovinae clade 
(containing the Bovinae subfamily) and an Antilopinae clade (comprised of all the remaining 
non-Bovinae subfamilies). Within the Bovinae subfamily, the buffalo (Syncerus and Bubulas) 
and cattle (Bos and Bison) species appear to form two distinct Bovini tribes (Figure 2), along 
with the Boselaphini and Tragelaphini [15]. 
There are three recognised subspecies of African buffalo – the Cape buffalo (Syncerus caffer 
caffer), the West African buffalo (Syncerus caffer brachyceros) and the Forest buffalo 
(Syncerus caffer nanus). Both the Cape and West African buffalo are found in African 
savannah regions, while the forest buffalo inhabits the rainforests of western and central 
Africa [16,17]. A fourth subspecies, the Central African Savannah buffalo (Syncerus caffer 
aequinoctialis), has also been proposed. The majority of the population structure, ecology 












1.5 Disease Risk Management (South Africa) 
The South African Department of Agriculture, Forestry and Fisheries established the Disease 
Risk Management Directive (2002) to provide guidelines for disease risk management in 
buffalo [19]. This document outlines the regulations with regard to buffalo movement, 
breeding and disease-testing within the provinces and disease zones in South Africa. The role 
of buffalo as a maintenance host and reservoir of foot-and-mouth disease (FMD), corridor 
disease (CD), bovine tuberculosis (BTB) and brucellosis (CA) make these diseases the 
primary focus of the control policy. 
Any land in South Africa used for keeping buffalo must be registered, and the disease status 
of the buffalo must be disclosed. All registered farms and their fences must be inspected 
annually by a State Veterinarian, and all buffalo must be tested for all relevant diseases 
before movement. For BTB, the SCIT (single comparative intradermal tuberculin) test is the 
required standard of testing. In BTB endemic areas, three to five consecutive negative skin 
tests are required 3 months apart, while in quarantine, before an animal is accepted as BTB 
free. Outside endemic areas, the interferon-gamma test may be used to determine disease 
status. The breeding of disease-free buffalo in South Africa for stocking other farms and 
conservancies is considered essential, given the current BTB prevalence and spread in certain 
areas. The movement of all buffalo and buffalo products, to and from breeding facilities, is 
strictly controlled with permits. 
1.6 Economic significance 
African buffalo are a species of great economic significance. Designated one of the „Big 
Five‟ most dangerous African animals, the buffalo plays an important role in the tourism 
industry. The ecotourism industry in South Africa alone generates billions of rands annually, 
so the importance of the Big Five cannot be underestimated. Wildlife utilization in the form 
of trophy hunting is also a lucrative industry, and sustainable hunting tourism, or 
conservation hunting, is becoming widely accepted as an important tool in conservation, job-
creation and rural development [20,21]. Buffalo are the most economically important species 
in the hunting industry in southern Africa, as they are one of the most sought after dangerous 
game trophies, and the addition of buffalo to hunting packages significantly increases their 
value and marketability [22]. In South Africa, the average price for a buffalo trophy is 
approximately US $11,000, far exceeding the price in surrounding countries. Lindsey et al. 




(2007) calculated that more than 160,000km2 of land in South Africa is utilised for trophy 
hunting, hosting approximately 8500 foreign hunters and generating upward of US $100 
million revenue per year. 
The establishment of breeding programmes for hunting, ecotourism and the stocking of other 
parks and conservancies create a constant demand for buffalo, and prices have continued to 
increase accordingly. The market value of buffalo within South Africa also varies according 
to disease status, with „disease-free‟ buffalo fetching approximately 10 times that of their 
counterparts at auction. As demand and prices for „disease-free‟ buffalo (free of BTB, 
corridor disease, brucellosis and foot and mouth disease) increased, more breeding farms 
were established to benefit from this opportunity. Today there are more than 130 buffalo 
breeding farms in the Mpumalanga province alone [23]. The breeding of genetically and 
phenotypically superior buffalo bulls for hunting purposes places an even higher price on 
excellence - the auction price of an exceptionally large-horned buffalo bull for trophy 
breeding recently reached R40 million [24].  
 
2. Bovine tuberculosis 
 
2.1 Origin and History 
Evidence suggests that the common ancestor of the Mycobacterium tuberculosis complex 
emerged approximately 40,000 years ago in East Africa. Two independent clades then 
evolved: one diversified in humans, resulting in the M. tuberculosis lineages, and the other 
spread from humans to animals, resulting in the other members of the complex, including 
Mycobacterium bovis [25]. The disease caused by M. bovis infection was termed „bovine 
tuberculosis‟ as reference to the principal host of this pathogen, cattle. However, the term is 
commonly used to describe M. bovis infection in any animal species. It has been suggested 
that BTB emerged in northern Italy and spread to Western Europe and the United Kingdom, 
whereafter it was transported across the world via infected cattle during the colonial 
expansions of the Netherlands and the United Kingdom [26,27]. BTB distribution across the 
world in the latter half of 2012 can be seen in Figure 3. 





Figure 3: Reported disease information for BTB from July-December 2012, in cattle or wildlife [28]. 
 
In South Africa, bovine TB was first reported in cattle in 1880, and in wildlife (Greater kudu, 
Tragelaphus strepsiceros) in the Eastern Cape Province in 1928. Circumstantial evidence 
indicates that BTB entered the KNP from the south in the late 1950‟s or early 1960‟s, after 
buffalo grazed with infected cattle in the Komatipoort/Malelane region [27]. The economic 
impact of increasing incidence of BTB in cattle led to the implementation of a National BTB 
control and eradication scheme in 1969 [29]. The first case of BTB in buffalo in HiP was 
diagnosed in 1986, and in KNP in 1990 [30,31].  
2.2 Mycobacterium bovis 
Mycobacterium bovis is an aerobic, non-motile Gram-positive bacillus that forms part of the 
Mycobacterium tuberculosis complex (Figure 4). Other members of this complex include M. 
tuberculosis, M. pinnipedii, M. africanum, M. microti, M. canettii and M. caprae [32]. M. 
tuberculosis is specifically adapted to human hosts, and although it has occasionally been 
isolated in other animals, it does not appear to sustain itself in these populations, but rather 
results as an opportunistic infection through the close proximity of humans and animals. M. 
pinnipedii, M. africanum and M. microti and M. caprae are commonly found in seals, 
primates, voles and goats, respectively [32]. M. bovis shows the widest host range of any of 
the members of the tuberculosis complex; while predominantly isolated from cattle, M. bovis 
has been found to infect many other domestic and wildlife species such as pig, sheep, dogs, 




cats, buffalo, badgers, possums, antelope, deer, bison, cheetahs, lions and many others, 
including humans [33]. It is a hardy pathogen that has been reported to survive in cow faeces 
for up to 5 months, and in soil for up to 2 years [34]. 
Despite the different host specificities of the strains, the M. tuberculosis complex members 
show a 99.9% similarity at the nucleotide level, and M. tuberculosis and M. bovis show a 
sequence divergence of only 0.05% [32]. The complete genome sequence assembly of M. 
bovis identified approximately 4000 genes within the 4.3 MB genome [35]. When identifying 
M. bovis isolates/strains, the most commonly used DNA typing methods are spoligotyping, 
which measures the unique number of spacer sequences located in the direct repeat region of 
the chromosome, and variable number of tandem repeats (VNTR) typing, which measures 
variation at multiple loci across the chromosome [32]. Michel et al. (2009) examined the 
genetic diversity of M. bovis strains in KNP and HiP (and its associated game reserves) using 
an integrated genotyping and spatial analysis study. Strain typing of 189 M. bovis isolates 
showed that unrelated strains were responsible for the BTB epidemics in KNP and HiP, 




Figure 4: Evolutionary relationships of the M. tuberculosis complex (adapted from Huard et al., 
2006). 
 




2.3 Transmission and pathogenesis 
M. bovis transmission occurs mainly via respiratory or alimentary processes. Respiratory 
transmission occurs when open pulmonary lesions result in mycobacteria becoming 
aerosolized in the respiratory tract and transmitted via breathing or coughing. This is the most 
common form of transmission within human and cattle populations [34,38]. Alimentary 
transmission occurs either via the uptake of mycobacteria-contaminated material such as 
sputum, draining sinuses, urine or faeces, or the consumption of primary infected material 
such as meat or internal organs. This is the main route of infection in carnivores. 
Percutaneous transmission has also been documented in kudu, where contaminated thorns 
scratch the skin of the animal and introduce mycobacteria in this manner, and in large 
predators with the introduction of M. bovis into fight wounds [27].  
In cattle, it is generally accepted that infection occurs primarily through inhalation of 
aerosolised bacteria that lodge within the respiratory tract, most likely the alveolar surface of 
the lung. The bacteria are then phagocytosed by macrophages, the preferred host cell of 
mycobacteria, eliciting the innate immune response. The aggregation of macrophages and T 
lymphocytes at the site of infection results in the formation of granulomas, or „tubercles‟ 
[34]. The innate immune response includes, but is not limited to, the production of lysosomal 
hydrolases, bactericidal peptides and toxic reactive oxygen. If these measures fail to destroy 
the bacilli, the macrophages process the mycobacterial antigens and present them to the T-
lymphocytes [38,34]. This stimulation of T-lymphocytes activates the acquired immune 
response and causes the release of IFNγ and stimulation of the CD8+ T cell cytolytic activity, 
which enhance the defence system [39]. The cell-mediated immune (CMI) response is most 
active in earlier stages of diseases, and wanes as disease progresses, while antibodies develop 
with increased bacterial load and disease progression (Figure 5). Under particular 
circumstances, such as disseminated TB, cattle can become anergic and have no detectable 
CMI response, although they still exhibit high levels of antibodies [38]. 
Buffalo generally display a lesion development pattern that is consistent with aerosol 
infection, thus inhalation is assumed to be the primary route of transmission. BTB positive 
buffalo typically develop lesions in the lymph nodes of the head, tonsils, lungs and thoracic 
lymph nodes within the first 3-6 months of infection, after which the infection spreads by 
local expansion or through the blood/lymph vessels to more distal sites. Lesions may progress 








Figure 5: Comparison of the CMI and antibody immune responses with increasing disease pathology 
in cattle [38]. 
 
2.4 Maintenance and spill-over hosts 
A species is considered a reservoir/maintenance host for a particular disease when it 
maintains an infection through horizontal transfer within a population in the absence of other 
sources of infection [27]. Many countries have successfully eradicated or significantly 
reduced bovine tuberculosis in cattle within their borders, but the effectiveness of BTB 
control programmes is drastically reduced in countries that have a wildlife maintenance host 
[40].  Buffalo are particularly well suited to act as wildlife maintenance hosts due to aspects 
of their population dynamics and ecology, such as their social herd structure, large population 
size and high susceptibility to BTB, all of which promote easy transmission of M. bovis 
between individuals [40,41]. BTB maintenance hosts have been identified in other countries, 
and include the brushtail possum (Trichosurus vulpecula) in New Zealand, the Eurasian 
badger (Meles meles) in the United Kingdom and the European wild boar (Sus scrofa) in 
Spain [42].  




Maintenance hosts enable the persistence of BTB within wildlife populations, and the 
transmission of M. bovis between wildlife species and to livestock. Spill-over hosts are those 
that acquire the infection from maintenance hosts, but have a limited ability to maintain the 
disease within the population in the absence of repeat infection events [27]. Many spill-over 
hosts of BTB have been discovered, including baboons (Papio ursinus), leopards (Panthera 
pardus), cheetah (Acinonyx jubatus), impala (Aepyceros melampus), kudu (Tragelaphus 
strepsiceros), warthogs (Phacochoerus africanus) and lions (Panthera leo) [29]. Established 
transmission routes of bovine TB within South Africa can be seen in Figure 6. 
 
 
Figure 6: Established transmission routes between the maintenance and spill-over hosts in a South 
African context. 1–aerosol transmission, 2-ingestion, 3-percutaneous transmission, 4–horizontal 
transmission, 5–vertical transmission. Adapted from Biet et al. (2005). 
 
2.5  Impact of infection 
The role of buffalo as pathogen reservoirs within the game reserves of South Africa could 
result in major economic, ecological and public health impacts, on other animal species as 
well as the surrounding livestock and farming communities [34,43]. Economic losses are 




suffered in the agricultural sector through the loss of productivity or slaughter of infected 
livestock, as well as by the negative impact of M. bovis infection on the international trade of 
animals and their products [34,40,44]. The maintenance of BTB also results in enormous 
economic losses through the continuing need for a BTB eradication scheme, which includes 
the cost of the cattle and/or wildlife testing programmes, as well as re-imbursement for 
slaughtered animals, where countries offer such compensation. The sale of wildlife between 
game reserves and to zoos around the world is compromised or prevented by the risk of BTB 
movement; at the very least, expensive testing and quarantine measures must be 
implemented. This is also problematic for species for which there is no established diagnostic 
test available, requiring a huge investment in research and development of tests prior to 
animal sale [26]. Spill-over of BTB into other wildlife species of ecological and economic 
importance, such as the lion, is of additional concern. Predators become infected either 
through the consumption of infected prey, or through aerosol transmission during prey 
capture. Lions are severely and fatally infected by BTB, and as a key predator species, this 
may have enormous consequences for the ecosystem [29]. 
Zoonotic diseases such as BTB can also be transmitted from animals to humans, which poses 
a growing public health concern. The incidence of TB in humans caused by M. bovis is 
accepted to be negligible in the developed world, but the situation is very different in 
developing countries. The close proximity of human, wildlife and livestock at interface 
zones, the regular consumption of unpasteurised milk and other dairy products, and the lack 
of BTB testing and/or control in many cattle herds make the risk of TB in humans due to M. 
bovis in developing countries significantly greater [26,42]. This is particularly concerning in 
areas with a high HIV prevalence, such as the rural communities surrounding many of South 
Africa‟s national parks, since HIV patients have significantly increased susceptibility to 
tuberculosis. This may also place an increased burden on health care systems [26,29,40,42].  
 
3. Host Genetics 
 
3.1  General 
Investigating the genetic variation found between individuals, populations or species 
facilitates the understanding of the heritability of traits and phenotypes, and is a commonly 
utilised approach in conservation, disease susceptibility, and molecular ecology studies [45].  




In terms of disease, there are many aspects involved in the outcome of infection by a 
pathogen. The host genome is one such factor, and plays an important role in determining 
whether an exposed individual will remain uninfected, become infected but remain 
asymptomatic, or become infected and progress to active disease. Other variables include 
environmental factors and the genome of the pathogen, and together these elements 
determine the disease risk profile of an individual (Figure 7) [44] . It is now widely accepted 
that the variability seen in disease response in cattle, both between breeds and between 
individuals, has a genetic component.  Concerns about vaccination and/or drug therapy in 
livestock animals has generated increased interest in the development of alternative, non-
chemical means of disease prevention, such as the breeding of genetically resistant animals. 
For many diseases, the genetic resistance component is polygenic, i.e. under the influence of 
many genes, and thus the resistance bred into a breed or population is unlikely to be absolute. 
However, breeding for genetic resistance could be a powerful tool when used in conjunction 
with other management strategies [47]. 
 
 
Figure 7: Factors influencing the disease profile of an individual following mycobacterial infection 
(adapted from Casanova and Abel, 2002). 
 
While health and reproductive traits have been selected for in breeding programs for many 
years, it is only more recently that regional or national schemes have begun to incorporate 




disease traits. Despite relatively low heritability estimates, breeding programs have been 
successfully implemented in cattle for resistance to diseases such as mastitis (Scandinavia) 
and brucellosis (Texas). The decreasing cost of molecular genotyping will facilitate the large-
scale typing of Quantitative Trait Loci (QTL) and DNA markers, making genetic selection 
for disease resistance using breeding programs a more feasible option in the future. This 
principal could be applied to the breeding of buffalo with greater BTB resistance [47]. 
3.2  SNP discovery 
The genome assembly of many different species has provided a wealth of genetic information 
for use in research. However, when the species of interest does not have an assembled 
genome and there is only limited genetic information available, sufficient data must first be 
generated in order to identify the genetic variants present in a population [49,50]. Sequence 
information can take many forms – microsatellite loci, mitochondrial DNA, single nucleotide 
polymorphisms (SNPs) and restriction fragment length polymorphisms (RFLPs) are all 
commonly used types of genetic data, and each has specific advantages and disadvantages. 
African buffalo studies to date have primarily utilised markers such as microsatellites, 
mitochondrial DNA and Y chromosomal loci to answer population and genetic diversity 
questions [7,2].  
For association studies in disease resistance, SNP data is likely to be the most informative, as 
particular genes known to be involved in the immune system can be targeted. SNPs also have 
numerous other benefits: they are abundant, easy to score and enable high-throughput 
screening [51]. Large-scale SNP discovery in the African buffalo would greatly facilitate 
further research in disease genetics, as well as inform other studies. The development of next-
generation sequencing technologies has enabled a faster and more cost-effective approach to 
large-scale SNP discovery. The sequence reads obtained from next-generation sequencing 
platforms provide a plentiful source for the identification and characterisation of novel SNPs, 
which can then be used for future applications. For non-model organisms, however, there 
must be a closely related species with an assembled genome against which the sequence reads 
can be mapped [45,52]. 
3.3  BTB genetic studies 
Experimental animal models, using gene knockout, recombinant and transgenic individuals, 
have provided the foundation for the elucidation of complex disease traits, such as TB. Early 




studies into BTB resistance utilised inbred strains of rabbits to demonstrate the heritability of 
BTB resistance/susceptibility. After infection with M. bovis, the rabbits displayed either a 
resistant or susceptible phenotype, suggesting that this phenotype was genetically inherited 
[53]. Mouse models have also been extensively utilised in TB studies. Gros et al. (1981) 
discovered that susceptibility to the M. bovis BCG (Bacille Calmette-Guerin) strain was 
controlled by a single genetic factor. This gene was named Bcg, which later became the 
natural resistance-associated macrophage protein gene, Nramp1. As early as the 1930‟s, 
evidence suggested that different cattle breeds showed differential susceptibility to BTB. 
Zebu cattle were shown to have increased resistance to BTB in both India and Uganda, and 
within breeds, Simmental and black pied lowland cattle showed differential BTB 
susceptibility in offspring from different sires [55]. More recent studies on host genetic 
susceptibility to BTB in both wildlife and cattle are extensively covered in Chapter 3. 
 
4. Disease Prevalence and Management 
 
4.1 BTB Control strategies 
Many developed countries have had great success in eradicating or drastically reducing BTB 
prevalence in cattle using regular tuberculin test and slaughter policies. Repeated test and cull 
events have resulted in the essential eradication of bovine TB in Australia, Switzerland, and 
Canada. Unfortunately, this is often not affordable or feasible in many developing countries, 
and these efforts are also severely compromised in any country with a wildlife maintenance 
host of BTB [56,26]. Other constraints in the eradication of this disease include the 
limitations and availability of diagnostic tests and the control of animal movements and trade 
[57]. Standard test and slaughter schemes using the tuberculin skin test involve the 
confinement of animals for 72 hours until the test results can be read, after which BTB 
positive individuals are destroyed, and BTB negative animals are released. One of the main 
disadvantages of this policy is the low or variable sensitivity of the tuberculin test – low 
sensitivity estimates mean that infected individuals can be missed and released back with the 
herd. In addition, there are concerns that the close confinement of a herd for 72 hours, under 
stressful conditions, may exacerbate the transmission of BTB during that time [27].  




The use of a vaccine to control the spread and infection of BTB would provide a publicly 
acceptable and feasible method of control, as an alternative to, or in conjunction with, lethal 
sampling. The BCG vaccine has been extensively tested in humans and cattle and is safe, 
inexpensive, and suitable for oral delivery, all of which make it appropriate for wildlife [56]. 
However, the vaccine sensitises animals to tuberculin, which can compromise the 
effectiveness of future diagnostics. The protection it confers is not complete, but in a wildlife 
context, incomplete protection may be enough to substantially slow the spread of disease. 
The delivery of a vaccine can be problematic - while oral bait has met with limited success in 
some wildlife species, it is far more challenging for those in protected areas and/or where 
supplementary feeding is inappropriate [56]. Vaccination also does not hold equal promise 
for all species. Vaccination in possums showed a 95% efficacy, while vaccination studies in 
cattle have found highly variable protective immunity [56]. In buffalo, the BCG vaccine 
showed no significant protection against experimental challenge with M. bovis, and 
consequently this does not seem to be a viable control strategy for this species at this time 
[58].  
4.2 Diagnostics 
The accuracy of the diagnostic method used to detect M. bovis infection is crucial in 
managing BTB in cattle and wildlife. The most commonly used method in South Africa is the 
tuberculin skin test, specifically the single comparative intradermal tuberculin (SCIT) test. 
The SCIT test measures dermal swelling due the cell-mediated immune response 72 hours 
after the injection of purified protein derivative in the skin of the neck or caudal fold. 
Comparisons are made between the reaction to avian and bovine tuberculin, to eliminate 
cross reactions due to exposure to other non-tuberculous mycobacteria. Disadvantages of the 
SCIT test include the difficulty/logistics of administration, the variability in interpretation of 
results and the low degree of standardisation. However, despite these limitations, it remains 
the most accurate test available, and shows a sensitivity of 55.1-93.5% and a specificity of 
88.8-100% in cattle [57]. Unpublished data suggests that the SCIT test in buffalo may have a 
sensitivity and specificity of 80.9% and 90.2%, respectively, but this has yet to be officially 
validated [31]. 
The interferon-gamma (IFNγ) test is a lab-based test that measures the in vitro cell-mediated 
immune response by quantifying the relative IFNγ levels after stimulation with avian and 
bovine tuberculin [57]. The advantages of this test are increased sensitivity, rapid testing and 




that no follow up is required. However, the disadvantages include reduced specificity, high 
cost and increased likelihood of non-specific response in young animals. In cattle, sensitivity 
estimates are 73-100%, and specificity estimates are 85-99.6% [57]. In buffalo, IFNγ release 
assays (IGRA) have shown sensitivities of approximately 93% and specificities of 68-85% 
[59]. False positives have been observed when using the standard protocol for IGRA, and this 
is thought to be a result of sensitisation from environmental mycobacteria. Modification of 
the standard protocol with the addition of M. fortuitum PPD increased the specificity without 
compromising sensitivity, and this protocol has been used in the Kruger National Park since 
2000 [59]. 
 
5. Scope of the thesis 
The research reported in this thesis addresses the role of genetic factors in the susceptibility 
to bovine tuberculosis in the African buffalo, and the practical applications of such 
information.  
The annual prevalence of BTB within the African buffalo population in Hluhluwe iMfolozi 
Park was investigated over a seven year period, at the herd and area level, to identify the 
extent of the epidemic and investigate changes in BTB prevalence over time (Chapter 2). 
This allowed the evaluation of the test and cull operation that is currently in place in the park, 
and which parameters of the operation may be the most important. A test and cull operation 
functions essentially like a small-scale breeding scheme, where susceptible animals are 
removed over time, and it is important to understand the parameters that are required for this 
to effect a change.  
While much research has been done in characterising the genetic component of susceptibility 
to human tuberculosis, the same is not true for bovine tuberculosis, particularly in wildlife 
species. A review of studies of the genetic susceptibility to BTB in cattle and wildlife was 
compiled in order to efficiently gather all the information in this area, address some 
considerations that must be taken into account in studies such as these, and make future 
suggestions for work in this area (Chapter 3). 
In order to generate new genetic data for this non-model species, next-generation sequencing 
was performed on African buffalo samples and the sequence reads were mapped to the 




domestic cow (Bos taurus) genome (Chapter 4). This enabled the identification of novel 
SNPs throughout the buffalo genome. Different software packages were used to compare and 
optimise the mapping of non-model organism sequences to a reference genome of a different 
species, as well as to identify the variants found. A subset of the SNPs identified were 
validated using fluorescent genotyping. A total of 69 candidate polymorphisms, located in 
genes involved in the immune response, were then selected from the SNP subset validated in 
Chapter 4. These SNPs were fluorescently genotyped in the full sample set of African buffalo 
(n=868) and tested for genetic associations with BTB infection status using a case-control 
approach (Chapter 5). 
When performing next-generation sequencing, only a percentage of the genome of interest is 
represented in the final data set. Because of this, specific regions or genes of interest to the 
researcher may not have been sequenced using this technology, and may benefit from a more 
thorough characterisation. This characterisation was performed on the African buffalo 
NRAMP1 gene, in order to provide a more extensive picture of the variation and structure of 
this gene (Chapter 6). Novel SNPs identified will then be available for use in future 
association studies. 
Finally, the suitability of using genetic information, such as was identified in this body of 
work, in a selective breeding program for increasing BTB resistance in African buffalo, was 
reviewed as an alternative and sustainable disease management strategy (Chapter 7). Main 
lines of evidence for the heritability of BTB resistance were discussed, factors that must be 
taken into account in selective breeding programmes were considered, and the three main 
types of breeding programmes were evaluated, with emphasis on how these approaches might 
be applied to African buffalo. 
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Providing an evidence base for wildlife population management is difficult, due to limited 
opportunities for experimentation and adequate study replication at the population level. We 
took advantage of a rare opportunity to assess the outcome of a test and cull programme 
aimed at limiting the spread of an important pathogen, M. bovis, in African buffalo. Buffalo 
act as reservoirs of Mycobacterium bovis, the causative agent of BTB, which can have major 
economic, ecological and public health impacts through the risk of infection to other wildlife 
species, livestock and surrounding communities. BTB prevalence data were collected in 
conjunction with disease control operations in Hluhluwe-iMfolozi Park (HiP), South Africa, 
from 1999-2006. The control programme utilised a mobile boma to capture buffalo, targeting 
different areas within the park each year. Throughout the study period, 4733 buffalo (250-950 
per year) were tested for BTB using the single comparative intradermal tuberculin (SCIT) 
test, with BTB-positive animals culled, and negative animals released back into the park. 
BTB prevalence in HiP was extremely spatially and temporally variable, ranging from 2.3% 
to 54.7%. Geographic area was a strong predictor of BTB transmission in HiP, owing to 
relatively stable herds and home-ranges. Our data suggests that HiP‟s test and cull 
programme is effective at reducing BTB transmission in buffalo herds: herds experiencing 
more intensive and frequent captures showed reduced per capita disease transmission risk and 
less increase in herd prevalence over time, disease hotspots did not expand spatially over 
time, and BTB prevalence in all but the hotspot areas was maintained at a prevalence between 
10-15% throughout the study period. We hope that future collaborative work between 
wildlife managers, veterinarians and scientists will build on these encouraging findings to 
optimise wildlife disease control programmes and mitigate conflict at the interface of 
conservation, agricultural and urban areas. 
Keywords: bovine tuberculosis, Mycobacterium bovis, African buffalo, prevalence, test and 
cull, wildlife management, disease control 
 
1. Introduction 
Despite increasing awareness and research in animal diseases, wildlife-livestock-human 
interfaces continue to expand, and the role of wildlife species in the transmission of 
pathogens continues to grow [1]. Interface expansion increases with human population 
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growth and encroachment into wildlife areas, as well as intensifying and expanding livestock 
practices.  These practices will continue to grow over time, thus highlighting the need for 
cross-disciplinary collaboration in the design and implementation of viable disease 
management strategies [1]. Commonly referred to as bovine tuberculosis (BTB), M. bovis 
infection is a highly infectious disease that is widespread amongst domestic cattle (Bos 
taurus) and endemic in a number of wildlife populations around the globe, including the 
brush-tailed possum (Trichosurus vulpecula; [2]), European badger (Meles meles; [3]), and 
African buffalo (Syncerus caffer; [4,5]). In southern Africa, buffalo act as the primary 
maintenance host for BTB. Several aspects of their population dynamics and ecology, such as 
their social herd structure, large population size and high susceptibility to BTB,  promote 
easy transmission of M. bovis among buffalo [6,7]. BTB has been detected in several buffalo 
populations in southern Africa and can reach high prevalence within herds. In the Kruger 
National Park, zone prevalence ranged from 0-27.1% in 1991/2, and 1.5-38.2% in 1998 [8], 
and in Queen Elizabeth National Park (QENP) in Uganda, BTB prevalence was 21.6% in 
1997 [9]. Studies have shown that buffalo herds with a high BTB prevalence exhibit 
increased parasite load and reduced body condition, adult survival and fecundity when 
compared to herds with a low BTB prevalence [4,10,11].  
Wildlife pathogen reservoirs for BTB pose a risk of infection to domestic livestock and 
humans, particularly in developing countries where humans, livestock and wildlife live in 
close proximity to one another [5,12]. Economic losses are incurred through the loss of 
productivity and/or slaughter of infected livestock, as well as by the negative impact of M. 
bovis infection on the international trade of animals and their products [7,13,14]. The impact 
of transmission to other wildlife species has enormous consequences for biodiversity, 
ecotourism and commercial game farming, and can severely compromise species 
conservation efforts [5,7,15]. M. bovis is also zoonotic and can thus be transmitted from 
animals to humans, which poses a potential public health concern, particularly in HIV 
prevalent areas such as southern Africa, since HIV patients have a significantly increased 
susceptibility to tuberculosis [5,15].  
Bovine tuberculosis was first detected in African buffalo in Hluhluwe iMfolozi Park (HiP), 
located in the KwaZulu Natal region of South Africa, in 1986 [4]. HiP is one of South 
Africa‟s flagship conservation areas due to its rich mammal and avian fauna, and is the 
source of most of southern Africa‟s restored white rhino population [16]. HiP‟s ability to 
export rhino and other animals to protected areas around the subcontinent is thus at the heart 
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of its biodiversity conservation mission, and BTB poses a clear threat to this mission. Buffalo 
are considered to be the primary maintenance host of BTB in HiP, with M. bovis infection 
subsequently documented in lion (Panthera leo), baboon (Papio ursinus) and greater kudu 
(Tragelaphus strepsiceros) [12]. Comprehensive surveys were conducted from 1998 to assess 
the prevalence of BTB in African buffalo in different regions of HiP (Figure 1). This data 
identified Masinda and Makhamisa as „trouble‟ areas with particularly high BTB prevalence, 





Figure 1: Map depicting regions of Hluhluwe iMfolozi Park. Pie charts depict the proportion of BTB 
infected and uninfected individuals in the first year of testing in that region, with numbers indicating 
the percentage infected. Mbhuzane, Makhamisa and Manzibomvu capture sites correspond with area 
names. Red pie chart = Gunjaneni capture site. Purple pie chart= Corridor capture site (spanning 
northern Masinda and Nqumeni). Blue pie chart= Masinda south capture site. The total number of 
animals in the first year of testing, for each area, were: Makhamisa=261, Mbhuzane=420, Masinda 
south=122, Corridor=520, Gunjaneni=207 and Manzibomvu=132. 
 
BTB is notoriously hard to control in wildlife. Test and cull programmes have been 
implemented in the United Kingdom for many years in an attempt to control the prevalence 
and transmission of BTB in the European badger and cattle, but have met with mixed success 
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[17,18]. Thus far, the only example of complete eradication of BTB was achieved in 
Australia, where the culling and eradication of an introduced wildlife host was aggressively 
undertaken. A similar approach in New Zealand, with the culling of brush-tailed possums, 
has made significant progress, although it has yet to achieve the success of the Australian 
programme.  However, such an aggressive approach to culling (and local eradication of a 
species) cannot be employed where the host species is endemic, and/or has an economic or 
social value [19]. 
HiP‟s BTB control programme aims to limit the prevalence of the disease in buffalo, in an 
attempt to protect the park‟s other mammal species from infection, and enable continued 
movement of animals from HiP to other public and privately-owned conservation areas. The 
programme uses a mobile capture boma to target different areas within the park on a 
rotational basis. Each area is processed at least every 4-5 years, with more heavily infected 
areas targeted more frequently. All captured buffalo are tested for BTB, positive animals are 
culled and animals with a negative test result are released back into the park. The objectives 
in this study were to determine the annual prevalence of BTB within the African buffalo 
population in Hluhluwe iMfolozi Park over the seven year period from 1999-2006. 
Prevalence changes over time were analysed to evaluate the effectiveness of the test and cull 
programme in limiting BTB prevalence in the buffalo population. Programme effectiveness 
was addressed with respect to the original aims of the operation, which were: (1) to reduce 
prevalence in disease hotspots, and (2) prevent increase of BTB in the more moderately 
affected areas.  
 
2. Materials and Methods 
2.1 Study Area, BTB Control Programme and Sampling 
Data was collected from Hluhluwe-iMfolozi Park in the KwaZulu Natal province of South 
Africa from 1999-2006. The park, situated at 28° S and 31-32° E, was established in 1895 
and occupies approximately 950km2. During the 1999-2006 study period, the park‟s buffalo 
population numbered between 3000-5000 animals [20], which occurred in herds of 70-200 
animals occupying well-defined home ranges [21]. Between 250-950 buffalo were tested for 
BTB annually. Buffalo herds were captured at different focal sites each year, representing 
distinct areas and buffalo subpopulations within the park - Makhamisa, Mbhuzane, Masinda 
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south, Corridor (northern Masinda and Nqumeni), Gunjaneni and Manzibomvu (Figure 1). 
The design and implementation of this disease control program required methods and 
equipment suitable for mass capture in the field. Moveable bomas were utilised to contain the 
buffalo herds that were brought in from distances between 0.5-5km away (Figure 2). Animals 
were spotted from the air, and a helicopter was used to guide the animals into a capture 
funnel that connected to the boma (Figure 2a). The funnel area was closed off with wire and 
hardware-cloth curtains as soon as a herd was inside, to prevent the buffalo from running 
back out (Figure 2b). Once in the boma structure, buffalo were partitioned into small groups 
and immobilised (Figure 2c) using etorphine hydrochloride (M99) and azaperone according 
to standard operating procedures (SOPs) developed by KwaZulu-Natal Wildlife‟s game 
capture veterinarians. Buffalo remained immobilised for approximately 10-30 minutes for 
BTB testing and data collection, followed by reversal of immobilisation using diprenorphine 




Figure 2: Buffalo capture set-up for the BTB disease control programme at HiP. a. A mobile metal 
boma and capture funnel are set up within a targeted buffalo population‟s home range. b. The funnel 
curtains are drawn closed as soon as the buffalo herd has entered the funnel. c. Gangways leading to 
the holding pens are equipped with sliding doors for separating animals into small groups. Buffalo are 
immobilized from a bridge, using a pole syringe. d. BTB intradermal skin testing: BTB antigen is 
injected on the left side of the neck, avian tuberculin is injected on the right side. 
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Not all animals from a given herd were typically captured, because herds would split into 
several groups while being herded towards the boma by the helicopter. While the animals 
were immobilised, each animal‟s age, sex, and any brand marks from previous captures were 
recorded. Age was estimated using tooth emergence, body size and horn development in 
animals less than 5 years old. Adult buffalo were aged using tooth wear as an indicator, by 
measuring the height of incisor 1 [20]. All captured buffalo were branded with a year-specific 
brand on one buttock, and a herd-specific brand on the other. The herd provenance of 
previously captured animals could thus be established, and the years of their previous 
negative BTB tests. 
2.2 BTB diagnosis 
Buffalo were tested for BTB using the single comparative intradermal tuberculin (SCIT) test. 
Small amounts of pure protein-derived (PPD) tuberculin prepared from M. bovis (PPD-B) 
and Mycobacterium avium (PPD-A) were injected into opposite sides of the neck of the 
animal (Figure 2d). Skin fold thickness was measured prior to injection and after 72 hours, 
with swelling indicating prior exposure to M. bovis or M. avium. A test result was considered 
positive when the difference in skin fold thickness at the injection site, at the time of injection 
vs 72 hours later, exceeded 2mm, taking into account the physical characteristics of the 
reaction. The avian tuberculin is used to distinguish between non-specific mycobacterial 
exposure and BTB infection, in order to exclude false positive results and thus improve test 
specificity. Thus, test results were interpreted as negative if swelling in response to avian 
tuberculin was as pronounced as swelling at the bovine tuberculin injection site. The 
comparative intradermal tuberculin test has been shown to have a sensitivity of 77-95% and a 
specificity of 96-99% in cattle [22]. Data from African buffalo, (J.P. Raath, unpubl.) suggest 
a test sensitivity and specificity of 80.9% and 90.2% in buffalo, respectively [4]. SCIT testing 
was performed by park and state veterinarians, and upon diagnosis BTB positive animals 
were slaughtered and BTB negative animals released back into the park.  
2.3 Data Analysis 
2.3.1 Data Compilation 
The herd brands recorded during each capture were used to determine which animals were 
resampled in multiple years, and thus which sampling groups were associated with one 
another. Multiple sampling groups were considered to be components of a single herd if five 
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or more individuals of one group were resampled in another group at a subsequent time point. 
A sampling group association matrix was compiled to designate herds. Each herd was 
assigned to an area within HiP based on the capture site of the herd or component groups 
(Table 1).  
 
Table 1: Areas and herds sampled, by year. 
Area 
Herds 




    24,25,26,28 
[261] 














































Manzibomvu   12,13,14 
[132] 
  31,32,33,34 
[302] 
  
*Letters refer to herds sampled at multiple time points; numbers refer to herds only sampled once. Square 
brackets contain total number of animals tested for that area in that year. 
 
Individuals were assigned to the following age cohorts: 0-1 years, 2-3 years and 4+ years, as 
this was the highest level of accuracy obtainable from the data when including all capture 
years. Analyses were performed at both the area and herd levels. A contact network between 
areas was compiled to depict the number of branded individuals from area X that were 
subsequently re-captured in area Y, in order to assess the validity of the area-based 
classifications. 
2.3.2 Prevalence and incidence estimation 
Prevalence was calculated as the proportion of skin test positive animals out of the total 
number of animals tested in a given herd or area, and capture year. Herd level prevalence 
calculations were complicated by the fact that most captures did not include the entire herds, 
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and captured herd fragments are often biased in age composition (Jolles, pers obs). For 
example, adult females with calves may tend to run together, or groups of sub-adult animals. 
To adjust for this possible age bias, herd level prevalence was determined by calculating the 
age cohort BTB prevalence values for each herd. Herd prevalence was then estimated based 
on observed prevalence for each age group, weighted according to the age distribution seen in 
the entire dataset (approximately 4500 individuals). The age distribution observed in buffalo 
herds is largely insensitive to BTB prevalence [4]; as such, using the whole population 
average age distribution will not have introduced systematic error with respect to BTB 
prevalence. Area level prevalence was calculated using all animals within a particular region 
for each time point. All data reported are apparent prevalence values, as the true prevalence 
cannot be calculated without published diagnostic sensitivity/specificity data; error bars for 
prevalence data were generated according to the sensitivity and specificity estimates by Raath 
(unpubl. data).  
Incidence, i.e. the per capita risk of becoming infected with BTB over a given time period, 
was calculated as the proportion of new cases since last capture. To estimate incidence – a 
direct measure of disease transmission risk – we needed to distinguish new BTB cases that 
occurred in the time period between one capture and the next, from older infections that could 
have occurred prior to the initial capture time point. This was done using individuals that 
were younger than the time since last capture, and older individuals that were branded, i.e. 
had been caught and tested before. The branded individuals would have had to be negative at 
last capture, or they would have been culled. These criteria ensure that the incidence 
estimates were calculated using only new cases. Incidence over the time period between 
captures (1-4 years) was thus estimated as the fraction of BTB-positive animals (new cases) 
in the candidate groups (young and branded) described above. 
2.3.3. Spatial and temporal patterns of BTB prevalence 
Spatial and temporal patterns of prevalence were evaluated at the area level, because no herds 
were re-sampled consistently through time. Linear regression was used to detect overall 
temporal trends in BTB prevalence in the areas sampled over the total time period. Fisher‟s 
exact tests were used to calculate whether there were significant short-term changes in 
prevalence within the areas. Geographic variation in BTB prevalence was analysed visually 
by plotting prevalence over time for all areas (Figure 4a); statistical comparisons between 
areas are included in the analyses described below. 
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2.3.4. Analysis of factors driving changes in disease transmission in buffalo herds 
General linear mixed models were used to test whether the test and cull programme achieved 
reductions in disease transmission over time. We assessed two outcomes: (i) incidence (per 
capita risk of infection) from one capture time point to the next, and (ii) change in herd 
prevalence from one capture time point to the next. Variability among herd capture events in 
terms of exposure to the disease control programme was expressed in terms of (a) number of 
animals captured (capture effort), and (b) time interval between captures. Herd was included 
in our models as a random effect.  Thus, in the incidence analysis we asked: did greater 
capture effort, and/or more frequent captures, result in reduced BTB incidence? The 
independent variables considered were:  
- Capture effort: the number of animals caught in each herd during the previous time step. If 
the test and cull programme works, then a more thorough capture, where most animals in 
the herd are tested, and most BTB-positives removed, should result in reduced BTB 
incidence subsequently: We hypothesized that BTB incidence would be negatively 
associated with capture effort. 
- Capture interval: the number of years between successive test and cull events. The longer 
the interval between captures, the more opportunities for disease transmission to have 
accrued over time. We hypothesized that BTB incidence would be positively associated 
with capture interval. 
- Area: Different geographic areas within the park vary in their precipitation and 
temperature patterns, their vegetation and animal densities. Area might therefore affect 
BTB transmission, and we included area as a candidate variable in our models. 
We used Akaike‟s Information Criterion (AIC) to select the models most strongly supported 
by our data from the set of models, including all combinations of our candidate independent 
variables. We considered all models within 2 points of the lowest AIC score and selected our 
final models to include independent variables that were statistically significant at a cut-off 
value of α = 0.05. All analyses were performed in R version 2.15.2 (freely available from 
www.r-project.org). Reductions in disease incidence are the most direct measure of success 
for disease control programs; however, our estimate of incidence was based on a sub-sample 
of captured animals, because of the challenge of distinguishing new from established cases of 
BTB (see section 2.3.3. above). We ran our analyses with change in herd prevalence as the 
dependent variable as well, to test whether using an outcome that allowed us to include the 
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whole set of captured animals would return results that were congruent with the incidence 
analysis. Change in herd prevalence was computed simply as the difference in observed herd 
prevalence from one capture time point to the next. We included the same candidate 
independent variables and modelling approach in our analysis of change in herd prevalence 
as described above. Analogous to the incidence analyses, we hypothesised that change in 
herd BTB prevalence would be negatively associated with capture effort, and change in herd 
BTB prevalence would be positively associated with capture interval. 
 
3. Results 
3.1. Change over time in area BTB prevalence 
The number of individuals re-captured in their previously assigned area far exceeded the 
number of individuals re-captured in a different area, for every area combination tested 
(Figure 3). This supports the area-based classifications used for the subsequent analyses. 
 
 
Figure 3: Contact network of animals in different areas. Amount of contact between regions is 
measured in the number of branded animals from area X re-captured in area Y, per 1000 animals 
captured in area Y. 
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Area level prevalence was calculated for the Makhamisa, Mbhuzane, Masinda south, 
Corridor, Gunjaneni and Manzibomvu areas and ranged between 2.3% and 54.7% (Table 2). 
The south-west area of the park clearly stood out as a BTB hotspot. In Masinda south, BTB 
prevalences varied between 12 and 54%. BTB at Masinda increased in prevalence from 1999 
to 2000 (Fisher‟s exact test, p<0.0001), and decreased from 2001 to 2002 (p<0.0001), after 
which Masinda‟s area prevalence stabilized. The neighbouring Makhamisa area also showed 
high BTB prevalence (36%), but was sampled only once during the study period (due to 
difficult access in this road-less wilderness area). Areas outside the south-west corner of the 
park – Mbhuzane, Gunjaneni, Corridor and Manzibomvu showed more moderate BTB 
prevalences, mostly below 15%. BTB prevalence at Mbhuzane remained fairly stable around 
10% throughout the study period, as did BTB prevalence in the Corridor area, except for an 
unusually low prevalence of 5.5% observed in 2002 (prevalence reduction 2001-2002: 
Fisher‟s exact test, p=0.034; prevalence increase 2002-2005, p=0.044). Gunjaneni showed a 
similar pattern (prevalence reduction 1999-2001, Fisher‟s exact test, p<0.0001; prevalence 
increase 2001-2005, p<0.0001). Manzibomvu was sampled only twice during the study 
period. BTB prevalence was moderate with a decrease from 2001 to 2004 (Fisher‟s exact test, 
p=0.0136). Linear regression indicated no significant temporal trend for any of the area 
datasets over the total time period (Supplementary table S1).  
 
Table 2: Prevalence statistics for the HiP areas 
Year 
Makhamisa Mbuzane Masinda Corridor Gunjaneni Manzibomvu 
Prev N Prev N Prev N Prev N Prev N Prev N 
1999     0.254 122 0.090 520 0.140 207   
2000     0.473 260       
2001     0.547 494 0.114 149 0.023 175 0.152 132 
2002   0.124 420 0.120 108 0.055 274     
2003 0.360 261 0.120 276         
2004           0.073 302 
2005   0.112 205 0.145 62 0.103 300 0.205 127   
2006   0.066 106 0.138 109   0.125 72   
*N: total number of animals used for the prevalence calculations in each area at each time point 
 
 




Figure 4a: Prevalence of BTB infection from 1999-2006, in six areas at HiP. Vertical lines denote 





Figure 4b: Observed prevalence of BTB infection from 1999-2006 in ten buffalo herds. Vertical lines 
denote standard error bars. 
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3.2 Does the test-can-cull programme reduce BTB transmission in buffalo herds? 
Our dataset of herds that were resampled over time consisted of ten herds. Five herds were 
sampled twice (resulting in a single line of data, each, for change in BTB prevalence, or 
incidence), three herds were sampled three times (resulting in 2 lines of data each), and two 
herds were sampled four times (three lines of data), i.e. a total of 17 data points from the ten 
herds. AIC values are shown in supplementary tables S2 and S3, for BTB incidence and 
change in herd prevalence, respectively. 
For BTB incidence, our final model included area, capture effort and capture interval as 
independent variables (Table 3). BTB incidence was much higher in the southern Masinda 
area than in the Corridor, Gunjaneni or Mbhuzane. Concordant with our hypothesis, capture 
effort was negatively associated with BTB incidence – i.e. a larger number of buffalo being 
tested per herd was associated with a lower subsequent disease incidence. Capture interval 
was supported as a model parameter by AIC and returned a positive estimate (as 
hypothesised), but had no statistically significant effect on BTB incidence. 
 
Table 3: Results of general linear mixed model evaluating BTB incidence in HiP buffalo herds. 
 Estimate MCMC mean 95% CI pMCMC Pr(>|t|) 
Intercept 12.950 9.7967 -8.669, 31.087 0.3040 0.1499 
capt. interval 3.801 4.2164 -2.383, 11.1987 0.2014 0.1182 
capture effort -0.105 -0.0967 -0.181, -0.0122 0.0282 0.0139 
area: Gun -4.495 -0.0001 -14.569, 15.0531 0.9986 0.6318 
area: Mas 52.427 54.0948 37.371, 71.2783 0.0002 0.0002 
area: Mbu 13.607 14.6796 -2.972, 33.8154 0.1048 0.1857 
 
 
The models for change in herd BTB prevalence yielded very similar results, with the best 
model also including capture interval, capture effort, and area (Table 4). Herds residing in 
Masinda south and Mbhuzane showed larger increases in prevalence from one capture to the 
next than herds in Gunjaneni or Corridor. Capture interval was positively associated with 
change in herd prevalence (Figure 5a), i.e. the greater the time interval between successive 
captures, the more herd BTB prevalence increased from the initial time point to the 
subsequent capture. Finally, capture effort was negatively associated with change in 
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prevalence, meaning that a more intensive test and cull effort was associated with a reduced 
increase (or possibly decrease) in herd BTB prevalence (Figure 5b). 
 
Table 4: Results of GLMM evaluating change in BTB prevalence in HiP buffalo herds. 
 Estimate MCMC mean 95% CI pMCMC Pr(>|t|) 
intercept -13.694 -13.5203 -32.7768, 4.9969 0.1416 0.1365 
capt. interval 11.713 11.6819 5.1939, 18.0682 0.0020 0.0024 
capture effort -0.108 -0.1087 -0.1912, -0.0306 0.0120 0.0125 
area: Gun -4.434 -4.6271 -18.0372, 9.2556 0.4672 0.4688 
area: Mas 30.628 30.5115 14.7904, 46.7031 0.0018 0.0012 
area: Mbu 20.556 20.3045 3.5970, 37.9821 0.0290 0.0212 
 
 
Overall, these results highlight massive variability in BTB transmission dynamics among 
geographic areas in HiP, and support the hypothesis that more intensive disease control 
efforts (in terms of test and cull programme frequency and efficacy) were associated with 




Figure 5a: Positive association between capture interval and change in prevalence. Change in 
Prevalence = -5.684 + 4.8123*x. 
 




Figure 5b: Negative association between capture effort and change in prevalence. Change in 




BTB prevalence in HIP was extremely spatially and temporally variable, ranging between 
2.3% and 54.7%. Geographic area was a strong predictor of BTB transmission in HiP, as 
assessed by our estimates of BTB incidence and change in BTB prevalence in buffalo herds. 
This may appear surprising, given the relatively small size of the reserve, and ability of 
buffalo to travel long distances. However, previous studies of the spatial ecology of buffalo at 
HiP, based on extensive radio-tracking, also concluded that buffalo herds in HiP appear to be 
remarkably stable and occupy well-delineated home ranges (Jolles, unpubl., [21]). Our 
analysis of recapture locations further supports that buffalo tend to remain within their 
original subpopulations at HiP. Variation in BTB transmission among geographic areas has 
many possible causes.  Variability in microclimate, substrate and habitat can affect host 
population contact patterns and susceptibility to infection, pathogen persistence in the 
environment, and exposure to parasites that might affect BTB transmission [23,24]. BTB 
prevalences observed at HiP bracket the range of prevalences seen in other buffalo 
populations in southern and East Africa (e.g. Kruger National Park, South Africa, 0-27.1% in 
1991/2, 1.5-38.2% in 1998 [8]; Queen Elizabeth National Park, Uganda, 21.6% in 1997 [9]). 
Although comparisons across studies are complicated by differences in time frame and 
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diagnostic methods used, it is clear that some areas within HiP had unusually high BTB 
prevalences, highlighting the fact that M. bovis is capable of infecting a very substantial 
proportion of animals in some buffalo populations.  
The data suggests that HiP‟s test and cull programme is effective at reducing BTB 
transmission in buffalo herds: herds experiencing more intensive and more frequent captures 
showed reduced disease transmission risk and lower increase in herd prevalence over time, 
disease hotspots did not expand spatially over time, and BTB prevalence (in all but the 
hotspot areas) was maintained at a low prevalence between 10-15% throughout the study 
period.  HiP‟s test and cull programme for BTB control, with its innovative, field-based mass 
capture technique for buffalo, thus represents a rare success story in the management of 
wildlife disease. However, these results should be interpreted with caution, particularly in 
contexts beyond HiP‟s buffalo population, for a number of reasons. First, despite our massive 
sampling effort, our dataset of re-sampled herds varying in disease control intensity was 
small, with only 17 data points from 10 buffalo herds: only moderately strong conclusions 
can be drawn from this data. Second, even though intensive, frequent captures may be most 
effective at reducing BTB transmission, they also reduce buffalo numbers [20]. Disease 
management must therefore operate within tight bounds if buffalo are to be maintained as an 
important ecological component of a reserve‟s mammal fauna. Optimising efficiency of the 
disease control programme to achieve the greatest reduction in BTB transmission without 
compromising buffalo population viability is a challenging goal. Future work explicitly 
modelling BTB dynamics under different disease control scenarios – varying the frequency, 
extent, spatial targeting of captures, and management action triggers – might assist with 
progress towards it. Third, test and cull disease management can have unintended 
consequences, which need to be weighed against the benefits when evaluating the merits of 
this management strategy. Captures are extremely stressful to the animals and can disrupt 
their social structure – both of which may add to their infection risk after being released back 
into the park [3,25]. This may be especially problematic in areas with high disease 
prevalence, where released susceptible animals experience a high encounter rate with infected 
buffalo. Comprehensive coverage of high prevalence hotspots may be essential to circumvent 
this pitfall. Moreover, any large-scale capture operation of wild animals will incur some rate 
of injury or death to the animals.  HiP‟s buffalo capture operation has evolved over more than 
a decade, and every effort is made to keep the animals unharmed. As a result, animal loss 
rates during capture are very low (Jolles, unpubl.).  Nonetheless, losses, including deaths 
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post-release, are difficult to assess with certainty. Perhaps of more concern, recent genetic 
evidence suggests that buffalo removals associated with BTB control may reduce 
immunogenetic variation in the population (de Lane-Graaf et al., in review). If so, 
management of disease may carry costs in terms of adaptability to future parasite and 
pathogen challenges – an undesirable outcome for modest-sized, isolated populations. 
Finally, even though the test and cull program may help limit BTB transmission, it is unlikely 
to be able to eradicate the disease, not least because of unknown diagnostic test sensitivity. 
Thus, park management are potentially faced with an indefinite, costly commitment to 
disease control. As such, economic, conservation and veterinary considerations must be 
carefully weighed in deciding what disease control strategy is optimal – a formidable 
challenge in the face of financial and ecological uncertainty.  
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Table S1: Linear regression statistics for area datasets 
 Masinda S Mbhuzane Gunjaneni Corridor Manzibomvu 
Best-fit values      











80.12 ± 53.57 24.74 ± 11.20 -18.32 ± 29.52 -1.553 ± 14.57 52.62 ± 
X-intercept when 
Y=0.0 
2009 2013 1989 1891 2007 
1/slope -25.08 -81.36 108.6 1218 -38.14 
95% CI      
























-infinity to -infinity to 
2000 
 
Goodness of Fit      
r² 0.3571 0.7076 0.1633 0.006318 1 




     
F 2.222 4.84 0.3902 0.01272  
DFn, DFd 1.000, 4.000 1.000, 2.000 1.000, 2.000 1.000, 2.000 1.000, 0.0000 
P value 0.2104 0.1588 0.5959 0.9205  
Deviation from zero? Not 
Significant 





Data      
Number of X values 6 4 4 4 2 
Maximum number of 
Y replicates 
1 1 1 1 1 
Total number of 
values 
6 4 4 4 2 
Number of missing 
values 




Table S2: Model selection for BTB incidence in buffalo herds at HIP. Statistically significant terms 
are shown in red for best-fitting models (i.e. within 2 AIC points of the model with the lowest AIC). 
The model selected as final model is marked with asterisks. “n.c.” stands for not competitive. 
Model: incidence ~ model rank AIC 
area 3 114.2 
capture interval n.c. 136.1 
capture effort n.c. 147.1 
area + capture interval 1 113.8 
area + capture effort n.c. 118.2 
capture interval + capture effort n.c. 143.9 
*area + capture interval + capture effort* 2 114.0 
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Table S3: Model selection for change in BTB prevalence in buffalo herds at HIP. Statistically 
significant terms are shown in red for best-fitting models (i.e. within 2 AIC points of the model with 
the lowest AIC). The model selected as final model is marked with asterisks. “n.c.” stands for not 
competitive. 
Model: incidence ~ model rank AIC 
area n.c. 124.1 
capture interval n.c. 138.5 
capture effort n.c. 145.9 
area + capture interval 2 115.1 
area + capture effort n.c. 127.3 
capture interval + capture effort n.c. 141.6 
*area + capture interval + capture effort* 1 114.8 
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Bovine tuberculosis (BTB) is a chronic, infectious disease found in domestic livestock and 
wildlife. It is caused predominantly by Mycobacterium bovis, which forms part of the 
Mycobacterium tuberculosis complex. BTB has serious implications for the movement of 
animals and animal products, biodiversity and public health, and is of significant economic 
concern. The existence of wildlife maintenance hosts makes it extremely difficult to eradicate 
BTB, even when established control strategies are in place, creating the need for alternative 
methods for controlling this disease. There are multiple factors that influence the outcome of 
infection by a pathogen, one of which is the host‟s genome. The identification of genetic 
variants involved in the susceptibility to bovine TB would supply a new selection of potential 
drug targets as well as the possibility for the breeding of animals with greater disease 
resistance. In this review, we collate the results of the BTB heritability and association 
studies performed in cattle and wildlife, discuss considerations and other methodologies 
(such as gene expression work) to be taken into account when performing genetic studies, 
and make some recommendations for future work in this area. 
Keywords: bovine, tuberculosis, genetics, susceptibility 
 
1. Introduction 
Bovine tuberculosis (BTB) in domestic livestock and wildlife is caused by Mycobacterium 
bovis, which forms part of the Mycobacterium tuberculosis complex [1]. It is a chronic, 
infectious disease that is transmitted predominantly by inhalation and is characterised by the 
formation of granulomas in the lungs, lymph nodes and various other organs [2]. The exact 
origin of this disease is unclear, but it has been suggested that bovine TB emerged in Europe 
and spread to the United Kingdom, and was subsequently introduced to many parts of the 
world through the movement of cattle from the UK and the Netherlands to former colonies 
[3]. BTB is widespread in cattle around the world, and is present in many wildlife species and 
domestic animals. This has serious implications for international trade and export of animals 
and animal products, including beef. Additional economic losses are suffered through the 
slaughter of livestock, and regular BTB testing incurs a vast expense [4]. Bovine TB is also a 
public health concern, as it is a zoonotic disease and can be transmitted to humans. This is of 
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particular concern in developing countries, where people and livestock live in close proximity 
to each other [4,5].  
Much interest has recently been focused on the role of wildlife reservoirs in the maintenance 
and spread of BTB, both within wildlife populations and to domestic livestock and other 
spill-over hosts. The brushtail possum (Trichosurus vulpecula) in New Zealand, the African 
buffalo (Syncerus caffer) in South Africa, the Eurasian badger (Meles meles) in the United 
Kingdom, the white-tailed deer (Odocoileus virginianus) in the USA and the European wild 
boar (Sus scrofa) in Spain are all considered maintenance hosts of BTB in their respective 
environments [3]. The list of spill-over hosts is far more extensive, and includes goats (Capra 
hircus), lynx (Lynx pardinus), lions (Panthera leo), dogs (Canis familiaris), cats (Felis 
catus), sheep (Ovis aries), mink (Lutreola vison) and many more [6,5].  
Multiple factors influence the outcome of infection by a pathogen. Host genetic factors 
interact with both environmental factors and the genome of the pathogen to determine the 
disease profile of an individual, with a particular interplay between them resulting in active 
disease. Many lines of evidence convincingly demonstrate that the host‟s genetic make-up 
plays a role in the outcome of infection with TB in both humans and animals. Twin studies 
have shown that when monozygotic and dizygotic twins are compared with respect to 
development of TB, the concordance is higher in monozygotic twins than in dizygotic twins 
[7]. In 1926, 251 babies unintentionally injected with a live dose of virulent M. tuberculosis 
showed a range of responses, demonstrating that there were innate factors involved in the 
outcome of infection [8]. With respect to Mycobacterium bovis susceptibility, in the 1940‟s it 
was found that inbred strains of rabbits displayed one of two phenotypes (susceptible or 
resistant) following infection with M. bovis. This inheritance pattern suggested that the 
disease profile displayed by the rabbits was largely genetically inherited [9]. The differential 
susceptibility of mice to the M. bovis Bacille Calmette-Guerin (BCG) vaccine led to the 
identification of the first TB susceptibility locus, namely the Nramp1 gene [10]. 
There are many different prevention and treatment strategies, used by different countries on 
different BTB hosts – test and slaughter policies, the BCG vaccine, wide-scale culling and 
restricted movement and legislation. All of these strategies have met with limited success in 
countries where a wildlife BTB reservoir exists, and there is a pressing need for alternative 
methods of controlling this disease [4,5]. The identification of genetic variants involved in 
susceptibility to bovine TB would supply a new selection of potential drug targets as well as 
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the possibility of breeding animals with greater disease resistance. Research into genetic 
resistance to BTB has begun in a number of countries (Figure 1) and the application of 
genetic resistance information to breeding programmes has already been implemented in 
cattle for other diseases such as mastitis [11]. Genetic and immunological information form 
an essential part of this approach, and breeding strategies for BTB resistance, either by 
marker-assisted selection or the incorporation of marker information into estimated breeding 
values (EBVs) for a whole-genomic selection approach [12], could be invaluable for both the 
commercial and private sectors. No single study design or approach can be relied on to 
identify all the genetic components of TB susceptibility, as each different approach has its 
own advantages and limitations. Heritability and association studies are the most commonly 
used approaches in investigating the genetic basis of disease susceptibility, and will be the 




Figure 1: Countries highlighted green represent those where genetic studies investigating resistance 
to BTB have taken place. 
 
Below, we summarise the results of the BTB heritability and association studies performed in 
cattle and wildlife, suggest considerations and other methodologies to be taken into account, 
and make some recommendations for future work in this area. 
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2. Heritability Studies 
Heritability studies are used to assess the extent of the genetic contribution to a particular 
phenotype, i.e. the extent to which the disease phenotype is controlled by the host‟s genetic 
make-up. In humans, this is most commonly done using twin studies, or more recently, using 
families and household contacts to determine the degree of concordance of genotype and 
phenotype [13]. In animals, this can be more thoroughly investigated using breeding 
programs and experimental infection. Heritability is an important aspect of any disease, and 
is an essential factor in the successful implementation of breeding programmes. Imperfect 
diagnostics, such as the limited sensitivity of the skin test in BTB detection, raises the 
possibility that the true heritability of this disease may be even higher than observed [14]. 
Historical data on differential BTB susceptibility in cattle breeds has been outlined by 
Vordermeier et al. [15] and will not be addressed here. 
2.1 Livestock 
Numerous studies have shown cattle breeds to display different levels of susceptibility to 
bovine TB. A study done by Ameni et al. [16] with Zebu, Zebu-Holstein crosses and Holstein 
cattle under identical field husbandry conditions in Ethiopia, showed both a higher 
prevalence and severity of BTB in the Holstein cattle compared to the Zebu or Zebu-Holstein 
crosses. Another study of Ethiopian cattle [17] identified breed as a significant factor 
affecting TB manifestation. Breed types were classified as local, exotic or cross-bred, and 
showed exotic cattle to have a higher risk of severe BTB pathology. 
Bermingham et al. [18] investigated the heritability of single comparative intradermal 
tuberculin (SCIT) test responsiveness and confirmed M. bovis infection in Irish Holstein-
Friesian dairy cattle. Approximately 600-800 herd tests encompassing 14,000 cows showed 
heritability estimates of 0.14 and 0.18 for SCIT test responsiveness and confirmed M. bovis 
infection, respectively. A similar study done on British Holstein-Friesian dairy cattle 
calculated heritability estimates of SCIT test responsiveness and confirmed M. bovis infection 
to be 0.16 and 0.18, respectively [19].  
2.2 Wildlife 
Red deer are found as both livestock and wildlife in various parts of New Zealand, Australia, 
the USA and Canada. They are highly susceptible to bovine TB and act as a reservoir for 
transmission to cattle [20]. A study by Mackintosh et al. [21] showed differential 
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susceptibility and transmission in red deer, which was attributed to host genetic variation. 
Experimental infection of stags showed a range of disease phenotypes, which was closely 
mirrored in the response of sired offspring, suggesting a strong genetic basis for resistance. 
The heritability of BTB resistance was calculated to be as high as 0.48. An investigation of 
BTB in white-tailed deer in Michigan, USA, by Blanchong et al. [22], using microsatellites, 
found BTB-infected deer to be significantly more closely-related than non-infected deer.  The 
heritability studies performed in livestock and wildlife can be seen in Table 1. 
 
Table 1: Bovine TB Heritability studies 




al. (2000) Red deer  BTB resistance 0.48 






and severity Higher in Holstein 
Blanchong et al. 
(2007) 
White-




















Biffa et al. 
(2012) Cattle 
Exotic/ local/ 
cross bred BTB severity 




3. Association studies 
Association studies compare the allele frequencies of specific markers between 
infected/diseased and uninfected/not diseased individuals, and are currently the most widely-
utilised in studying susceptibility to infection or disease. These case-control association 
studies are better than linkage studies at detecting genes that have a small effect [23], and as 
TB is known to be under polygenic control, there are likely to be many genes that each have a 
small effect on susceptibility. Genetic association studies can be roughly divided into two 
categories – candidate gene or whole-genome studies. The candidate gene approach 
investigates SNPs or other variation in genes deemed to be of biological relevance to the 
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question at hand. For example, in the case of TB, one might select genes involved in the 
immune response, or that have been shown to be associated with other infectious diseases, 
even in other species. This approach utilises a relatively small number of markers, but can be 
expanded depending on budget and time. One of the main disadvantages of this approach, 
however, is that the marker associated with disease resistance may not be causative, but may 
be in linkage disequilibrium (LD) with the causative variant. This is particularly applicable to 
those species with small effective population sizes and limited ranges, where LD blocks are 
likely to be longer [23]. The whole genome approach involves genotyping polymorphic 
markers across the whole genome, and therefore makes no prior assumptions as to which 
genes may or may not be involved. This can be a distinct advantage, as it is likely that there 
will be many more genes involved in disease resistance than those of the immune system. 
This approach thus utilises a large number of markers and is more likely to identify novel 
genes or pathways involved in susceptibility [24]. The candidate gene approach is less 
commonly employed in animals with assembled genomes, where sufficient data exists to 
interrogate the whole genome. However, in animals without sufficient genomic data, such as 
most wildlife species, candidate genes are a frequently utilised starting point, even though the 
implicit assumptions are that relatively few loci underpin the phenotype, and their effect is 
detectable. 
3.1 Livestock 
Kadarmideen et al. [25] investigated polymorphisms of the 3‟UTR microsatellite of the 
SLC11A1 (NRAMP1) gene and their association with BTB in African Zebu cattle. They 
compared four phenotypes – namely SCIT test responsiveness, presence of visible lung 
lesions, culture test outcome and the predicted true infection using a Bayesian model, and 
found two alleles to be significantly associated with reduced incidence of BTB traits. Driscoll 
et al. [26] analysed genetic factors in British cattle using microsatellite loci and found two 
markers, BMS2753 and INRA111, to be strongly associated with BTB reactor status. The 
BMS2753 marker lies in close proximity to IFNGR1 and several other immune response 
genes, and INRA111 was previously associated with mastitis [27]. A genome-wide 
association scan of bovine TB susceptibility in Holstein-Friesian dairy cattle by Finlay et al. 
[28] found three SNPs in a region on BTA 22 to be associated with bovine TB susceptibility. 
This region contains the taurine transporter gene SLC6A6. Sun et al. [29] investigated the role 
of polymorphisms in the toll-like receptor 1 and 9 genes with susceptibility to BTB in 
Chinese Holstein cattle. Significant associations were found with TLR1 genotype variants at 
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TLR1-G1596A and BTB susceptibility, and a trend towards significance with TLR1-
A1475C.  
3.2 Wildlife 
The European wild boar is abundant on the Iberian Peninsula, and its range and population 
size are increasing steadily. It has become a wildlife reservoir for BTB in regions of Spain 
and concern has been raised about the spread and management of this disease in both wild 
and contained populations [30]. Acevedo-Whitehouse et al. [30] investigated the genetic 
component of resistance in European wild boars from southern Spain, and found that 
increased genetic heterozygosity had a significant positive effect on BTB resistance, both in 
terms of infection status and disease severity/dissemination. Several of the loci tested also 
revealed high homology to regions of the genome with immune-related functions. Naranjo et 
al. [31] investigated polymorphisms of a methylmalonyl-CoA mutase (MUT) microsatellite 
and their relationship to BTB susceptibility in European wild boar. The microsatellite is 
located next to exon 2 of the gene, and exhibited three polymorphisms within the population. 
The authors found evidence of a balancing polymorphism, with one allele conferring 
significant protection, another conferring significant increased risk of infection, but the 
presence of both alleles conferring the highest level of protection against infection. African 
buffalo are a maintenance host of BTB in southern Africa and pose a risk of infection to 
cattle and surrounding communities, and a threat to biodiversity and ecotourism [32]. Le 
Roex et al. [32] explored polymorphisms in immune-related genes and their association with 
BTB susceptibility in the African buffalo using fluorescent genotyping. SNPs located in three 
genes – SLC7A13, IL1α and DMBT1 – were found to be significantly associated with BTB 
status in the buffalo. The association studies performed in livestock and wildlife can be seen 
in Table 2. 
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Table 2: BTB Association studies 
Author Animal Breed Associated factor Gene/marker 
Acevedo-
Whitehouse et al. 
(2005) 
European 
wild boar  





Naranjo et al. 
(2008) 
European 




Driscoll et al. 




al. (2011) Cattle African Zebu 
Skin test response; 
visible lesions SLC11A1 




EBV (based on skin 
test response) Chr 22, SLC6A6 
Sun et al. (2012) Cattle Chinese Holstein Skin test response TLR1 










4. Considerations in genetic studies 
Despite the popularity of association studies and their ability to identify susceptibility loci, 
they may also identify spurious associations [23]. These should be minimised in the first 
instance in order to avoid reporting inaccurate results, and any associations need to be 
rigorously replicated and/or validated before being accepted as probable. In order to reduce 
the likelihood that spurious associations are identified, there are a number of considerations 
that must be taken into account.  
4.1 Sample collection and phenotype classification 
The first consideration is the accuracy of the disease diagnosis. The best diagnostic tool 
available - i.e. the test with the highest specificity and sensitivity - should be used for 
designating individuals as cases or controls, as too many misclassifications could severely 
bias the association tests [33,34]. The phenotypes must also be clearly defined according to 
the question/objective at hand – for example, if one is interested only in active disease, the 
SCIT test alone may not be an appropriate diagnostic. The cases and controls should have 
comparable exposure to the pathogen in order to be correctly classified as having a 
susceptible or resistant phenotype. Cases and controls should also ideally be matched as 
closely as possible in all other ways (age, environment etc.) so as not to introduce additional 
variables that may confound the association testing [33]. The total number of samples in a 
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study is an important consideration, often overlooked. This must be sufficiently large to 
generate enough statistical power to detect variants that have a relatively small effect, as is 
the usual situation in a complex disease. Statistical power is a function of the size of the study 
population, the allele frequency of the SNP, the size of the effect of the SNP and the level of 
linkage disequilibrium. Power calculations of a real as opposed to theoretical sample set can 
only be done retrospectively, so in order to increase power at the outset, sample numbers 
should be in the order of hundreds, or even thousands. Lack of study power through 
inadequate samples numbers is one of the most frequent causes of non-reproducible 
association results  [23]. 
4.2 Experimental design and analysis 
The experimental design of a study is crucial in order to produce results that are not false 
positives or false negatives. Batch effects occur when different sets of samples are run on 
different days or in batches under slightly different conditions, caused by human error, 
different reagents or hardware, and can result in spurious associations. If samples must be run 
in different batches, controlling for batch effects can be done by the randomisation of 
samples and variables across batches. Population stratification is the other most common 
cause of spurious associations. If subgroups within the study population have different allele 
frequencies, associations may be found that are a function of the population substructure 
rather than disease susceptibility [13,23]. Any possible subgroups should be randomised 
across batches and controlled for during statistical analyses. In studies where large numbers 
of markers are compared across many genes, multiple comparisons are made. In order to 
minimise the occurrence of type 1 errors, correction for multiple testing, e.g. Bonferroni 
correction, should be applied where appropriate [13]. 
4.3 Wildlife 
When working with wildlife species, there are additional factors which may hamper a genetic 
study. Many wildlife species have not had their full genomes sequenced, and thus the 
availability of genetic information is limited. This means that much work must be done prior 
to beginning a genetic association study. This includes the identification and development of 
suitable markers and, ideally, the elucidation of the complex genetic interactions and 
pathways that may operate within the species. Even in well-established models, such as 
cattle, many proteins and gene products have not been characterised and much annotation is 
merely hypothesised rather than experimentally established. Associated markers may also not 
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be the causal variant in a disease, but rather may be in linkage disequilibrium (LD) with the 
causal variant [13,23]. In the absence of established LD information for a particular species, 
this can be difficult to ascertain. Wildlife species are not managed in the same fashion that 
domestic livestock may be, and thus relatedness can be a concern. A lack of population 
ecology data on a particular species leaves researchers unable to establish the level of 
relatedness in a population and this can introduce confounding effects. Phenotype 
determination in wildlife may also be more difficult due to absent/reduced diagnostic 
capabilities for many species, and the logistical complications of capture and/or recapture in a 
natural environment. 
4.4 Additional challenges 
The type of association study should reflect the aim of the study, with candidate gene studies 
having greater power to detect small effects, and genome-wide studies being better suited to 
identifying novel genes/pathways [24]. In the same way that the host‟s genetic make-up 
influences the outcome of infection, so too does the genetic make-up of the pathogen. 
Information regarding the genetic variation and lineage of the pathogen should be included, 
and reported, where known. BTB is influenced by many genes, and the role of gene-gene 
interactions and gene-environment interactions cannot be excluded. A genetic variant not 
found to be associated on its own may still play a role in conjunction with another gene or 
variant, and the same may also be true for studies undertaken under different environmental 
conditions [33,13]. Current methodologies seldom include this type of analysis and thus these 
genes are missed. The type of markers used in a study is also important – while microsatellite 
markers are often well-characterised, and work very well in linkage studies, the high allelic 
diversity and reduced LD at these loci may reduce the power to detect associations with a 
disease phenotype in a population-level study [35]. 
 
5. Gene expression studies 
Studying the gene expression pattern of a particular phenotype provides another approach to 
identifying candidate genes. Gene expression studies look to identify gene transcripts that are 
differentially expressed in groups of animals, in order to identify markers of infection. The 
primary goal is generally for use in diagnostics, but these studies can also inform genetic 
researchers of candidate genes worthy of investigation, as well as contributing information 
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that can be used in conjunction with genetic and other data in a systems biology approach to 
build a more complete understanding of the pathways/systems involved in disease [36,37]. 
Gene expression studies will not be covered extensively in this review, as they are not strictly 
genetic studies, but nevertheless can be of great assistance. Studies using natural models of 
infection, i.e. that investigate differential gene expression in cells/tissues of animals that were 
naturally infected with BTB, are particularly useful, as this is the closest approximation of 
what might happen in nature.  
Studies using natural BTB infection in cattle have identified many genes that are 
differentially expressed between M. bovis-infected and uninfected animals – these include, 
but are not limited to:  ADAM17, CXCR3, IER5, PHB2, CD84, TBK1, TLR2, TLR3, BCL2, 
NFATC4, IFNG, IFNGR1, TNFSF13B, KIAA1971, SLAMF1, CASP1, DEFB10, IFNAR1, 
KIR3DS1, MYD88, PTPN2, STAT1, STAT2, TREM1, TYK2, TYROBP, CD83, CTLA4, 
IL1A, IL8 and IL15 [38–41]. In wildlife, studies of naturally infected wild boar have 
identified the differential expression of many genes, including C3, MUT, ANX, CUL, 
VCAM-1, C7, ARG, OPN, CXCR4, VDR, BAP29, GAL-1, SLA class I and II, Ig, CC1qB 
[42–44]. A gene expression study in Iberian red deer showed the differential expression of 
SMAP-29 and CK2 between M. bovis-infected and uninfected individuals [45]. It is evident 
that a number of the genes listed above are involved in the immune system, many of which, 
such as VDR, IFNG, and TLR2, are also implicated in human TB association studies [46–
48], lending further credence to the identification of the gene and its product as an important 
factor in mycobacterial disease. 
 
6. Conclusions and future directions 
The identification of genetic markers linked to a resistant BTB phenotype can inform studies 
in other species, and may enable the breeding of animals with greater disease resistance. This 
would, at the very least, be a useful additional measure in conjunction with the other control 
strategies currently available. The ability to breed animals with a greater BTB resistance may 
be of considerable commercial benefit to the cattle farming industry, and would certainly be 
invaluable in other species, such as the African buffalo, which forms part of a multi-million 
dollar hunting and breeding industry in South Africa, with “disease-free” buffalo particularly 
prized. This also pertains to other wildlife species kept in a farm or reserve environment, 
where selective breeding can produce very tangible benefits. Allen et al. [34] suggested that 
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several other bovine pathogens such as Brucella abortus and Mycobacterium avium 
paratuberculosis may operate within their hosts in a similar manner to M. bovis, and thus the 
breeding of BTB resistance may also inadvertently select for resistance to those pathogens as 
well. However, it is also possible that such animals may show increased susceptibility to 
other diseases. 
To date, most of the genetic research has focused on heritability and candidate gene 
association studies investigating single markers. While association studies remain the most 
popular choice in disease susceptibility studies, there are a number of considerations to be 
taken into account, in the collection and classification of samples, the experimental design 
and analyses as well as the species under investigation. Current human studies in TB 
susceptibility have included a number of genome-wide association studies, and this may be a 
direction future animal work will take, provided an assembled genome of the animal of 
interest is available. The large number of subjects required, and the relatively low power of 
genome-wide association studies to detect associations of small effect does hamper this 
approach, but the identification of novel loci may become increasingly important [49]. Gene 
expression studies, particularly of natural infections, provide an excellent pool of 
differentially expressed candidate genes for selection, and should be utilised to inform 
genetic studies wherever possible. 
Future genetic work may also need to progress from the strategy of looking for individual 
loci. There are three main approaches to investigating genetic markers and their associations: 
(i) to investigate individual markers in isolation, and their association with the biological 
phenotype, (ii) to investigate gene-gene interactions, by testing marker/SNP combinations for 
association with the phenotype, and (iii) to investigate pathways, and determine whether a 
group of related genes/markers are associated with the phenotype. As we know, genes do not 
work in isolation, and there is increasing interest in the analysis of gene-gene interactions and 
pathways. Studies in humans have begun investigating these processes [50,51] but this has 
yet to be embarked upon in animal disease studies.  
In summary, investigations into the role of the host‟s genetic make-up in bovine TB 
susceptibility are in their infancy, and there is an enormous amount of work still to be done 
before any true understanding of the interplay between host genetics and BTB susceptibility 
can be definitively achieved. The genome assembly of a growing number of species will 
provide researchers with the tools and information needed to tackle this imposing question 
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from a number of angles, and the co-operation of multiple disciplines will ensure the best 
success at identifying the host genetic component of bovine TB resistance. 
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The African buffalo, Syncerus caffer, is one of the most abundant and ecologically important 
species of megafauna in the savannah ecosystem. It is an important prey species, as well as a 
host for a vast array of nematodes, pathogens and infectious diseases, such as bovine 
tuberculosis and corridor disease. Large-scale SNP discovery in this species would greatly 
facilitate further research into the area of host genetics and disease susceptibility, as well as 
provide a wealth of sequence information for other conservation and genomics studies. We 
sequenced pools of Cape buffalo DNA from a total of 9 animals, on an ABI SOLiD4 
sequencer. The resulting short reads were mapped to the UMD3.1 Bos taurus genome 
assembly using both BWA and Bowtie software packages. A mean depth of 2.7X coverage 
over the mapped regions was obtained. Btau4 gene annotation was added to all SNPs 
identified within gene regions. Bowtie and BWA identified a maximum of 2,222,665 and 
276,847 SNPs within the buffalo respectively, depending on analysis method. A panel of 173 
SNPs was validated by fluorescent genotyping in 87 individuals. 27 SNPs failed to amplify, 
and of the remaining 146 SNPs, 43-54% of the Bowtie SNPs and 57-58% of the BWA SNPs 
were confirmed as polymorphic. dN/dS ratios found no evidence of positive selection, and 
although there were genes that appeared to be under negative selection, these were more 
likely to be slowly evolving house-keeping genes. 
 
1. Introduction 
Investigating genetic variation between individuals, populations or species provides the basis 
for understanding the heritability of traits and phenotypes, and provides researchers with the 
opportunity to study complex issues in conservation, disease susceptibility, molecular 
ecology and many other disciplines [1]. Animal models have long provided the foundation 
for the genetic analysis of complex traits, using gene knockouts, recombinant and transgenic 
animals. The advent of whole-genome sequencing and the subsequent assembly of the 
genomes of the domestic cow, mouse, rat and others provides a resource pool of genetic 
markers with which to work in subsequent studies [2,3]. However, when studying a species 
for which limited sequence information is available, it is necessary to generate sequence data 
in order to identify the genetic variants present in the population. The discovery of genetic 
variants, in particular large-scale SNP discovery, identifies genetic markers that may have the 




power to answer multiple research questions, and can be performed using a wide variety of 
technologies [4,5]. 
The development of next-generation sequencing technologies, such as the ABI SOLiD, 
Illumina GA and HiSeq and Roche 454 platforms, has enabled a faster and more cost-
effective approach to generating sequence data and SNP discovery. Each of these platforms 
has its own particular chemistry and combination of template preparation, sequencing and 
data analysis, and thus each has its own advantages and disadvantages [6,7]. Benefits of 
working with SNP data include the fact that they are abundant, distributed throughout the 
genome, are easy to score and can be used in high-throughput screening [1,8]. The sequence 
data obtained using next-generation technologies are typically short sequence reads of 
approximately 50-750bp. Whole genome shotgun or re-sequencing using short reads requires 
the alignment of millions of sequence reads to a high quality reference genome sequence.  
Once the reads have been mapped to the reference genome, nucleotide variation between the 
sample and the reference can be identified [4]. For most species that do not have a fully 
sequenced genome, this can be problematic. However, if the genome of a closely related 
species is available, this can be used as a reference, although the proportion of data that can 
be mapped to the genome may be significantly reduced, and the data obtained will indicate 
variation seen between species as well as between individuals of the same species [9–11]. 
Other considerations such as depth of coverage and quality must be taken into account, 
particularly when using this approach. 
The African buffalo, Syncerus caffer, is one of the most abundant and ecologically important 
species of megafauna in the savannah ecosystem. There are three recognised subspecies of 
African buffalo – the Cape buffalo (Syncerus caffer caffer), the West African buffalo 
(Syncerus caffer brachyceros) and the Forest buffalo (Syncerus caffer nanus). A fourth 
subspecies, the Central African Savannah buffalo (Syncerus caffer aequinoctialis), has also 
been proposed. All individuals used in this study were Syncerus caffer caffer. African buffalo 
are an important prey species, as well as a host for a vast array of nematodes, pathogens and 
infectious diseases [12]. Some of the infectious diseases for which the African buffalo is a 
wildlife host are bovine tuberculosis (BTB), corridor disease and foot-and-mouth disease 
[13]. Their current distribution extends throughout much of sub-Saharan Africa, although 
within this range the distribution is fragmented and largely confined to protected areas. The 
most recent IUCN census data estimates the global African buffalo population to be 
approximately 900,000 [14]. Previous genetic studies on buffalo have focused primarily on 




population differentiation and genetic diversity, using markers such as microsatellites, 
mitochondrial DNA and Y chromosomal loci [15–17]. Large-scale SNP discovery in this 
species would greatly facilitate further research into the area of host genetics and disease 
susceptibility, as well as provide a wealth of sequence information for other conservation and 
genomics studies. 
Our goals in this study were to perform next-generation sequencing and mapping of the 
African buffalo genome using two different software packages, implement large-scale 
identification of novel SNPs within the African buffalo genome, and determine and compare 
the SNP validation rates using fluorescent genotyping. This data can then inform future 
studies. 
 
2. Materials and Methods 
 
2.1 Ethics 
The Stellenbosch University Animal Care and Use Committee (SU ACU) deemed it 
unnecessary to obtain ethical clearance for this study as the blood samples used for DNA 
extraction were collected under the directive of SANParks and KwaZulu Natal Wildlife for 
other purposes, and their use in the present study is incidental. 
2.2 Samples 
EDTA blood samples from nine Cape buffalo from Hluhluwe iMfolozi Park, in the KwaZulu 
Natal province of South Africa, were obtained during an annual BTB test and cull operation. 
Genomic DNA was extracted from the blood samples using the Qiagen DNeasy Blood and 
Tissue Kit, according to the manufacturer‟s instructions. Equimolar amounts of DNA from 
four and five animals were made into two barcoded paired end libraries. Fragment libraries 
were constructed according to manufacturer‟s instructions using the SOLiD™ Fragment 
Library Construction Kit, and sequenced on a single plate of an ABI SOLiD4 sequencer 
(Lifetech) to generate 50bp reads. 
2.3 Mapping and SNP detection 
Due to the absence of an assembled African buffalo reference genome, the Bos taurus 
UMD3.1 genome sequence, produced by the Centre for Bioinformatics and Computational 
Biology (CBCB) at the University of Maryland, was used as the reference genome in this 




study [18] . The short reads were mapped to the Bos taurus genome in colour space using two 
separate packages, BWA [19]  and Bowtie [20]. SNPs were called from Bowtie reads with 
pileup and mpileup, and SNPs were called from BWA reads with pileup and Genome 
Analysis Tool Kit 1.1-3 (GATK) [21]. Reads were initially mapped with Bowtie with the 
following parameters -C (colorspace); --snpfrac 0.01 (1% of positions expected to be 
polymorphic);  -3 1 (trim one base from the 3‟ end of the read). SNPs were extracted from the 
reads mapped with Bowtie using pileup in SAMtools with the –c and –r 0.01 (1% of positions 
expected to be polymorphic) options [22]. 173 SNPs identified by this pipeline were 
submitted for validation. Subsequently the data was reanalysed using Bowtie with --snpfrac 
0.001, followed by Picard Tools v1.48 to remove duplicates, and SAMtools mpileup with 
options -B (Disable probabilistic realignment); -d 29 (maximum depth 29) to identify SNPs. 
BWA was run with option -q 20 (trim low quality reads from 3‟ end). SNPs were extracted 
from reads mapped with BWA with SAMtools using the same options as for Bowtie, and also 
with Picard Tools and GATK [21] for base quality score recalibration, indel realignment, 
duplicate removal, and  SNP and INDEL discovery and genotyping [23]. Shellscripts for 
calling SNPs with GATK are available from the authors on request. Nucleotide differences 
called by SAMtools were classified as SNPs if (i) the alternate allele was supported by a 
minimum coverage of 2, and (ii) the alternate allele had a minimum Phred quality score of 
20. Nucleotide differences called by GATK were classified as SNPs if they were flagged as 
“PASS”. The use of the Bos taurus reference genome in this study enabled the identification 
of two classes of SNPs - those that occur between the cow and buffalo, and those that occur 
within the buffalo population.  
2.4 Annotation 
Gene annotation was added to the SNPs identified within whole gene regions, which were 
defined as from 1000bp upstream of the 5‟ end to 1000bp downstream of the 3‟ end of any 
gene. A local Perl script was then used to submit the SNPs within gene regions to the 
Ensembl v66 Application Programme Interface (API) to determine functional consequence 
[24,25]. SNPs and annotations were written to a local MySQL database for storage and 
interrogation.  
2.5 Signatures of selection 
The ratio of non-synonymous to synonymous substitutions (dN/dS) was calculated for all 
buffalo genes using PAML [26]. The Ensembl v66 API was used to identify the positions of 




SNPs within the coding sequence of bovine genes (Bos taurus genome build UMD3.1), and 
Cape buffalo SNPs were substituted into the gene coding sequences at these positions before 
submission to a local copy of PAML to obtain the dN/dS ratios. P values were obtained by 
taking twice the absolute difference between the log likelihood of the observed dN/dS ratio 
and the ratio obtained with dN/dS set to 1 and comparing it to 2 with one degree of freedom. 
The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used to 
identify whether there were pathways that were overrepresented in the gene lists [27].  
2.6 Validation 
A selection of 173 SNPs was made from the collective BWA pileup and Bowtie pileup SNP 
pool based on the predicted consequence and/or gene location of the SNP, in order to use the 
validation data in a subsequent case-control association study. SNPs were fluorescently 
genotyped in 87 Cape buffalo by KBioscience (www.kbioscience.co.uk), using their 
competitive allele-specific KASP SNP genotyping platform. Assays were designed for each 
of the SNPs by KBioscience. The KASP assay system is a competitive allele-specific PCR 
incorporating a FRET quencher cassette (www.kbioscience.co.uk). All but six of the SNPs 
validated as polymorphic within Cape buffalo were also validated in the original 9 
individuals from the sequencing pool; the six SNPs not genotyped in the original samples 
were omitted due to technical reasons. KBioscience assay IDs are shown in Table S1 and are 




3.1 Mapping  
The number of reads generated by the SOLiD sequencing was 442,984,249 in total. Sequence 
reads have been submitted to the sequence read archive at NCBI (accession number 
SRA051668.1). Given the relatively large genetic distance between Bos taurus and Cape 
buffalo, we initially used a high value of snpfrac (0.01) in the Bowtie parameters; this is the 
proportion of positions that are expected to be polymorphic. With snpfrac at 0.01, 23% of the 
reads mapped to the reference genome but the validation rate of the SNPs was relatively low 
(43%; see below). We therefore repeated the mapping with snfrac = 0.001, which reduced the 
percentage mapping to 21% and increased the validation rate to 54%. The mapped Bowtie 
reads were all 47 bases in length and covered 1.58GB, which is equivalent to 56% of the 




bovine genome being covered by at least one read, and represents 2.7X coverage of aligned 
data. Even fewer reads mapped with BWA (19%), of which 9.7% were PCR duplicates. The 
BWA reads were trimmed based on the base quality; 61% of reads were 48 bases and the 
mean length was 44.5 bases. The percentage of 35bp reverse reads that mapped was very low 
with both alignment programmes (<2%) and these data were not used. The percentage of 
exon sequence covered by at least one read was slightly higher (64%) than that of the genome 
as a whole, which is consistent with exons occurring in more highly conserved regions of the 
genome.  
3.2 SNP discovery and annotation 
In order to be identified as SNPs, nucleotide variants called by SAMtools had to be supported 
by at least two reads, and have a base quality of at least 20, indicating 99% accuracy in the 
call. SNPs identified by GATK had to be classified as „PASS‟. A flow diagram of the 
analysis is shown in Figure 1.  The number of SNPs called by different pipelines varied 
substantially, with BWA followed by pileup having about a tenth of the other methods 




Figure 1: SNP discovery pipeline using Bowtie and BWA 
 
 




GATK was run on the same BWA generated bam files as pileup and found 7 times more 
SNPs, so the difference in this case was due to the SNP calling and not the mapping. Bowtie 
and mpileup generated about half the number of SNPs as Bowtie and pileup; however, in this 
case Bowtie was run with snpfrac at 0.001 and 0.01 respectively and Picard tools was used to 
remove duplicates prior to mpileup but not pileup, so it is likely that the number of SNPs 
observed was reduced at several points in the pipeline leading to mpileup compared to that 
leading to pileup.   
 
Table 2: Comparison of SNPs identified after mapping with BWA and Bowtie 








Relative to reference sequence 445,546 3,739,203 6,881,214 4,234,692 
Within buffalo population 109,361  276,847 2,222,665 933,948 
Within gene regions* 28,807  76,615 493,578 224,087  
*Gene regions are from the gene start to the gene end and include introns 
 
3.3 SNP validation 
173 SNPs were sent for validation on 87 Cape buffalo DNA samples, and 146 were amplified 
successfully. Of these 146 SNPs, 71 appeared to be monomorphic and 75 were polymorphic. 
The different mapping and SNP calling methods produced different numbers of validated 
SNPs (Table 1).  
 
Table 1: Counts of SNP that converted to successful assays predicted by different pipelines 
Validation result BWA pileup BWA GATK Bowtie  pileup Bowtie mpileup 
Monomorphic 20 (12)* 31 (23) 71 (11) 46 (21) 
Polymorphic 45 (6) 68 (12) 75 (4) 73 (13) 
Not amplified. Number, (%) 12, 16% (1)  20, 17%  (1) 27, 16% (0) 23, 13% (0) 
Validated % 58%  57% 43% 51% 
Percent of assays correctly 
identified as polymorphic 
58% (67%) 57% (67%) 43% (45%) 54% (74%) 
*Figures in brackets are the number of loci that were predicted monomorphic (fixed for alternate allele) by the 
corresponding pipeline. The percentage correctly identified as polymorphic shows the percentage of all assays 
that were polymorphic and in brackets the percentage of assays predicted polymorphic that were confirmed.  




The difference in validation rates between the three software packages was statistically 
significant (Chi sq test,  28, 4df, p <0.001). BWA followed by SAMtools Pileup or GATK 
did not detect 20 or 7 SNPs respectively that were detected by Bowtie and Pileup and 
validated as polymorphic.  SNPs called by GATK were scored as “PASS” or “LowQual”; 
there was no difference in validation rate between these two classes of SNPs (ChiSq =0.6, p = 
0.45). Validated SNPs and KBioscience assay IDs can be seen in Table S1.  Given the higher 
validation rate from the BWA data, this data was used for the subsequent analysis. An 
unbiased pattern of substitution would be expected to show a transition/transversion (Ti/Tv) 
ratio of 0.5, as transversions are twice as likely as transitions. However, a ratio of around 2.1 
is usually observed in mammals, and a ratio that is significantly lower than 2.1 can be an 
indicator of poor quality sequencing data [23].  The observed Ti/Tv ratio for homozygous 
SNPs in this study was 2.18. Therefore, despite the relatively low validation rate, the Ti/Tv 
ratio suggested that SNP calls were in the expected proportions and were therefore not 
random.
3.4 SNP Consequences 
The predicted consequences of the SNPs were obtained from Ensembl and a summary of the 
numbers of the different types of consequences obtained using the BWA and GATK pipeline 
is shown in Table 3.  
 
Table 3: Counts of BWA/GATK SNPs of each consequence within gene regions 
SNP CONSEQUENCE COUNT 
DOWNSTREAM  3,400 
STOP_LOST  1 
UPSTREAM  3,265 
INTRONIC  67,542 
WITHIN_MATURE_miRNA  1 
STOP_GAINED  26 
SYNON  1,408 
SPLICE_SITE  205 
NON-SYNON  982 
3‟UTR  690 
5‟UTR  54 
WITHIN_NON_CODING_GENE  106 
ESSENTIAL_SPLICE_SITE  8 
 




11,054 SNP had multiple annotations either because they were in multiple transcripts or 
because a SNP had more than one consequence e.g. SPLICE_SITE and INTRONIC and 
3,105 SNP within gene regions had no annotation. A complete list of SNPs in exons with 
consequences is shown in Table S2. DAVID was used to discover whether any specific 
pathways were particularly affected by premature stop codons but none were significantly 
overrepresented after correction for multiple testing (minimum p value =0.706) suggesting 
that these genes were affected at random. A web page was created where SNPs could be 
filtered by genomic region, gene, SNP consequence or restriction site 
(http://www.genomics.liv.ac.uk/tryps/resources.html) [28]. The inclusion of the restriction 
sites affected makes it possible to obtain lists of SNPs that can be used in RFLP assays. These 
are very useful where a set of markers is required across a genome region but the particular 
SNPs assayed are not important. The website implements Primer3 [29] to design primers 
around SNPs according to user-specified criteria.   
3.5 Signatures of selection 
Genes were screened for particularly high or low non-synonymous/synonymous substitution 
ratios (dN/dS) that might be indicative of positive or negative selection, respectively (Table 
S3). No genes had dN/dS ratios that were significantly higher than 1 (2 p < 0.05).  DAVID 
analysis of the 205 genes with no synonymous SNPs suggested that C-type lectins might be 
overrepresented in this set (Table S4). In contrast 1,231 genes had dN/dS ratios significantly 
less than 1 (p<0.05) suggesting that they were more conserved than expected. Genes involved 
in the regulatory processes “nucleoside binding” and “phosphorylation” were the most 
overrepresented (Table S5). 
 
4. Discussion 
The African buffalo has become a species of interest in recent years due to its role as a 
wildlife maintenance host for a variety of infectious and zoonotic diseases, such as corridor 
disease, foot-and-mouth disease and bovine tuberculosis [13]. There is no African buffalo 
reference genome available for use in disease association studies, and much benefit would be 
gained by the generation of sequence data and large-scale SNP discovery in this species. The 
cost efficiency, large data output and fast turnaround time of the next-generation sequencing 
technologies have greatly facilitated the generation of novel sequence data as well as large-
scale SNP discovery in non-model organisms. ABI SOLiD technology was used in this study 




to generate over 400 million 50bp reads of African buffalo genome sequence, and for the 
preliminary identification of approximately a quarter of a million novel SNPs within the 
buffalo genome. When investigating a species for which a complete genome sequence is not 
available, the reference genome of a related species can be used for mapping and SNP 
discovery. The success of this approach was recently shown by mapping sequence reads of 
the great tit, Parus major, to the reference genome of the zebra finch, Taeniopygia guttata 
[10]. Using this method, the authors were able to identify 20,000 novel SNPs. A similar 
approach was used in mapping sequence reads of the turkey, Meleagris gallopavo, to the 
sequenced genome of the chicken, and approximately 8000 SNPs were identified in the 
turkey genome [30].  
In this study, the Cape buffalo sequence reads were mapped to the reference genome of the 
domestic cow, Bos taurus. The most recent common ancestor of the domestic cow and the 
African buffalo is estimated to have existed approximately 5-10 million years ago (MYA), at 
the time of the divergence of the subtribes Bubalina, which consists of the Syncerus and 
Bubalus genera, and Bovina, which is comprised of the Bos and Bison genera [31]. Despite 
the relatively recent split of these two genera, only 19% to 23% of the buffalo short reads 
mapped to the reference cow genome using BWA and Bowtie. These percentages are 
comparable to those achieved by van Bers et al. [10], where 26% and 32% of the great tit 
sequence reads generated in two pools were mapped to the zebra finch genome using data 
generated by the Illumina Genome Analyser. Similarly, Kerstens et al. [30] mapped 
approximately 30% of the raw sequence reads generated in the turkey to the chicken genome.  
The low percentage mapping resulted in a depth of coverage that was substantially below a 
level that would be ideal for SNP discovery. It would appear that 2-4 times more raw data is 
required when using a distant relative as a reference sequence, although the longer reads that 
are now available from the Illumina sequencers (100-150bp) might improve the percentage 
mapping.  Nevertheless the extra data required when using a distant relative is still 
substantially less than would be required for a de novo assembly (>80X coverage), and 
mapping to a related species dramatically simplifies the SNP discovery and annotation 
compared to that required for a de novo assembly.  
Significantly different results were found in this study when using different mapping and 
SNP calling methods (Table 2). From the combined BWA pileup and Bowtie pileup SNP 
pool, 173 SNPs from within the Cape buffalo population were selected for validation. The 
selection was based on gene function and SNP consequence, in order to use the validation 




data in a subsequent case-control association study. Validation required SNPs to pass two 
tests 1) that the loci amplified and 2) that the loci were polymorphic in Cape buffalo. The 
number of SNPs detected by each method that were validated ranged from 45–75, and the 
percentage ranged from 43–58% (Table 1).  BWA and GATK had highest percent validated 
(57%), although it is probably not statistically significantly better than the Bowtie/mpileup 
combination (54% validated), which yielded more SNPs. The BWA/GATK SNPs were used 
for the functional analyses discussed below. It is not possible to accurately estimate false 
positive rates for any method except Bowtie and pileup since all SNPs assayed were 
originally identified with this method. The identification of false positives in SNP discovery 
may be a result of sequencing errors, alignment errors or the occurrence of paralogous 
sequence variants [1]. The error rate of the ABI SOLiD is estimated at 0.0006% [32] , which 
would lead to about 50,000 erroneous base calls or 10% of the BWA and 0.5% of the Bowtie 
SNPs; in either case this is insufficient to explain the observed error rate, particularly since 
the Ti/Tv ratio was 2.18 as would be expected for a mammalian genome, rather than a rate 
nearer 0.5 which would be expected from random SNP calls.  Therefore it seems more likely 
that the errors resulted from the low coverage (2.7X) and problems with aligning to the 
genome of a different species [33]. Since selected SNPs from this study will be used in future 
candidate gene association studies, it was desirable to identify as many SNPs as possible in 
order to obtain the largest number of candidates, and therefore false positives were 
considered less problematic than false negatives. SNPs within genes were annotated using the 
Ensembl SNP annotation API. Although this provided consequences for 57,054 SNPs, no 
general conclusions could be drawn from the data. There were no pathways overrepresented 
amongst the genes associated with the 27 SNPs that modified stop codons. It should be noted 
that the 1000 genomes project found 250-300 loss of function variants within genes in each 
individual [34], so the discovery of 27 in a pool of DNA from nine individuals probably does 
not have significant biological implications. 
The non-synonymous/synonymous substitution ratios provided very little evidence for genes 
being under positive selection, although a large number appeared to be under purifying 
selection. This may be because this approach was developed for comparing distantly related 
taxa, and the relatively small number of SNPs between the Cape buffalo and the cow (mean 
4.2 per gene) means that the power to detect positive selection is very limited [35]. The large 
number of genes that are apparently under purifying selection in the buffalo may contain 
many that are too slowly evolving to exhibit a detectable signal between these two species. 




Housekeeping genes appeared to be overrepresented in this list but this may be a consequence 
of their tendency to be relatively slowly evolving rather than evidence of purifying selection.  
This investigation of the Cape buffalo, a species without an assembled genome, has yielded a 
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Table S1: List of the 69 validated SNPs, their Btau4 and UMD3 positions and KBioscience assay IDs 
Name Assay ID UMD3.1 
Position 
Btau4 Position Consequence 
of SNP 
Gene Name Ensembl Gene ID Description of gene 
SNP_1 1538-0001 Chr11:7179447 Chr11:7403981 NON-SYNON Q75R58_BOVIN ENSBTAG00000001034 IL-18 receptor alpha Fragment  
[Source:UniProtKB/TrEMBL;Acc:Q75R58] 
SNP_4 1538-0004 Chr17:63612902 Chr17:64549854 NON-SYNON NP_001019728.1 ENSBTAG00000014628 2-prime-5-prime-oligoadenylate synthetase 2  
[Source:RefSeq peptide;Acc:NP_001019728] 
SNP_6 1538-0006 Chr1:111031389 Chr1:112144359 NON-SYNON PTX3_BOVIN ENSBTAG00000009012 Pentraxin-related protein PTX3 Precursor 
(Pentaxin-related protein PTX3) 
[Source:UniProtKB/Swiss-Prot;Acc:Q0VCG9] 
SNP_7 1538-0007 Chr1:143152388 Chr1:144420892 NON-SYNON MX2_BOVIN ENSBTAG00000008471 Interferon-induced GTP-binding protein Mx2 
(Myxovirus resistance protein 2) 
[Source:UniProtKB/Swiss-Prot;Acc:Q9BDI7] 
SNP_8 1538-0008 Chr22:53599791 Chr22:54390942 NON-SYNON CCR5_BOVIN ENSBTAG00000008099 C-C chemokine receptor type 5 (C-C CKR-
5)(CC-CKR-5)(CCR-5)(CCR5)(CD195 antigen) 
[Source:UniProtKB/Swiss-Prot;Acc:Q2HJ17] 
SNP_13 1538-0013 Chr3:78427756 Chr3:83795862 NON-SYNON B2MU63_BOVIN ENSBTAG00000014983 Interleukin 23 receptor  
[Source:UniProtKB/TrEMBL;Acc:B2MU63] 
SNP_16 1538-0016 Chr5:36884961 Chr5:39910725 NON-SYNON IRAK4_BOVIN ENSBTAG00000021105 Interleukin-1 receptor-associated kinase 4 
(IRAK-4)(EC 2.7.11.1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q1RMT8] 
SNP_17 1538-0017 Chr5:36890957 Chr5:39916721 NON-SYNON IRAK4_BOVIN ENSBTAG00000021105 Interleukin-1 receptor-associated kinase 4 
(IRAK-4)(EC 2.7.11.1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q1RMT8] 
SNP_18 1538-0018 Chr5:47797051 Chr5:51485425 NON-SYNON B3FXL5_BOVIN ENSBTAG00000007636 Interleukin-1 receptor-associated kinase M 
transcript variant 3  
[Source:UniProtKB/TrEMBL;Acc:B3FXL5] 
SNP_19 1538-0019 Chr5:47817597 Chr5:51505676 NON-SYNON B3FXL5_BOVIN ENSBTAG00000007636 Interleukin-1 receptor-associated kinase M 
transcript variant 3  
[Source:UniProtKB/TrEMBL;Acc:B3FXL5] 
SNP_25 1538-0025 Chr7:98739431 Chr7:97743988 NON-SYNON ERAP2_BOVIN ENSBTAG00000039275 Endoplasmic reticulum aminopeptidase 2 (EC 
3.4.11.-) [Source:UniProtKB/Swiss-
Prot;Acc:A6QPT7] 
SNP_30 1538-0030 Chr20:33550138 Chr20:35669518 3‟UTR CO7_BOVIN ENSBTAG00000011766 Complement component C7 Precursor  
[Source:UniProtKB/Swiss-Prot;Acc:Q29RQ1] 
SNP_41 1538-0041 Chr14:79862771 Chr14:76297528 NON-SYNON A7E3E3_BOVIN ENSBTAG00000040461 SLC7A13 protein Fragment  
[Source:UniProtKB/TrEMBL;Acc:A7E3E3] 
SNP_56 1538-0056 Chr22:55714039 Chr22:56497049 3‟UTR NP_001071304.1 ENSBTAG00000005857 "solute carrier family 6 (neurotransmitter 
transporter, GABA), member 1  [Source:RefSeq 
peptide;Acc:NP_001071304]" 
SNP_57 1538-0057 Chr3:103930723 Chr3:110248862 3‟UTR GTR1_BOVIN ENSBTAG00000009617 "Solute carrier family 2, facilitated glucose 
Stellenbosch University  http://scholar.sun.ac.za




Name Assay ID UMD3.1 
Position 
Btau4 Position Consequence 
of SNP 
Gene Name Ensembl Gene ID Description of gene 
transporter member 1 (Glucose transporter type 
1, erythrocyte/brain)(GLUT-1) 
[Source:UniProtKB/Swiss-Prot;Acc:P27674]" 
SNP_59 1538-0059 Chr5:45246904 Chr5:48631315 3‟UTR S35E3_BOVIN ENSBTAG00000031919 Solute carrier family 35 member E3  
[Source:UniProtKB/Swiss-Prot;Acc:A4IFK2] 
SNP_62 1538-0062 Chr7:23330398 Chr7:20718957 3‟UTR NP_001039967.1 ENSBTAG00000000668 solute carrier family 22 member 5  
[Source:RefSeq peptide;Acc:NP_001039967] 
SNP_63 1538-0063 Chr9:63303181 Chr9:64264202 3‟UTR NP_001029809.1 ENSBTAG00000014057 "solute carrier family 35 (CMP-sialic acid 
transporter), member A1  [Source:RefSeq 
peptide;Acc:NP_001029809]" 
SNP_64 1538-0064 Chr11:96772566 Chr11:100196170 3‟UTR NP_001039918.1 ENSBTAG00000013314 pre-B-cell leukemia transcription factor 3  
[Source:RefSeq peptide;Acc:NP_001039918] 
SNP_65 1538-0065 Chr11:96772626 Chr11:100196230 3‟UTR NP_001039918.1 ENSBTAG00000013314 pre-B-cell leukemia transcription factor 3  
[Source:RefSeq peptide;Acc:NP_001039918] 
SNP_67 1538-0067 Chr13:59903453 Chr13:60149955 3‟UTR NP_001068977.1 ENSBTAG00000002065 transcription factor AP-2 gamma  
[Source:RefSeq peptide;Acc:NP_001068977] 
SNP_75 1538-0075 Chr20:8038747 Chr20:8480635 3‟UTR NP_001020485.1 ENSBTAG00000010012 basic transcription factor 3  [Source:RefSeq 
peptide;Acc:NP_001020485] 
SNP_76 1538-0076 Chr23:27968593 Chr23:28088619 5‟UTR NP_001094527.1 ENSBTAG00000010698 "general transcription factor IIH, polypeptide 4, 
52kDa  [Source:RefSeq 
peptide;Acc:NP_001094527]" 
SNP_80 1538-0080 Chr25:33291910 Chr25:34830312 3‟UTR GTF2I_BOVIN ENSBTAG00000009780 General transcription factor II-I (GTFII-I)(TFII-
I) [Source:UniProtKB/Swiss-Prot;Acc:A7MB80] 
SNP_82 1538-0082 Chr25:33297474 Chr25:34835878 SYNON GTF2I_BOVIN ENSBTAG00000009780 General transcription factor II-I (GTFII-I)(TFII-
I) [Source:UniProtKB/Swiss-Prot;Acc:A7MB80] 
SNP_95 1538-0095 Chr5:28826280 Chr5:31609528 3‟UTR NP_001076866.1 ENSBTAG00000019312 transcription factor CP2  [Source:RefSeq 
peptide;Acc:NP_001076866] 
SNP_99 1538-0099 Chr5:29279068 Chr5:32123465 NON-SYNON ATF1_BOVIN ENSBTAG00000018131 Cyclic AMP-dependent transcription factor 
ATF-1 (Activating transcription factor 1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q08DA8] 
SNP_100 1538-0100 Chr5:95801232 Chr5:102318724 SYNON NP_001095795.1 ENSBTAG00000003221 activating transcription factor 7 interacting 
protein  [Source:RefSeq 
peptide;Acc:NP_001095795] 
SNP_103 1538-0103 Chr7:47384295 Chr7:44983209 3‟UTR NP_001092656.1 ENSBTAG00000001002 "transcription factor 7 (T-cell specific, HMG-
box)  [Source:RefSeq 
peptide;Acc:NP_001092656]" 
SNP_104 1538-0104 Chr9:29122178 Chr9:29953026 3‟UTR NP_001076874.1 ENSBTAG00000012946 heat shock transcription factor 2  [Source:RefSeq 
peptide;Acc:NP_001076874] 
SNP_105 1538-0105 Chr3:83571563 Chr3:89312654 NON-SYNON DOCK7 ENSBTAG00000019877 Dedicator of cytokinesis protein 7  
[Source:UniProtKB/Swiss-Prot;Acc:Q96N67] 
SNP_109 1538-0109 Chr6:92798767 Chr6:94259546 3‟UTR NP_001095623.1 ENSBTAG00000010956 "scavenger receptor class B, member 2  
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Name Assay ID UMD3.1 
Position 
Btau4 Position Consequence 
of SNP 
Gene Name Ensembl Gene ID Description of gene 
[Source:RefSeq peptide;Acc:NP_001095623]" 
SNP_113 1538-0113 Chr6:38121032 Chr6:37512128 SYNON OSTP_BOVIN ENSBTAG00000005260 Osteopontin Precursor (Bone sialoprotein 
1)(Secreted phosphoprotein 1)(SPP-1) 
[Source:UniProtKB/Swiss-Prot;Acc:P31096] 
SNP_114 1538-0114 Chr5:102960154 Chr5:110568539 NON-SYNON B6ULZ4_BOVIN ENSBTAG00000034678 WC1  
[Source:UniProtKB/TrEMBL;Acc:B6ULZ4] 
SNP_118 1538-0118 Chr9:99649203 Chr9:102168606 5‟UTR NP_001070495.1 ENSBTAG00000011106 PARK2 co-regulated  [Source:RefSeq 
peptide;Acc:NP_001070495] 
SNP_119 1538-0119 Chr3:19695912 Chr3:21166345 3‟UTR TP8L2_BOVIN ENSBTAG00000020394 "Tumor necrosis factor, alpha-induced protein 8-
like protein 2 (TIPE2) 
[Source:UniProtKB/Swiss-Prot;Acc:Q3ZBK5]" 
SNP_120 1538-0120 Chr13:60253499 Chr13:60552967 SPLICE_SITE NSF1C_BOVIN ENSBTAG00000006533 NSFL1 cofactor p47 (p97 cofactor p47) 
[Source:UniProtKB/Swiss-Prot;Acc:Q3SZC4] 
SNP_121 1538-0121 Chr3:27020461 Chr3:29341010 SPLICE_SITE AT1A1_BOVIN ENSBTAG00000001246 Sodium/potassium-transporting ATPase subunit 
alpha-1 Precursor (Sodium pump subunit alpha-
1)(EC 3.6.3.9)(Na(+)/K(+) ATPase alpha-1 
subunit) [Source:UniProtKB/Swiss-
Prot;Acc:Q08DA1] 
SNP_122 1538-0122 Chr29:22710735 Chr29:23625098 SPLICE_SITE VGLU2_BOVIN ENSBTAG00000038347 Vesicular glutamate transporter 2 
(VGluT2)(Solute carrier family 17 member 6) 
[Source:UniProtKB/Swiss-Prot;Acc:A6QLI1] 
SNP_123 1538-0123 Chr17:14434651 Chr17:15210331 STOP_GAINE
D 
FREM3 ENSBTAG00000044051 FRAS1-related extracellular matrix protein 3 
Precursor  [Source:UniProtKB/Swiss-
Prot;Acc:P0C091] 
SNP_124 1538-0124 Chr5:99860724 Chr5:106747054 5‟UTR NP_001002884.1 ENSBTAG00000022861 killer cell lectin-like receptor family J member 1  
[Source:RefSeq peptide;Acc:NP_001002884] 
SNP_125 1538-0125 Chr1:6491257 Chr1:6409151 NON-SYNON NP_001070335.1 ENSBTAG00000020122 ubiquitin specific protease 16  [Source:RefSeq 
peptide;Acc:NP_001070335] 
SNP_126 1538-0126 Chr10:28787955 Chr10:28257660 NON-SYNON AVEN ENSBTAG00000044029  
SNP_128 1538-0128 Chr13:46685530 Chr13:46498304 NON-SYNON IDI1_BOVIN ENSBTAG00000004075 Isopentenyl-diphosphate Delta-isomerase 1 (EC 
5.3.3.2)(Isopentenyl pyrophosphate isomerase 
1)(IPP isomerase 1)(IPPI1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q1LZ95] 
SNP_130 1538-0130 Chr16:44300796 Chr16:40372961 NON-SYNON NP_001095974.1 ENSBTAG00000010401 ubiquitination factor E4B  [Source:RefSeq 
peptide;Acc:NP_001095974] 
SNP_133 1538-0133 Chr2:89583887 Chr2:93460963 NON-SYNON ADO_BOVIN ENSBTAG00000009725 Aldehyde oxidase (EC 1.2.3.1) 
[Source:UniProtKB/Swiss-Prot;Acc:P48034] 
SNP_136 1538-0136 Chr26:11124520 Chr26:11485676 NON-SYNON NP_001069166.1 ENSBTAG00000017367 interferon-induced protein with tetratricopeptide 
repeats 5  [Source:RefSeq 
peptide;Acc:NP_001069166] 
SNP_137 1538-0137 Chr26:42797281 Chr26:43046766 NON-SYNON Q28908_BOVIN ENSBTAG00000022715 Mucin Fragment  
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Name Assay ID UMD3.1 
Position 
Btau4 Position Consequence 
of SNP 
Gene Name Ensembl Gene ID Description of gene 
[Source:UniProtKB/TrEMBL;Acc:Q28908] 
SNP_139 1538-0139 Chr4:70052100 Chr4:72322760 NON-SYNON SNX10_BOVIN ENSBTAG00000001822 Sorting nexin-10  [Source:UniProtKB/Swiss-
Prot;Acc:Q0IIL5] 
SNP_141 1538-0141 Chr1:58938059 Chr1:59327116 3‟UTR VATA_BOVIN ENSBTAG00000002703 V-type proton ATPase catalytic subunit A (V-
ATPase subunit A)(EC 3.6.3.14)(Vacuolar 
proton pump subunit alpha)(V-ATPase 69 kDa 
subunit) [Source:UniProtKB/Swiss-
Prot;Acc:P31404] 
SNP_142 1538-0142 Chr10:12412917 Chr10:12288215 3‟UTR PTAD1_BOVIN ENSBTAG00000015155 Protein tyrosine phosphatase-like protein 
PTPLAD1 (Protein-tyrosine phosphatase-like A 
domain-containing protein 1) 
[Source:UniProtKB/Swiss-Prot;Acc:A7YY55] 
SNP_144 1538-0143 Chr11:46349799 Chr11:48188084 3‟UTR IL1A_BOVIN ENSBTAG00000010349 Interleukin-1 alpha Precursor (IL-1 alpha) 
[Source:UniProtKB/Swiss-Prot;Acc:P08831] 
SNP_145 1538-0144 Chr13:43330508 Chr13:43253392 3‟UTR GDIB_BOVIN ENSBTAG00000005316 Rab GDP dissociation inhibitor beta (Rab GDI 
beta)(Guanosine diphosphate dissociation 
inhibitor 2)(GDI-2) [Source:UniProtKB/Swiss-
Prot;Acc:P50397] 
SNP_146 1538-0145 Chr15:17460234 Chr15:15622104 3‟UTR ELMD1_BOVIN ENSBTAG00000002691 ELMO domain-containing protein 1  
[Source:UniProtKB/Swiss-Prot;Acc:Q0IIE6] 
SNP_147 1538-0146 Chr15:3493351 Chr15:2115975 3‟UTR CASPD_BOVIN ENSBTAG00000020884 Caspase-13 Precursor (CASP-13)(EC 3.4.22.-
)(Evolutionary related interleukin-1-beta-
converting enzyme)(ERICE) [Contains Caspase-
13 subunit 1;Caspase-13 subunit 2] 
[Source:UniProtKB/Swiss-Prot;Acc:O75601] 
SNP_149 1538-0148 Chr15:47331292 Chr15:45808076 3‟UTR PRDBP_BOVIN ENSBTAG00000019754 Protein kinase C delta-binding protein  
[Source:UniProtKB/Swiss-Prot;Acc:A4FV37] 
SNP_150 1538-0149 Chr19:5818851 Chr19:4770650 3‟UTR NP_001069069.1 ENSBTAG00000000205 monocyte to macrophage differentiation-
associated  [Source:RefSeq 
peptide;Acc:NP_001069069] 
SNP_151 1538-0150 Chr2:125811079 Chr2:129403297 3‟UTR PTAFR_BOVIN ENSBTAG00000027051 Platelet-activating factor receptor (PAF-
R)(PAFr) [Source:UniProtKB/Swiss-
Prot;Acc:Q9TTY5] 
SNP_152 1538-0151 Chr29:5056001 Chr29:5264699 3‟UTR CHRD1_BOVIN ENSBTAG00000013615 Cysteine and histidine-rich domain-containing 
protein 1 (CHORD domain-containing protein 1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q29RL2] 
SNP_153 1538-0152 Chr3:78644503 Chr3:84013404 3‟UTR S35D2_BOVIN ENSBTAG00000005445 UDP-N-acetylglucosamine/UDP-glucose/GDP-
mannose transporter (Solute carrier family 35 
member D2) [Source:UniProtKB/Swiss-
Prot;Acc:A2VE55] 
SNP_156 1538-0155 Chr13:7542738 Chr13:7503555 SYNON Q0IIB7_BOVIN ENSBTAG00000004302 C13H20ORF7 protein Fragment  
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Name Assay ID UMD3.1 
Position 
Btau4 Position Consequence 
of SNP 
Gene Name Ensembl Gene ID Description of gene 
[Source:UniProtKB/TrEMBL;Acc:Q0IIB7] 
SNP_157 1538-0156 Chr15:6203634 Chr15:4895096 SYNON NP_001092477.1 ENSBTAG00000040567 matrix metalloproteinase 27  [Source:RefSeq 
peptide;Acc:NP_001092477] 
SNP_160 1538-0159 Chr22:1807200 Chr22:1605654 SYNON NP_001092396.1 ENSBTAG00000018227 "solute carrier family 4, sodium bicarbonate 
cotransporter, member 7  [Source:RefSeq 
peptide;Acc:NP_001092396]" 
SNP_161 1538-0160 Chr22:1807251 Chr22:1605705 SYNON NP_001092396.1 ENSBTAG00000018227 "solute carrier family 4, sodium bicarbonate 
cotransporter, member 7  [Source:RefSeq 
peptide;Acc:NP_001092396]" 
SNP_162 1538-0161 Chr22:29391700 Chr22:29991401 SYNON RYBP ENSBTAG00000022689 RING1 and YY1-binding protein (Death effector 
domain-associated factor)(DED-associated 
factor)(YY1 and E4TF1-associated factor 
1)(Apoptin-associating protein 1)(APAP-1) 
[Source:UniProtKB/Swiss-Prot;Acc:Q8N488] 
SNP_163 1538-0162 Chr23:25183813 Chr23:25961459 SYNON ELOV5_BOVIN ENSBTAG00000003359 Elongation of very long chain fatty acids protein 
5  [Source:UniProtKB/Swiss-Prot;Acc:Q2KJD9] 
SNP_165 1538-0164 Chr26:32981542 Chr26:33115701 SYNON PLSB_BOVIN ENSBTAG00000011917 "Glycerol-3-phosphate acyltransferase, 
mitochondrial Precursor (GPAT)(EC 2.3.1.15) 
[Source:UniProtKB/Swiss-Prot;Acc:Q5GJ77]" 
SNP_166 1538-0165 Chr26:42711970 Chr26:42951722 SYNON O97658_BOVIN ENSBTAG00000008389 Serine protease Fragment  
[Source:UniProtKB/TrEMBL;Acc:O97658] 





Table S2: Complete list of BWA/GATK SNPs with consequences and annotated gene names 
This table is too large to be reproduced here and can be accessed at 
http://www.plosone.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0048792.s002 
 
Table S3: List of genes that had at least one synonymous or non-synonymous SNP, with dN/dS ratios and p values calculated with PAML 
This table is too large to be reproduced here and can be accessed at 
http://www.plosone.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0048792.s003
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Table S4: David annotation of genes with dN/dS ratios of 99, which are mainly those with no synonymous SNPs 
Annotation 
Cluster 1 
Enrichment Score: 2.404780122112932 









Bonf Benj FDR 
INTERPRO IPR001304:C-type 
lectin 




56 49 9171 13.3688 0.385 0.385 3.661 




31 49 4364 11.49177 0.138 0.138 3.774 
INTERPRO IPR016186:C-type 
lectin-like 




56 56 9171 11.6977 0.509 0.299 5.306 
 
 
Table S5: David annotation of genes that had dN/dS ratios significantly less than 1 
This table is too large to be reproduced here and can be accessed at 
http://www.plosone.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0048792.s005
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Bovine tuberculosis (BTB) is a chronic, highly infectious disease that affects humans, cattle 
and numerous species of wildlife. In developing countries such as South Africa, the existence 
of extensive wildlife-human-livestock interfaces poses a significant risk of Mycobacterium 
bovis transmission between these groups, and has far-reaching ecological, economic and 
public health impacts. The African buffalo (Syncerus caffer), acts as a maintenance host for 
Mycobacterium bovis, and maintains and transmits the disease within the buffalo and to other 
species. In this study we aimed to investigate genetic susceptibility of buffalo for 
Mycobacterium bovis infection. Samples from 868 African buffalo of the Cape buffalo 
subspecies were used in this study. SNPs (n=69), with predicted functional consequences in 
genes related to the immune system, were genotyped in this buffalo population by 
competitive allele-specific SNP genotyping. Case-control association testing and statistical 
analyses identified three SNPs associated with BTB status in buffalo. These SNPs, SNP41, 
SNP137 and SNP144, are located in the SLC7A13, DMBT1 and IL1α genes, respectively. 
SNP137 remained significantly associated after permutation testing. The three genetic 
polymorphisms identified are located in promising candidate genes for further exploration 
into genetic susceptibility to BTB in buffalo and other bovids, such as the domestic cow. 
These polymorphisms/genes may also hold potential for marker-assisted breeding 
programmes, with the aim of breeding more BTB-resistant animals and herds within both the 
national parks and the private sector. 




Bovine tuberculosis (BTB) is a chronic, highly infectious disease which affects humans, 
cattle and wildlife. BTB is caused by infection with Mycobacterium bovis, which is a member 
of the Mycobacterium tuberculosis complex. In developing countries such as South Africa, 
the existence of extensive wildlife-human-livestock interfaces poses a significant risk of 
transmission between these groups, and has far-reaching ecological, economic and public 
health impacts [1–3]. In addition to the impact on biodiversity and ecotourism, rural 
communities at these wildlife interfaces can also be severely affected, with bovine TB 
compromising their health, food supply and livelihoods. Many people are reliant on 




unpasteurised milk and meat from their livestock for food supply and high levels of HIV 
prevalence within these communities dramatically increases susceptibility to BTB infection 
[1,3]. 
 
In the absence of a wildlife reservoir, most developed countries have effectively used test and 
cull schemes to reduce BTB prevalence in cattle to extremely low levels. This system is 
seldom utilised, or effective, in developing countries with a wildlife reservoir that maintains 
BTB within the environment [4]. In South Africa, the African buffalo (Syncerus caffer), acts 
as a maintenance host/reservoir for M. bovis, and thus maintains and transmits the disease 
within the buffalo populations and to other species [1,5]. It is a species of enormous 
economic and ecological importance, due to its occurrence in large numbers in the savannah 
ecosystem, commercial game farming, tourism, and for hunting purposes [1]. This poses a 
significant obstacle to the management and control of BTB. Different BTB management 
strategies with regards to buffalo are implemented in the different game parks and private 
reserves within South Africa, and new methods of detection and control are constantly under 
investigation.  
 
Studies in humans have reported multiple genetic factors and polymorphisms in a number of 
different genes to be associated with tuberculosis susceptibility [6]. In animal studies, the 
heritability of BTB resistance has been shown to be 0.48 ± 0.09 in red deer [7], 0.18 ± 0.04 in 
British dairy cattle [8] and 0.18 ± 0.04 in Irish cattle [9], suggesting a genetic component in 
BTB susceptibility in these animals, which may be more pronounced in wildlife. A recent 
study by Sun et al. [10] investigated the role of host genetic factors in susceptibility to BTB 
in Chinese Holstein cattle, and found the G1596A polymorphism in the toll-like receptor 1 
(TLR1) gene to be associated with BTB infection status. Finlay et al. (2012) performed a 
genome-wide association scan in Irish cattle and identified a genomic region on BTA 22 
associated with BTB susceptibility [11]. The identification of host genetic factors involved in 
BTB susceptibility in African buffalo may allow for marker-assisted selection for breeding 
programs, as a possible long-term disease management alternative, particularly in areas 
currently free of BTB or with low prevalence levels. 
 
Mycobacterium bovis is primarily transmitted between animals by inhalation, and to a lesser 
degree, ingestion [3,12]. After inhalation, bacilli adhere to the alveolar surface of the lung 
and are phagocytosed by macrophages. Macrophages then process the mycobacterial antigens 




and present them to T-lymphocytes, which are considered essential recognition components 
of the immune response. Typical tuberculous lesions in buffalo occur most often in the lungs 
and lymph nodes, but can also be found in other, more distal sites [5]. Resistance to infection 
and disease could be mediated by either the innate or adaptive immune systems and therefore 
the genes related to either of these processes may be candidate genes for BTB susceptibility 
loci.  
In this study, candidate polymorphisms in genes involved in the immune response were 
selected from the SNPs that we recently identified and validated in the African buffalo [13]. 
These SNPs were tested for genetic associations with BTB infection status in African buffalo, 
using a case-control approach. 
 
2. Materials & Methods 
2.1 Ethics 
The Stellenbosch University Animal Care and Use Committee (SU ACU) deemed it 
unnecessary to obtain ethical clearance for this study as the blood samples used for DNA 
extraction were collected under the directive of SANParks and Ezemvelo KZN Wildlife for 
other purposes, and their use in the present study is incidental. 
2.2 Study Population 
The DNA used in the association study was derived from 868 African buffalo (198 cases, 670 
controls) of the Cape buffalo subspecies, consisting of two independent populations. The 
population subgroups consisted of 434 buffalo from the Kruger National Park (KNP), and 
434 buffalo from Hluhluwe iMfolozi Park (HiP) (Figure 1). Both KNP and HiP have known 
histories of BTB in both buffalo and other wildlife species, and given the social herd structure 
of this species, both cases and controls were considered equally exposed. Blood samples were 
taken from the buffalo subpopulations during routine BTB testing operations, by qualified 
SANParks or Ezemvelo KZN Wildlife veterinary staff. In the KNP samples, cases and 
controls were defined by the positive or negative outcome of the Bovigam® ELISA assay. 
HiP samples were defined as cases or controls based on the results of the standard single 
comparative intradermal tuberculin (SCIT) test, administered following capture, with a test 
result considered positive when the difference in skin fold swelling between the avian and 
bovine inflammatory responses was greater than or equal to 2mm. Recent publications have 




suggested that that a cut-off of >2mm for positive test interpretation in cattle is most 
appropriate in sub-Saharan Africa [14,15]. Overall BTB prevalence in our samples in the 
KNP and HiP subpopulations was 22% and 23.5% respectively (own unpublished data). 
 
 
Figure 1: Location of the African buffalo populations in South Africa used in this study. 
 
2.3 Preparation of genomic DNA 
The Kruger National Park DNA samples were extracted from blood, using a salt-chloroform 
extraction method [16]. KNP Samples which contained insufficient concentrations of DNA 
for the purposes of this study were subjected to whole genome amplification (WGA) using 
the Illustra Genomiphi DNA Amplification Kit (GE Healthcare Life Sciences, Piscataway, 
USA), which employs a strand displacement amplification technique, according to the 
manufacturer‟s instructions. DNA was extracted from the HiP EDTA blood samples using 
the Qiagen DNeasy Blood and Tissue Kit (Qiagen Group®), according to the manufacturer‟s 
instructions. 
2.4 SNP selection and genotyping 
SNP selection was made from previously validated SNPs [13], with priority given to those 
with higher frequencies in the validation panel. These SNPs all had potentially functional 




consequences, due to their positions in the 3‟UTR, 5‟UTR and coding regions, in genes 
related to the immune system. In total, 69 SNPs were fluorescently genotyped in the full 
buffalo population by LGC Genomics KBioscience [17] (London, United Kingdom), using 
their competitive allele-specific KASP® SNP genotyping platform. The KASP® assay 
system relies on the discrimination power of a FRET-based homogenous form of competitive 
allele-specific PCR to determine the alleles at a specific locus within genomic DNA [17]. A 
block randomisation technique was employed to evenly distribute the samples across the 10 
plates used for the genotyping in order to minimise batch effects. Variables considered 
included BTB infection status, location and sex. Positive controls were included on all plates 
to ensure consistent results. The selected SNPs and their assay IDs can be seen in Table S1. 
2.5 Statistical analysis 
Genetic differentiation between the KNP and HiP subpopulations was tested using FST 
values in Genepop v4.0.10 [18,19]. Further statistical analyses were performed in Plink v1.07 
(http://pngu.mgh.harvard.edu/purcell/plink/) [20]. SNPs in this study were not removed if 
they were out of Hardy-Weinberg Equilibrium (HWE), as due to the social structure of a 
buffalo herd, non-random mating is observed and thus the expectations of HWE do not hold 
for this data. African buffalo display a male dominance hierarchy, with a select number of 
dominant bulls mating with the sexually mature females, who are often related. This suggests 
a degree of relatedness within a herd [21]. The populations were analysed together in order to 
minimise the effect of any possible relatedness present in the individual herds. Quality 
control consisted of removing individuals with more than 10% missing data (genotyping 
failure) and SNPs that had a call rate of less than 90%. Pairwise linkage disequilibrium 
measures were calculated for all SNP pairs using correlations based on genotype allele 
counts, including those on different chromosomes. Allele frequencies, odds ratios (OR) and 
95% confidence intervals were determined and the associated p-values were calculated using 
Fisher‟s Exact test. A p-value <0.05 was regarded as significant. The Cochran-Mantel-
Haenszel (CMH) test was used to obtain an average odds ratio and associated p-value for 
each SNP, adjusting for the two subpopulations. Genotypic associations with BTB infection 
were tested using the Cochran-Armitage trend test for the additive allele effect. The Cochran-
Armitage trend test was considered the most applicable genotypic test for this study, as it 
does not assume HWE. Logistic regression analysis was also used to calculate odds ratios and 
95% confidence intervals, assuming an additive effect of allele dosage. We controlled for 
subpopulation and sex by including those covariates in the logistic regression model. 




Permutation testing was performed using the max(T) permutation method with 5000 
permutations, to obtain an empirical p-value for each SNP. SNPs found to be significantly 
associated with BTB status in the buffalo after correcting for the population structure were 
investigated further. Non-synonymous SNPs were submitted to the Ensembl Variant Effect 
Predictor [22] in order to establish the type and position of the amino acid changes caused.  
 
3. Results 
The SNPs in this study comprised 69 loci across 64 genes, previously selected for possible 
functional consequence and gene location. The FST value for the genetic differentiation 
between the two subpopulations was 0.1345. Quality control removed 24 individuals due to 
missing data. No SNPs were excluded due to call rate. Because of the non-random mating 
structure within the buffalo herds, HWE was not tested. Two loci, SNP105 and SNP160, 
were identified as being in linkage disequilibrium with other SNPs (r2 > 0.5) and were 
excluded. Fisher‟s Exact test for allelic association identified four SNPs with significantly 
different frequencies between cases and controls (p < 0.05): SNP30, SNP41, SNP137 and 
SNP144. After adjusting for differences due to the subpopulations using the CMH test, three 
of the four previously identified SNPs remained significantly associated. Following 
correction for false positives using the max(T) permutation method, SNP137 was identified 
as significantly associated with BTB status. Associated SNPs in the allelic association and 
CMH tests, and the accompanying odds ratios and p values, can be seen in Table 1. SNP30 
and SNP144 are located in the 3‟UTRs of the complement component C7 gene and the 
interleukin 1-alpha (IL1α) gene, respectively. SNP41 and SNP137 are located in the coding 
regions of the solute carrier family 7 (anionic amino acid transporter), member 13 
(SLC7A13) gene and Deleted in Malignant Brain Tumour (DMBT1) genes, respectively. All 
SNPs, allele frequencies, odds ratios and p values for the CMH test can be seen in Table S2. 
The Cochran-Armitage trend test for genotypic association identified the same four SNPs 
(SNP30, SNP41, SNP137 and SNP144) as significant. No significant associations remained 








Table 1: Allele frequencies, odds ratios and p-values of four significant SNPs  
SNP Allele Fcase Fcont OR (95% CI) P CMH OR (95% CI) CMH P Pemp 
30 G 0.225 0.276 0.761 (0.581-0.995) 0.048 0.765 (0.584-1.002) 0.0514 0.973 
41 C 0.347 0.285 1.335 (1.047-1.702) 0.022 1.377 (1.075-1.764) 0.0116 0.559 
137 G 0.423 0.332 1.472 (1.163-1.863) 0.001 1.608 (1.243-2.079) 0.0003 0.024 
144 T 0.353 0.294 1.312 (1.03-1.67) 0.032 1.421 (1.095-1.843) 0.008 0.431 
Pemp: Empirical p-value obtained by max(T) permutation 
 
Logistic regression analysis incorporating both sex and subpopulation as covariates identified 
SNP41, SNP137 and SNP144 as significantly associated with BTB status. Logistic regression 
analysis incorporating only subpopulation as a covariate produced the same result, and sex 
was not identified as a significant factor in this study (data not shown). After correction using 
max(T) permutation, SNP137 remained significantly associated. We note that the SNP137 
was also significantly associated in the allelic, genotypic and logistic regression tests in both 
the HiP and KNP populations when analysed separately (data not shown). The significant 
logistic regression model results, odds ratios and p-values can be seen in Table 2, and the 
logistic regression results for all SNPs in Table S3. 
 
Table 2: Logistic regression model with significant SNPs, odds ratios and p-values 
SNP Allele Test OR (95% CI) P Pperm 
41 C ADD 1.349 (1.06-1.715) 0.01474* 0.6265 
41 C COV1 a 1.222 (0.8746-1.708) 0.2397 
 137 G ADD 1.574 (1.221-2.029) 0.000461* 0.02599* 
137 G COV1 1.47 (1-2.16) 0.04982*  
144 T ADD 1.435 (1.101-1.87) 0.007569* 0.3893 
144 T COV1 1.396 (0.9605-2.029) 0.08032 
 aCOV1 refers to the population subgroup 
* denotes statistical significance, p<0.05 
 
The amino acid changes caused by SNP41 and SNP137, as well as their positions in their 
respective proteins, were identified by the Ensemble Variant Effect Predictor (Table 3). 
Although both the DMBT1 and SLC7A13 proteins are uncharacterised in the cow, SNP137 
was predicted to occur in a CUB domain within the DMBT1 protein. CUB domains are 




evolutionarily conserved protein domains found commonly in extracellular and plasma-
membrane associated proteins [23].  
 





















41 14:79862771 C ENSBTAG00000040461 missense 1444 1330 444 I/V 
137 26:42797281 G ENSBTAG00000022715 missense 3350 3350 1117 H/R 




To our knowledge, this is the first report of genetic susceptibility to bovine TB in the African 
buffalo. In other bovids, specifically the domestic cow, very few loci have been identified, 
apart from microsatellite loci [24], TLR1 [10] and a genomic region on BTA 22 [11].  In this 
study, we investigated 69 SNPs located in genes relating to the immune system for 
association with BTB infection status in African buffalo, using a large sample set of 868 
buffalo samples from two independent populations, the Kruger National Park and Hluhluwe 
iMfolozi Park. Prior to correction for the population subgroups, four SNPs were identified as 
associated with BTB status – SNP30, SNP41, SNP137 and SNP144. The FST value of 0.13 
suggests that there is a degree of differentiation between the buffalo populations, which 
necessitates controlling for. After correction for population subgroups using the Cochran-
Mantel-Haenszel test and logistic regression analysis, three SNPs remained significantly 
associated: SNP41, SNP137 and SNP144. 
SNP41 occurs in the SLC7A13 gene, and is predicted to cause a non-synonymous amino acid 
substitution at position 444 in this protein, from isoleucine to valine. The SLC7A13 gene 
forms part of the family of heteromeric amino acid transporters (HATs). HATs are comprised 
of a heavy and a light chain/subunit, and the SLC7A13 gene encodes one of the light subunits 
[25,26]. The light subunits are highly hydrophobic and are suggested to have a 12 
transmembrane-domain topology [25]. While SLC7A13 is relatively uncharacterised, other 
transporters, such as SLC11A1 (NRAMP1), have been associated with TB infection in 
humans [27,28].   




SNP137 is located in the coding region of the Deleted in Malignant Brain Tumour-1 
(DMBT1) gene. This SNP is predicted to cause a substitution at position 1117 of the protein, 
from histidine to arginine. The DMBT1 gene produces a number of different protein 
isoforms, all of which belong to the scavenger receptor cysteine-rich (SRCR) superfamily of 
proteins. SRCR proteins are highly conserved throughout the metazoa, and contain two CUB 
domains and one zona pellucida domain [29]. The glycoprotein isoforms have been shown to 
have a range of functions that include the binding of both gram-positive and gram-negative 
bacteria, binding to viral proteins, and binding to host surfactant proteins A and D, among 
others, which are collectins that play an important role in the innate immune response 
[30,31]. Both DMBT1 and the mouse homolog of this protein (CRP-ductin) are regarded as 
pattern recognition receptors (PRRs), which are a well-established part of the human host 
defence system against invading organisms such as M. tuberculosis. PRRs recognize 
conserved structures in bacterial cell walls, yeast cell walls, and bacterial DNA that are vital 
to the survival of the invading organism [29,32]. Many members of the SRCR superfamily 
have been shown to be located on immune cells such as B-lymphocytes, T-lymphocytes and 
macrophages, and the role of the DMBT1 proteins in the innate immune response has been 
well established [30]. While evidence is lacking for the bovine protein, the conserved nature 
of these proteins suggests a similar function in the domestic cow.  
SNP144 is found in the 3‟ untranslated region (UTR) of the Interleukin 1 alpha (IL1α) gene. 
The IL1α protein belongs to the IL1 family of pro-inflammatory cytokines, and plays a role 
in the activation of T-lymphocytes, the recruitment of leucocytes to sites of inflammation, 
and mediating local and systemic inflammation, and is expressed predominantly by 
macrophages and neutrophils [33,34]. A study by Bellamy et al. [35] found a significant 
association between the IL1 gene cluster and M. tuberculosis in humans, although this was 
lost for IL1α after Bonferroni correction. 
While the results of this study are promising, there were some limitations, most notably the 
difficulties of working with a non-model organism without an assembled genome or well-
established population data. Because our buffalo herd data falls somewhere between that of 
population data and family data, and the degree of relatedness among the cases and controls 
prevented the investigation of SNPxSNP interactions. The second limitation faced was the 
different diagnostic methods used for the two population groups. The Bovigam® ELISA 
assay was used to diagnose BTB infection in the Kruger National Park buffalo, and the SCIT 
test was used in Hluhluwe iMfolozi Park, but since both of these tests are based on a cell-




mediated immune response and therefore expected to detect animals at a similar stage of 
infection [36,37], this was not considered problematic in this study. 
In conclusion, our study has identified three genetic polymorphisms, in the SLC7A13, IL1α 
and DMBT1 genes, that are associated with bovine TB infection status in the African buffalo. 
The association of the three polymorphisms listed above were robust to correction for buffalo 
population, and one remained significant after permutation testing. The large number of 
individuals used in this study, the randomisation procedure and statistical controls employed, 
and the plausibility of the genes identified suggest that these polymorphisms are located in 
excellent candidate genes for further exploration into genetic susceptibility to BTB in both 
the buffalo and other bovids, such as the domestic cow. These genes may also have potential 
for marker-assisted breeding programmes, with the aim of breeding more BTB resistant 
animals and herds within both the national parks and the private sector. 
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Table S1: SNP identifiers, Assay IDs, UMD3 positions, Ensembl gene ID and names, consequences 
Name KBioscience Assay UMD3 Chr UMD3 position EnsGeneId Gene  Consequence 
SNP_1 1538-0001 Chr11 7179447 ENSBTAG00000001034 IL-18Ra Non-Synon 
SNP_4 1538-0004 Chr17 63612902 ENSBTAG00000014628 Oas2 Non-Synon 
SNP_6 1538-0006 Chr1 111031389 ENSBTAG00000009012 PTX3 Non-Synon 
SNP_7 1538-0007 Chr1 143152388 ENSBTAG00000008471 MX2 Non-Synon 
SNP_8 1538-0008 Chr22 53599791 ENSBTAG00000008099 CCR5 Non-Synon 
SNP_13 1538-0013 Chr3 78427756 ENSBTAG00000014983 IL-23R Non-Synon 
SNP_16 1538-0016 Chr5 36884961 ENSBTAG00000021105 IRAK4 Non-Synon 
SNP_17 1538-0017 Chr5 36890957 ENSBTAG00000021105 IRAK4 Non-Synon 
SNP_18 1538-0018 Chr5 47797051 ENSBTAG00000007636 IrakM Non-Synon 
SNP_19 1538-0019 Chr5 47817597 ENSBTAG00000007636 IrakM Non-Synon 
SNP_25 1538-0025 Chr7 98739431 ENSBTAG00000039275 ERAP2 Non-Synon 
SNP_30 1538-0030 Chr20 33550138 ENSBTAG00000011766 C7 3' UTR 
SNP_41 1538-0041 Chr14 79862771 ENSBTAG00000040461 SLC7A13 Non-Synon 
SNP_56 1538-0056 Chr22 55714039 ENSBTAG00000005857 SLC6A1 3' UTR 
SNP_57 1538-0057 Chr3 103930723 ENSBTAG00000009617 SLC2A1 3' UTR 
SNP_59 1538-0059 Chr5 45246904 ENSBTAG00000031919 SLC35E3 3' UTR 
SNP_62 1538-0062 Chr7 23330398 ENSBTAG00000000668 SLC22A5 3' UTR 
SNP_63 1538-0063 Chr9 63303181 ENSBTAG00000014057 SLC35A1 3' UTR 
SNP_64 1538-0064 Chr11 96772566 ENSBTAG00000013314 PBX3 3'UTR 
SNP_65 1538-0065 Chr11 96772626 ENSBTAG00000013314 PBX3 3'UTR 
SNP_67 1538-0067 Chr13 59903453 ENSBTAG00000002065 TFAP2C 3'UTR 
SNP_75 1538-0075 Chr20 8038747 ENSBTAG00000010012 Btf3 3'UTR 
SNP_76 1538-0076 Chr23 27968593 ENSBTAG00000010698 GTF2H4 5'UTR 
SNP_80 1538-0080 Chr25 33291910 ENSBTAG00000009780 GTF2I 3'UTR 
SNP_82 1538-0082 Chr25 33297474 ENSBTAG00000009780 GTF2I Synon 
SNP_95 1538-0095 Chr5 28826280 ENSBTAG00000019312 TFCP2 3'UTR 
SNP_99 1538-0099 Chr5 29279068 ENSBTAG00000018131 ATF1 Non-Synon 
SNP_100 1538-0100 Chr5 95801232 ENSBTAG00000003221 ATF7IP Synon 
SNP_103 1538-0103 Chr7 47384295 ENSBTAG00000001002 TCF7 3'UTR 
SNP_104 1538-0104 Chr9 29122178 ENSBTAG00000012946 HSF2 3'UTR 
SNP_105 1538-0105 Chr3 83571563 ENSBTAG00000019877 DOCK7 Non-Synon 
SNP_109 1538-0109 Chr6 92798767 ENSBTAG00000010956 SCARB2 3'UTR 
SNP_113 1538-0113 Chr6 38121032 ENSBTAG00000005260 SPP1 Synon 
SNP_114 1538-0114 Chr5 102960154 ENSBTAG00000034678 Unchar Non-Synon 
SNP_118 1538-0118 Chr9 99649203 ENSBTAG00000011106 PACRG 5'UTR 
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Name KBioscience Assay UMD3 Chr UMD3 position EnsGeneId Gene  Consequence 
SNP_119 1538-0119 Chr3 19695912 ENSBTAG00000020394 TNFAIP8L2 3'UTR 
SNP_120 1538-0120 Chr13 60253499 ENSBTAG00000006533 NSFL1C Splice_Site 
SNP_121 1538-0121 Chr3 27020461 ENSBTAG00000001246 ATP1A1 Splice_Site 
SNP_122 1538-0122 Chr29 22710735 ENSBTAG00000038347 SLC17A6 Splice_Site 
SNP_123 1538-0123 Chr17 14434651 ENSBTAG00000044051 FREM3 Stop_Gained 
SNP_124 1538-0124 Chr5 99860724 ENSBTAG00000022861 KLRJ1 5‟UTR 
SNP_126 1538-0126 Chr10 28787955 ENSBTAG00000044029 AVEN Non-Synon 
SNP_128 1538-0128 Chr13 46685530 ENSBTAG00000004075 IDI1 Non-Synon 
SNP_130 1538-0130 Chr16 44300796 ENSBTAG00000010401 UBE4B Non-Synon 
SNP_136 1538-0136 Chr26 11124520 ENSBTAG00000017367 IFIT5 Non-Synon 
SNP_137 1538-0137 Chr26 42797281 ENSBTAG00000022715 DMBT1 Non-Synon 
SNP_139 1538-0139 Chr4 70052100 ENSBTAG00000001822 SNX10 Non-Synon 
SNP_141 1538-0141 Chr1 58938059 ENSBTAG00000002703 ATP6V1A 3‟UTR 
SNP_142 1538-0142 Chr10 12412917 ENSBTAG00000015155 PTPLAD1 3‟UTR 
SNP_144 1538-0143 Chr11 46349799 ENSBTAG00000010349 IL1A 3‟UTR 
SNP_145 1538-0144 Chr13 43330508 ENSBTAG00000005316 GDI2 3‟UTR 
SNP_146 1538-0145 Chr15 17460234 ENSBTAG00000002691 ELMOD1 3‟UTR 
SNP_147 1538-0146 Chr15 3493351 ENSBTAG00000020884 CASP13 3‟UTR 
SNP_149 1538-0148 Chr15 47331292 ENSBTAG00000019754 PRKCDBP 3‟UTR 
SNP_150 1538-0149 Chr19 5818851 ENSBTAG00000000205 MMD 3‟UTR 
SNP_151 1538-0150 Chr2 125811079 ENSBTAG00000027051 PTAFR 3‟UTR 
SNP_152 1538-0151 Chr29 5056001 ENSBTAG00000013615 CHORDC1 3‟UTR 
SNP_153 1538-0152 Chr3 78644503 ENSBTAG00000005445 SLC35D1 3‟UTR 
SNP_156 1538-0155 Chr13 7542738 ENSBTAG00000004302 C13H20orf7 Synon 
SNP_157 1538-0156 Chr15 6203634 ENSBTAG00000040567 MMP27 Synon 
SNP_160 1538-0159 Chr22 1807200 ENSBTAG00000018227 SLC4A7 Synon 
SNP_161 1538-0160 Chr22 1807251 ENSBTAG00000018227 SLC4A7 Synon 
SNP_162 1538-0161 Chr22 29391700 ENSBTAG00000022689 RYBP Synon 
SNP_163 1538-0162 Chr23 25183813 ENSBTAG00000003359 ELOVL5 Synon 
SNP_165 1538-0164 Chr26 32981542 ENSBTAG00000011917 GPAM Synon 
SNP_166 1538-0165 Chr26 42711970 ENSBTAG00000008389 HTRA1 Synon 
SNP_168 1538-0167 Chr28 8444446 ENSBTAG00000016804 LYST Synon 
SNP_169 1538-0168 Chr3 48853655 ENSBTAG00000020344 SLC44A3 Synon 
SNP_171 1538-0170 Chr5 80508595 ENSBTAG00000005365 OVCH1 Synon 
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Table S2: All allele frequencies, odds ratios and p-values for Cochran-Mantel-Haenszel test 
SNP A1 MAF P OR L95 U95 
SNP1 T 0.2257 0.994 0.999 0.7589 1.315 
SNP4 A 0.1924 0.8609 1.029 0.7501 1.411 
SNP6 A 0.3726 0.8837 1.021 0.7782 1.338 
SNP7 C 0.4656 0.7015 1.046 0.8309 1.317 
SNP8 A 0.4618 0.923 1.011 0.8027 1.275 
SNP13 C 0.3865 0.5633 1.074 0.8434 1.367 
SNP16 T 0.2125 0.8461 1.028 0.7773 1.359 
SNP17 G 0.3683 0.5312 0.9238 0.7188 1.187 
SNP18 A 0.3582 0.723 1.046 0.8105 1.351 
SNP19 C 0.2088 0.5743 1.088 0.8118 1.458 
SNP25 G 0.3714 0.6563 1.058 0.825 1.357 
SNP30 G 0.2648 0.05136 0.7651 0.5843 1.002 
SNP41 C 0.2992 0.01157 1.377 1.075 1.764 
SNP56 A 0.4222 0.8318 0.9745 0.7678 1.237 
SNP57 T 0.4334 0.09275 1.22 0.9675 1.538 
SNP59 A 0.4839 0.2167 0.8609 0.6791 1.091 
SNP62 A 0.2749 0.8018 1.034 0.7976 1.34 
SNP63 A 0.117 0.9125 0.9799 0.6827 1.407 
SNP64 G 0.07895 0.3054 0.7869 0.4976 1.244 
SNP65 G 0.3943 0.4663 0.9036 0.6832 1.195 
SNP67 A 0.2822 0.6623 0.9439 0.7277 1.224 
SNP75 A 0.2313 0.7808 0.9618 0.7315 1.265 
SNP76 A 0.2287 0.06302 1.281 0.9855 1.664 
SNP80 G 0.2643 0.9927 0.9987 0.7623 1.308 
SNP82 G 0.4393 0.7198 1.043 0.8284 1.314 
SNP95 C 0.09476 0.9157 1.022 0.6826 1.53 
SNP99 C 0.1752 0.6263 0.9258 0.6783 1.264 
SNP100 A 0.07355 0.7649 0.9352 0.6015 1.454 
SNP103 A 0.07873 0.7784 0.9378 0.5999 1.466 
SNP104 T 0.2173 0.9697 0.9946 0.7533 1.313 
SNP105 A 0.2038 0.6905 0.9365 0.6779 1.294 
SNP109 A 0.3966 0.9377 1.011 0.7758 1.317 
SNP113 G 0.3521 0.8984 0.9819 0.7434 1.297 
SNP114 T 0.3255 0.8603 1.022 0.7985 1.309 
SNP118 A 0.3237 0.8256 0.9722 0.7562 1.25 
SNP119 A 0.1358 0.9725 0.9941 0.709 1.394 
SNP120 T 0.2151 0.07114 0.7481 0.5473 1.023 
SNP121 A 0.1105 0.8343 0.9615 0.6656 1.389 
SNP122 A 0.0427 0.3563 0.7502 0.4067 1.384 
SNP123 C 0.1615 0.4722 1.119 0.823 1.523 
SNP124 T 0.4119 0.9227 1.012 0.7988 1.282 
SNP126 A 0.08523 0.5599 0.8807 0.5753 1.348 
SNP128 A 0.1866 0.07736 1.299 0.9717 1.736 
SNP130 G 0.3132 0.788 0.9655 0.7477 1.247 
SNP136 G 0.04111 0.2946 1.337 0.7763 2.303 
SNP137 G 0.3529 0.0002763 1.608 1.243 2.079 
SNP139 T 0.2506 0.8931 1.019 0.7709 1.348 
SNP141 A 0.2506 0.697 1.053 0.8108 1.369 
SNP142 A 0.2557 0.9318 1.012 0.7713 1.327 
SNP144 T 0.3076 0.007927 1.421 1.095 1.843 
SNP145 G 0.3854 0.6788 0.9505 0.7475 1.209 
SNP146 G 0.2385 0.7778 0.9615 0.7321 1.263 
SNP147 A 0.3824 0.8902 1.018 0.7941 1.304 
SNP149 T 0.1955 0.3136 0.8561 0.633 1.158 
SNP150 A 0.3508 0.8912 0.9819 0.7562 1.275 
SNP151 C 0.391 0.2565 1.145 0.9064 1.446 
SNP152 C 0.4187 0.5018 0.9191 0.7161 1.18 




SNP A1 MAF P OR L95 U95 
SNP153 A 0.2416 0.7053 0.9394 0.6797 1.298 
SNP156 G 0.3794 0.5895 0.9342 0.7301 1.196 
SNP157 T 0.4117 0.595 0.9381 0.741 1.188 
SNP160 C 0.446 0.5935 0.939 0.7455 1.183 
SNP161 T 0.4461 0.578 0.9365 0.7432 1.18 
SNP162 T 0.3966 0.2459 1.15 0.908 1.457 
SNP163 T 0.278 0.773 1.038 0.8052 1.338 
SNP165 G 0.1617 0.7681 0.9526 0.6896 1.316 
SNP166 A 0.4898 0.2536 1.145 0.9036 1.45 
SNP168 G 0.2497 0.6306 0.9352 0.7124 1.228 
SNP169 T 0.09325 0.8509 1.039 0.6985 1.545 
SNP171 T 0.3474 0.2393 1.16 0.906 1.485 
 




Table 3: Logistic regression odds ratios and p-values for all SNPs 
SNP A1 TEST OR L95 U95 P 
SNP1 T ADD 0.9989 0.7526 1.326 0.9939 
SNP1 T COV1 1.099 0.7895 1.529 0.5769 
SNP4 A ADD 1.029 0.7505 1.41 0.8609 
SNP4 A COV1 1.058 0.7196 1.555 0.7753 
SNP6 A ADD 1.021 0.7768 1.341 0.8824 
SNP6 A COV1 1.079 0.712 1.635 0.7199 
SNP7 C ADD 1.045 0.8321 1.312 0.705 
SNP7 C COV1 1.078 0.7759 1.499 0.6535 
SNP8 A ADD 1.012 0.8021 1.276 0.9227 
SNP8 A COV1 1.074 0.7741 1.491 0.6683 
SNP13 C ADD 1.055 0.8558 1.299 0.618 
SNP13 C COV1 1.143 0.8141 1.604 0.4406 
SNP16 T ADD 1.028 0.778 1.357 0.8474 
SNP16 T COV1 1.093 0.7843 1.523 0.6003 
SNP17 G ADD 0.9217 0.7146 1.189 0.5303 
SNP17 G COV1 1.151 0.7974 1.662 0.4523 
SNP18 A ADD 1.046 0.8113 1.348 0.7289 
SNP18 A COV1 1.05 0.7168 1.538 0.8022 
SNP19 C ADD 1.087 0.8121 1.455 0.5747 
SNP19 C COV1 1.133 0.796 1.613 0.488 
SNP25 G ADD 1.057 0.8263 1.352 0.6598 
SNP25 G COV1 1.069 0.7462 1.532 0.7155 
SNP30 G ADD 0.7621 0.5805 1.001 0.05043 
SNP30 G COV1 1.055 0.7618 1.46 0.7483 
SNP41 C ADD 1.349 1.06 1.715 0.01474 
SNP41 C COV1 1.222 0.8746 1.708 0.2397 
SNP56 A ADD 0.9756 0.7728 1.232 0.8354 
SNP56 A COV1 1.079 0.7669 1.518 0.6628 
SNP57 T ADD 1.22 0.9671 1.538 0.09339 
SNP57 T COV1 1.123 0.8094 1.559 0.4867 
SNP59 A ADD 0.8678 0.6887 1.093 0.2289 
SNP59 A COV1 1.012 0.7169 1.428 0.9476 
SNP62 A ADD 1.034 0.7975 1.341 0.8008 
SNP62 A COV1 1.08 0.7726 1.508 0.654 
SNP63 A ADD 0.9806 0.6873 1.399 0.9139 
SNP63 A COV1 1.106 0.7966 1.535 0.5479 
SNP64 G ADD 0.7936 0.5056 1.246 0.3148 
SNP64 G COV1 1.148 0.8158 1.616 0.4278 
SNP65 G ADD 0.9018 0.6799 1.196 0.4733 
SNP65 G COV1 0.9724 0.6197 1.526 0.9032 
SNP67 A ADD 0.9408 0.7201 1.229 0.6549 
SNP67 A COV1 1.057 0.756 1.479 0.7448 
SNP75 A ADD 0.9447 0.6792 1.314 0.7356 
SNP75 A COV1 1.107 0.7966 1.539 0.5447 
SNP76 A ADD 1.272 0.982 1.647 0.06843 
SNP76 A COV1 1.074 0.777 1.485 0.6648 
SNP80 G ADD 0.9976 0.6841 1.455 0.9899 
SNP80 G COV1 1.125 0.7715 1.639 0.5413 
SNP82 G ADD 1.044 0.8269 1.319 0.7164 
SNP82 G COV1 1.101 0.796 1.523 0.5609 
SNP95 C ADD 1.022 0.684 1.526 0.916 
SNP95 C COV1 1.093 0.7665 1.559 0.6233 
SNP99 C ADD 0.9228 0.6718 1.268 0.62 
SNP99 C COV1 1.099 0.7879 1.534 0.5774 
SNP100 A ADD 0.9358 0.6031 1.452 0.7671 
SNP100 A COV1 1.1 0.7954 1.522 0.5636 
SNP103 A ADD 0.9391 0.6038 1.461 0.7806 




SNP A1 TEST OR L95 U95 P 
SNP103 A COV1 1.098 0.7733 1.558 0.6022 
SNP104 T ADD 0.9946 0.7533 1.313 0.9697 
SNP104 T COV1 1.114 0.8051 1.54 0.5156 
SNP105 A ADD 0.9317 0.6662 1.303 0.6792 
SNP105 A COV1 1.154 0.7619 1.749 0.4985 
SNP109 A ADD 1.01 0.7824 1.304 0.9396 
SNP109 A COV1 1.123 0.7557 1.668 0.5662 
SNP113 G ADD 0.9825 0.7473 1.292 0.8994 
SNP113 G COV1 1.117 0.7348 1.7 0.6036 
SNP114 T ADD 1.023 0.7972 1.312 0.8593 
SNP114 T COV1 1.09 0.7816 1.521 0.6106 
SNP118 A ADD 0.9822 0.804 1.2 0.8606 
SNP118 A COV1 1.072 0.7682 1.496 0.6831 
SNP119 A ADD 0.9937 0.7023 1.406 0.9717 
SNP119 A COV1 1.094 0.7858 1.522 0.5957 
SNP120 T ADD 0.744 0.5423 1.021 0.06678 
SNP120 T COV1 1.31 0.9031 1.901 0.1547 
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NRAMP1 polymorphisms have been associated with susceptibility to salmonella, brucellosis, 
and paratuberculosis in numerous animal species. While the African buffalo is of high 
economic significance in the ecotourism and hunting industries in southern Africa, its role as 
a maintenance host of foot-and-mouth disease, corridor disease, bovine tuberculosis and 
brucellosis is of much concern. Ten African buffalo samples were used to sequence the full 
coding region and partial 5‟UTR, intronic and 3‟UTR regions of the NRAMP1 gene. 
Computer software was used to analyse the gene composition, identify variation, analyse the 
predicted structure of the protein and compare the translated amino acid sequence to other 
species. The NRAMP1 coding region spanned 1647 base pairs and generated an amino acid 
sequence of 548 residues and a stop codon. 15 novel SNPs and three microsatellites were 
identified within the gene. The predicted NRAMP1 protein contained 11 hydrophobic 
transmembrane domains, two N-linked glycosylation sites, four protein kinase C 
phosphorylation sites, and a cytoplasmic consensus transport signature. Phylogenetic analysis 
grouped the African buffalo NRAMP1 sequence closest to the water buffalo. This 
characterisation of the African buffalo NRAMP1 gene could facilitate further research in the 
burgeoning fields of disease genetics, animal breeding and vaccine development. 





The natural resistance-associated macrophage protein 1 (NRAMP1, also known as 
SLC11A1) gene is a member of a small family of closely related genes, homologs of which 
have been identified in plants, animals, yeast and bacteria [1]. NRAMP1 is an integral 
membrane protein defined by a hydrophobic core, that typically consists of 10 
transmembrane domains, two N-glycosylation sites and a conserved transport motif, known 
as the „binding protein-dependent transport systems inner membrane component signature‟ 
[2,3]. These domains are highly conserved, and mutations in these regions are likely to have 
significant consequences. The NRAMP1 protein is expressed on macrophage endosomes and 
lysosomes, plays a role in oxygen and nitrogen-dependent antimicrobial activity and the 




maintenance of divalent metal homeostasis, and is believed to control the growth of 
intracellular pathogens during the early stages of infection [4].  
Nramp1 was identified as the candidate gene for the Bcg/Lsh/Ity locus in mice, which confers 
innate resistance to intracellular pathogens such as Mycobacteria, Leishmania and 
Salmonella [2,5]. Mice with a Gly to Asp substitution at amino acid 169, located in the fourth 
transmembrane domain of the Nramp1 protein, are susceptible to infection by the 
aforementioned pathogens [6]. Human studies have linked NRAMP1 polymorphisms with 
susceptibility to leprosy [7], tuberculosis [8,9], Crohn‟s disease [10] and rheumatoid arthritis 
[11]. In animal studies, NRAMP1 polymorphisms have been associated with salmonella in 
chickens [12], brucellosis in water buffalo [13], and with paratuberculosis in cattle [14] and 
sheep [15]. 
African buffalo are one of the most abundant and ecologically important species of 
megafauna in the savannah ecosystem. They are an important prey species, as well as a 
species of high economic significance in the ecotourism and conservation hunting industries 
[16]. However, African buffalo host a vast array of nematodes, pathogens and infectious 
diseases, and their role as maintenance hosts of foot-and-mouth disease, corridor disease, 
bovine tuberculosis and brucellosis is of much concern [17]. This limits conservation options, 
since wildlife reservoirs of diseases such as these can lead to major economic, ecological and 
public health impacts on other wildlife species, livestock and surrounding farming 
communities [18,19].  
It has become widely accepted that the variability seen in disease response in cattle, both 
between breeds and between individuals, has a genetic component. While genetic studies in 
disease resistance are relatively common in species for which there is a wealth of genetic 
information, this is not the case for other species, particularly wildlife, that are less well-
characterised. The discovery of genetic variants involved in disease susceptibility can provide 
an assortment of potential drug and/or vaccine targets, as well as allow for the possibility of 
breeding animals with enhanced disease resistance. The application of genetic resistance 
information in breeding programs has been implemented in cattle for diseases such as 
mastitis [20], and would be invaluable in both the commercial and private sectors. For species 
such as the buffalo that have not had their genomes assembled, it is important that the genes 
potentially involved in disease resistance first be properly characterised, in order to enable 
future investigation. 




In this paper, we sequence and report the full coding region of the African buffalo NRAMP1 
gene, as well as partial 5‟UTR, intronic and 3‟UTR sequences. We identify variation present 
within the gene, which can be used to inform future genetic disease resistance studies, 
analyse the predicted structure of the protein, and compare the translated amino acid 
sequence to other species. 
 
2. Materials and methods 
2.1 Samples 
DNA samples from ten African buffalo of the Cape buffalo subspecies (Syncerus caffer 
caffer), previously extracted from blood using the salt-chloroform extraction method [21], 
were used for the generation of the coding region of the NRAMP1 gene in this study. The 
buffalo samples originated from Kruger National Park, South Africa. 
2.2 Primer design 
Cattle and water buffalo NRAMP1 sequences (AY438096.1, DQ493965.1, DQ493966.1, 
AY398759.1, AY398761.1, AY398765.1, AY398767.1, EF682067.2, DQ441408.1) from the 
NCBI database (http://www.ncbi.nlm.nih.gov/genbank/) [22] were aligned in BioEdit v7.1.11 
[23] and used to generate a full NRAMP1 consensus sequence. The consensus sequence and 
Primer3web v4.0 [24] were used to design primers to span the exons of the NRAMP1 gene, 
in addition to the use of previously described primers used for water buffalo [25]. Primers 
were synthesized by the Synthetic DNA Laboratory, University of Cape Town, South Africa. 











Table 1: Primer sequences, amplicon sizes and exons spanned. 






PromF: GGGAGAGGTGCAGAACTCA                           PromR: TGCTCACCTGACATGAGGA  315 60 5‟UTR 
1F: CAGCCACTCGCACAGAGAG  1R: CTGGTGAGATCCCGCATGAT 786 62 1 & 2 
3F: CCAAGACCCCTCATTCCACT 3R: GGACTTGCAATGCTCCACTT 698 62 3 & 4 
5F: TGCAGGACTGAGACAAGAGA1 5R: GATGAGAGGCACACACCCA1 675 62 5 & 6 
7bF: AGTGCTCAGGATATCAGCCA1 7cR: GCTAAGGTCCTCTCCCCTGT 258 60 7 
8F: GACTTTCACTCACCCCAC 7bR: ATTCAGAGGCAGGCGTCGAG 278 60 8 
9F: ACTTCGATGCTTCCGTCCTT 9R: AGTCCCCTGCAGAACTTGAG 239 62 9 
10bF: ACATCTCCTTCCTACTGCCC 10bR: CCACATCCGCGTCCTGAGTG 442 60 10 & 11 
12F: CATCCCACCACCGAGTTCC 12R: GGATTGCTGTGGTTCCTGTT 247 62 12 
13F: AAGGTTGCACAGTGAAGCAG 14bR: CTGTGGTCTCCTCTCCTTGC 785 60 13 & 14 
14F: CACTTCCTCCATCATGGTG UTRR: ATGGAACTCACGTTGGCTG2 658 62 15 
UTRF: TGTGTGTGTGAAGGCAGCA2 UTRR: ATGGAACTCACGTTGGCTG2 190 60 3‟UTR 
* size is the inferred size from the Bos taurus NRAMP1 complete gene sequence (DQ848779.1) and Bos taurus 




2.3 Amplification and alignment 
PCR amplification was done in 20µl reactions, containing final concentrations of 1X KAPA 
Biosystems ReadyMix Taq, 0.2µM forward and reverse primers, and 1-2µl DNA. PCR 
conditions were as follows: 94°C denaturing for 5 min, followed by 35 cycles of 94°C for 40 
sec, 57-62°C for 35 sec and 72°C for 30 sec, followed by a final extension of 5 min at 72°C. 
PCR fragments were visualised by agarose gel electrophoresis and purified using the 
Promega Wizard Gel Purification Kit, according to the manufacturer‟s protocol. Sequencing 
of PCR products was performed by the Central Analytical Facility (CAF) at Stellenbosch 
University, South Africa. The sequences obtained for each region were subjected to BLAST 
analysis (www.ncbi.nlm.nih.gov/BLAST) to confirm their identity, and were checked 
visually and aligned in BioEdit. The nucleotide sequences were compared in BioEdit in order 
to identify novel polymorphisms within the gene, and used to generate a consensus sequence 
for each region. The African buffalo consensus sequences were aligned with the Bos taurus 
NRAMP1 cds (DQ493965.1) sequence and concatenated in order to generate a final coding 
region NRAMP1 sequence. The buffalo coding region nucleotide sequence was translated in 
BioEdit to obtain the amino acid sequence.  
2.4 Analysis 
The percentage homologies between the nucleotide and amino acid sequences of the African 
buffalo, cow (Bos taurus; DQ493965.1) and water buffalo (Bubulas bubalis; FJ827149.1) 




NRAMP1 coding regions were calculated. Positions and consequences of SNPs were 
determined. TopPred [26] was used to predict the location of transmembrane domains within 
the buffalo NRAMP1 protein, and ScanProsite [27] was used to identify putative 
glycosylation and phosphorylation sites. Neighbour-joining phylogenetic analysis was 
performed in MEGA v5.2.1 [28] under default settings using the NRAMP1 amino acid 
sequences of Syncerus caffer, Bos taurus (NP777077.1), Bos indicus (ABF61464.1), Bubulas 
bubalis (ACO53852.1), Bubulas carabanensis (ACO53851.1), Bison bison (AAB17552.1), 
Cervus elaphus (AAC28240.1), Ovis aries (AAC28241.1), Homo sapiens (AAG15405.1), 
Mus musculus (NP_038640.2) and Sus scrofa (AAF36527.1).  
2.5  3’UTR characterisation 
Initial amplification and sequencing of the 3‟UTR microsatellite region suggested the 
presence of more than two alleles per individual for this fragment. In order to clarify the 
situation, cloning and sequencing of the PCR amplicons was done. PCR amplification was 
done in 25ul reactions, containing final concentrations of 1X Supertherm Gold PCR buffer, 
1.5mM MgCl2, 2mM dNTPs, 0.2µM of each primer, 2µl DNA and 0.05µl Supertherm Gold 
Taq. PCR conditions were as follows: 94°C denaturing for 5min, followed by 35 cycles of 
94°C for 40 sec, 60°C for 35 sec and 72°C for 30 sec, followed by a final extension of 7 min 
at 72°C. PCR fragments were visualised by agarose gel electrophoresis under long 
wavelength UV, excised and gel-purified using Promega Wizard Gel Purification Kit, 
according to the manufacturer‟s protocol. Purified PCR fragments were ligated into the 
pGEM-T Easy vector (Promega, USA), and cloned into JMN109 competent E. coli cells. 
Plasmid DNA was isolated from each clone using the Promega Wizard SV Miniprep 
Purification Kit, as per the manufacturer‟s protocol, and sequenced by the Central Analytical 
Facility (CAF) at Stellenbosch University, South Africa. Sequences were checked visually, 
edited and aligned in BioEdit.  
 
3. Results and discussion 
The African buffalo NRAMP1 sequences were aligned with the Bos taurus NRAMP1 gene 
(DQ848779.1) and combined to produce a final sequence for the African buffalo NRAMP1 
gene (accession number KF264050). The final NRAMP1 coding region spanned 1647 base 




pairs (Figure 1A), had a base composition of 58.9% G+C content, and generated an amino 
acid sequence of 548 residues (Figure 1B).  
Comparative analysis identified 15 novel single nucleotide polymorphisms and three 
microsatellites within the buffalo NRAMP1 gene. Of these 15 SNPs, 5 were found in the 5‟ 
and 3‟ untranslated regions, 9 were intronic, and one was exonic. The distribution of the 
SNPs, with  positions in brackets relative to the African buffalo NRAMP1 sequence 
(KF264050), were as follows: 5‟UTR – three SNPs (104, 214, 228), intron 1 – one SNP 
(580), intron 3 – four SNPs (2206, 2226, 2236, 2279), intron 5 – two SNPs (3902, 3974), 
intron 6 – one SNP (4554), exon 7 – one SNP (4608), intron 12 – one SNP (8176), and 
3‟UTR – two SNPs (10631, 10655). The exonic SNP was a synonymous substitution. The 
greater number of intronic versus exonic SNPs is to be expected, due to the evolutionary 
constraints placed on the coding regions of expressed genes. Similarly, the presence of only 
one exonic SNP that does not alter the amino acid sequence of this highly conserved protein 
is unsurprising. However, variants within the 5‟ UTR can have a significant impact on gene 
expression, and thus variants from this region are often the targets of genetic association 
studies. Three (GT)n microsatellites were present within the 3‟UTR region (positions 10538, 
10631, 10667), showing a range of allele sizes. Cloning confirmed the presence of four 
alleles per individual for part of the 3‟UTR. The presence of multiple alleles per individual 
suggests that at least one duplication of this region may have occurred in the African buffalo; 
however, this requires further investigation for confirmation. This region has been associated 
with brucellosis and paratuberculosis [13,14], among other diseases, and would benefit from 
further research. 
 






Figure 1: A - African buffalo NRAMP1 partial 5‟UTR, full coding region and partial 3‟UTR. The 
5‟UTR and 3‟UTR segments are underlined. B - Translated NRAMP1 amino acid sequence of the 
African buffalo. The binding-protein-dependent transport system inner membrane component 
signature (BPDTSIMCS) is underlined. 
 
 
At the nucleotide level, the African buffalo NRAMP1 coding region showed a 98.79% and 
98.72% homology to that of the cow and water buffalo, respectively. The translated buffalo 
amino acid sequence was identical in length, and showed a 98.91% and 98.72% homology, to 
that of the cow and water buffalo, respectively. Analysis of the protein structure revealed the 
presence of 11 transmembrane domains, including the core Pfam NRAMP1 domain, two N-
glycosylation sites, and four potential protein kinase C phosphorylation sites (Figure 2). The 
binding-protein-dependent transport system inner membrane component signature 
(BPTSIMCS) motif was found from amino acid residues 370-389, located on the intracellular 




loop between transmembrane domains 7 and 8. These structural features are in agreement 
with the features typical of this family of transport proteins, which are: 10-12 transmembrane 





Figure 2: Schematic diagram of the 11 predicted hydrophobic transmembrane domains of the African 
buffalo NRAMP1 protein. Shaded segments indicate unambiguous transmembrane domains; clear 
segments indicate putative transmembrane domains. The BPTSIMCS is shown as a thick, bold portion 
of the intracellular loop. N-glycosylation sites are indicated with solid triangles; protein kinase C 
phosphorylation sites are indicated with solid circles. 
 
 
The phylogenetic relationship between the African buffalo (Syncerus caffer), cattle (Bos 
taurus), cattle (Bos indicus), water buffalo (Bubulas bubalis), water buffalo (Bubulas 
carabanensis), bison (Bison bison), red deer (Cervus elaphus), sheep (Ovis aries), human 
(Homo sapiens), mouse (Mus musculus) and pig (Sus scrofa) NRAMP1 amino acid 
sequences can be seen in Figure 3. Phylogenetic analysis grouped the African buffalo 
NRAMP1 amino acid sequence closest to that of the water buffalo, followed by the cow and 
bison group. This reflects the proposed phylogenetic placement of the African buffalo in the 
Bovini tribe [29]. 
 





Figure 3: Unrooted neighbour-joining phylogenetic tree of NRAMP1 amino acid sequences. 
Bootstrap values are based on 1000 replications. 
 
To the best of our knowledge, this is the first characterisation of the NRAMP1 gene in 
African buffalo. While disease association studies in animals that have fully assembled 
genomes, such as cattle, commonly utilise genome-wide association studies, this is not 
possible in many other species for which genome-wide information is not available. As such, 
the characterisation of the NRAMP1 gene in the African buffalo and identification of novel 
polymorphisms can facilitate further research in the burgeoning fields of disease genetics, 
animal breeding and vaccine development. 
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The high prevalence of bovine tuberculosis (BTB) in buffalo herds in southern African game 
reserves represents not only an ecological threat to biodiversity but a health risk through the 
wildlife-cattle-human interface. With standard test and slaughter methods not being 
logistically feasible in this free range system, the co-existence of alternative BTB hosts and 
the limited effectiveness of the BCG vaccine in buffalo, there is a need for another method of 
BTB management. This review assesses breeding for increased resistance to BTB in buffalo 
as a possible method of BTB management and future eradication of the disease. Main lines of 
evidence for the heritability of BTB resistance in mammals are briefly discussed, and we 
consider how the information obtained from these studies can be applied to breeding 
programmes. The principles and challenges of selective breeding are addressed, and the 
different methods that can be employed in such breeding programmes are examined in more 
detail. Finally, conclusions and suggestions for the future are discussed. 
Keywords: M. bovis, BTB, buffalo, resistance, breeding 
 
1. Introduction 
African buffalo are a significant component of the savannah ecosystem, due to their physical 
size, large numbers and their role as coarse grazers, which has implications for other fauna 
and flora [1]. They also form a considerable proportion of the prey biomass of lions, which 
are the apex predator in this ecosystem.  Varying environmental conditions, such as drought, 
can cause a dramatic decrease in the buffalo population, as a result of reduced body condition 
and susceptibility to starvation, predation and infectious disease. This was seen during the 
drought of 1982/3 in the Kruger National Park (KNP), South Africa, when the buffalo 
population declined by more than 50% [2]. Under severe drought conditions, both the spread 
and severity of bovine tuberculosis may be altered, due to changes in herd density and the toll 
that environmental stress takes on the immune system, respectively [3,4]. Thus, although 
stable at present, the presence of this new, introduced disease may have profound 
implications for the long-term stability of the buffalo population.  
The high prevalence of BTB in buffalo herds in southern African game reserves represents 
not only an ecological threat to biodiversity, but also a health risk through the wildlife-cattle-
human interface.  In a study of cattle from 27 villages in Tanzania, Cleaveland et al. [5] 




reported that cattle in contact with wildlife showed a significantly higher prevalence of BTB 
infection. Sufficient interface contact also makes M. bovis, the causative agent of BTB, a 
zoonotic risk to human health, since infection in humans has been known to occur through 
the consumption of unpasteurized milk or meat of infected livestock. High HIV prevalence 
within the rural communities that surround South African game reserves puts people at an 
increased risk of acquiring TB due to compromised immune systems [6,7]. 
Cattle are believed to have introduced M. bovis into KNP through the (then) unfenced 
southeast corner of the park during the late 1950‟s/early 1960‟s [8]. The first confirmed BTB 
diagnosis in buffalo within the park occurred in 1990, and the extent of disease spread and 
the large herd sizes and ranges meant that standard test and slaughter methods were not 
logistically feasible in this free-range system [9]. Furthermore, any large-scale slaughtering 
would have resulted in public outcry, causing negative publicity for the park. The 
establishment of a BTB control strategy was also complicated by the presence of co-
existing/spill-over BTB hosts, such as lion (Panthera leo), chacma baboon (Papio ursinus), 
warthog (Phacochoerus africanus) and greater kudu (Tragelaphus strepsiceros) [7].   
While prevention may be better than cure, the BCG vaccine has limited effectiveness. In 
buffalo, the BCG vaccine showed no significant protection against experimental challenge 
with M. bovis, and consequently this does not represent a viable control strategy for this 
species [3,10]. Many developed countries have had great success in eradicating or drastically 
reducing BTB prevalence in cattle using regular tuberculin test and slaughter policies, but the 
logistic demands of operating such a programme in free-ranging wildlife populations of this 
size render this option impractical as well [11]. For the above reasons, selective breeding for 
increased BTB resistance or tolerance should be seriously considered as a potential control 
strategy in the management of bovine tuberculosis in African buffalo. 
Resistance and tolerance are the two main aspects of self defence against pathogens; these 
aspects determine the disease severity and have been shown to exhibit substantial genetic 
variation in animal models [12]. Whilst resistance involves limiting the actual bacterial 
burden, tolerance involves the restriction of the harmful consequences caused by the bacteria. 
Resistance and tolerance are often shown to be negatively correlated in infectious disease, 
with a trade-off occurring between them as they employ opposing strategies: the cost of an 
increased immune control of infection is typically an increase in „collateral damage‟ of 
infected tissue [12]. A possible negative outcome to breeding for increased resistance is the 




antagonistic co-evolution of the pathogen. Any alteration in the resistance of the host to the 
pathogen places selective pressure on the pathogen and corresponding counter-adaptations 
could occur. No such selective pressure is placed on the pathogen if selection of the host is 
tolerance-based, thus diminishing the antagonistic co-evolution of host and pathogen [12]. 
However, the presence of co-existing BTB hosts makes increasing the resistance of buffalo to 
BTB a more desirable goal, as it would be more effective at reducing interspecies spread by 
reducing BTB prevalence in a major host.  
In this review, we briefly discuss lines of evidence of the heritability of BTB resistance in 
mammals, and consider the benefits and challenges of selective breeding. We compare the 
different methods of selective breeding, as well as the suitability of each of these methods for 
breeding BTB resistance in African buffalo. Finally, we make recommendations for future 
work. 
 
2. Evidence of resistance to BTB in mammals 
The heritability of resistance to infection after exposure to M. bovis has been noted in a 
number of mammals. As early as the 1940‟s, studies showed that resistance to M. bovis 
infection was heritable. Lurie [13] showed that inbred strains of rabbits displayed one of two 
phenotypes (susceptible or resistant) following infection with M. bovis. This inheritance 
pattern suggested that the disease profile displayed by the rabbits was largely genetically 
inherited. 
A 3-year heritability study by Mackintosh et al. [14] on M. bovis resistance in farmed red 
deer, was the first of its kind in livestock. Red deer stags were challenged intratonsillarly with 
virulent M.bovis, and following euthanasia, lesion severity was graded and BTB infection 
confirmed. Lesion severity scores (LSS) calculated for each individual were used to select six 
stags to represent the range of resistance. Their semen was used to artificially inseminate 
BTB-free red deer hinds, resulting in the birth of 70 BTB-free calves. These calves were then 
challenged with M. bovis intratonsillarly, and regular skin testing took place until the calves 
were euthanised and necropsied. Each calf‟s parentage was determined via genetic marker 
analysis and its lesion severity score calculated [14]. The lesion scores in offspring 
corresponded with the lesion scores of stags: offspring from the non-infected stags had the 
lowest lesion scores and offspring from the severely infected stags had the highest lesion 




scores. A heritability estimate of 0.48 was calculated for the observed resistance. None of the 
resistant stags produced antibody in response to the tuberculin, whilst susceptible stags 
produced levels of antibody to tuberculin that correlated with their severity of infection [14]. 
Thus the resistant and susceptible stags showed two distinctive immune response patterns 
which could be tested for and exploited through phenotypic selection. 
In Irish Holstein-Friesian dairy herds, 15,182 cows and 8,104 heifers with a high likelihood 
of M. bovis exposure were repeatedly tested over three years for responsiveness to M. bovis-
purified protein derivative (PPD) in single comparative intradermal tuberculin tests (SCITT), 
and produced heritability estimates of 0.14 and 0.12 respectively for responsiveness [15]. 
Data on the presence of TB lesions in the carcasses, confirming M. bovis infection, produced 
a heritability estimate of 0.18 in cows for susceptibility to infection. A strong correlation 
between responsiveness to M. bovis-PPD and resistance to confirmed M. bovis infection was 
evident, making indirect selection an option: selection for responsiveness would be effective 
at shifting the population mean towards decreased susceptibility [15]. The correlation also 
suggests that both traits may be influenced by the same or closely positioned genes. 
These studies serve as examples of the heritability of M. bovis infection, and how this 
information might be utilised in selective breeding programmes. A more extensive review of 
the genetic studies showing evidence of heritability or association of BTB resistance in cattle 
and wildlife can be found in le Roex et al. [16]. 
 
3. Selective breeding 
The genetic improvement of livestock through selective breeding programmes has been 
successfully applied to many species and traits.  Selective breeding programmes seek to 
identify those individuals with a particular trait of interest, and utilise these individuals 
preferentially for breeding. Thus over time, the trait will become more prevalent in a 
particular population. 
Heritability is a crucial parameter in breeding programs, since it provides an indication of the 
potential success of this strategy for a particular trait [17]. Ideally, heritability studies should 
first be undertaken in African buffalo in order to determine the extent to which the observed 
phenotypic variation of BTB resistance is caused by genetic variance and is not a function of 
environmental variance. The higher the heritability score, the greater the role that genetics 




plays in determining the phenotype and the more potentially enhanceable the trait is through 
selective breeding [17]. In the case of free-ranging mixed herd wildlife populations, where 
the family structure or relatedness of the individuals is unknown, a breeding plan must first 
be developed, and the offspring from the second generation allowed to mature before 
heritability values can be calculated. 
Selective breeding programmes could also benefit from risk management practices, such as 
frequent testing and status monitoring, quarantine and treatment of infected animals with 
antibiotics, but these practices are not possible in a free-ranging environment. In order to 
benefit from these management practices, wildlife populations such as buffalo would need to 
be maintained in a fenced environment under controlled conditions, similar to that of cattle. 
This practice has other advantages in African buffalo, such as increased feed quality and 
availability, which results in a younger age of first calving (pers. comm Bernard Wooding). 
Another factor that needs to be considered is the suitability of the phenotypic test. The more 
accurate the diagnostic test to determine the phenotype, the more reliable the association 
between genotype and phenotype, and the better the results from a selective breeding 
programme. The single comparative intradermal tuberculin test (SCITT) is the most 
commonly used diagnostic test for BTB infection, and sensitivity and specificity estimates for 
this test in buffalo have not been officially established. The direct selection for the ability to 
pass the SCITT test, rather than direct selection for resistance phenotypes, may also result in 
the diminished ability of buffalo to develop a measureable response to the SCITT. This 
would result in an inability to detect exposure to M. bovis/BTB infection, thus undermining 
the very usefulness of the test [18].  
The selection of individuals for these breeding programmes can be based on either 
phenotypic or genotypic merit. A schematic diagram of the basic steps of a selective breeding 
programme for BTB resistance in African buffalo can be seen in Figure 1. The methods used 
for these approaches, and their suitability to African buffalo, are discussed below. 
 





Figure 1: Schematic overview of steps for breeding BTB resistance in African buffalo 
 
3.1 Phenotypic selection 
The selection of animals for breeding programs has traditionally been based on the estimated 
breeding values (EBVs) of individuals, calculated using phenotypic records, pedigrees and 
the heritability of a particular trait [19,20]. An EBV is an estimate of the genetic merit of an 
individual with regards to a particular trait, without identifying or having knowledge of the 
actual genes involved in the trait. Many of the traits that are important in agriculture are 
complex or quantitative traits; these traits are influenced by many genes and produce a 
continuous distribution of phenotypes among individuals [19]. Beef and dairy cattle stud 
farms routinely measure quantitative traits across herds in order to enhance traits such as total 
milk yield, butter fat percentage and body composition. Extensive data is also kept on the 
family structure within herds, which is essential for analysing the relationships between 
individuals. Such analyses contribute to the calculation of each animal‟s breeding value, as 
incorporating the phenotypic information of the offspring gives a more reliable indication of 
the genetic merit of the bull than the bull‟s phenotypic measure alone [21,22]. In situations 
where pedigrees are unknown, appropriate breeding and record keeping must first be carried 
out. 




Phenotypic studies have investigated the resistance of cattle to M. bovis through the 
measurement of the individual‟s inflammatory response and by trial exposures in vivo and in 
vitro. The continuous distribution of resistance as a trait (measured by lesion scores or SCCIT 
inflammatory responses), and the likelihood of this trait being polygenic and multi-factorial, 
suggests that resistance to M. bovis can be regarded as a quantitative trait [21].  Thus the 
same process should be applicable to breeding for BTB resistance as it is for a quantitative 
trait. The breeding value of a bull as a function of its resistance to BTB can be calculated 
using the relative phenotypic resistance of closely related animals, and is a more robust 
measure than the bull‟s own phenotypic measure of resistance [21,22]. This breeding value is 
a measure of how breeding with that male could influence the overall resistance of the herd. 
In order to draw the most accurate comparisons between parent and offspring resistance 
phenotypes, the offspring should be of immunologically comparable age when tested. For 
example, a study to establish the disease status in African buffalo calves performed gamma-
interferon testing at 9 and 9.5 months, and skin testing from 11 months, which ensured that 
the immune responses of the offspring were not influenced by milk-derived maternal 
immunity [10]. 
While selection of complex traits (such as milk yield in cows) based on phenotypic records 
has been successful in the past, it also can be difficult, and costly. Often the phenotype of 
interest can only be measured at a particular stage of life, after death, in one sex, or is very 
expensive to test [19]. 
3.2  Marker-assisted selection 
Marker-assisted selection incorporates the information obtained from a small number of 
markers into the traditional EBV calculations – that is, breeding values are calculated by 
combining pedigree, phenotype and marker information [19]. Markers are typically identified 
by candidate gene association studies in the trait of interest. The success of marker-assisted 
selection depends on a number of factors, such as the number of genes contributing to a trait, 
the relative contribution of each gene, and what has been previously attained in terms of 
genetic improvement using phenotypic selection [23]. For example, if phenotypic selection 
has been implemented for many years and substantial improvement has already been 
achieved, it is unlikely that the addition of a single significant genetic marker to the EBV 
calculation will have a considerable effect. However, in relatively new breeding programs, 
the incorporation of any genetic information into the calculation of breeding values could 




substantially improve the EBV calculations and thus the success of the program [23]. Marker-
assisted selection has been used in a number of livestock species already, to improve traits 
such as reproductive rate, body composition and growth rate [24].  
In candidate gene association studies, genes are selected based on prior knowledge of the 
physiology of a particular trait, and polymorphisms/variants within the gene are tested for 
statistical association with that trait. While BTB resistance is a polygenic trait, if the effect of 
a particular gene is large enough to cause a discontinuity of the phenotype (despite the effects 
of other loci and non-genetic factors), it can be detected in an association study and thus has 
possible utility in breeding programs [21]. In cattle, strong and consistent correlations have 
been shown between the microsatellite markers INRA111 and BMS2753 and the reactor 
status of the SCITT test within nine diverse breeds [25]. Marker INRA111 has also shown 
association with ovine foot rot and is located in a region of the cow genome associated with 
mastitis. The 2-2 genotype of INRA111, common in all of these nine breeds, confers a 
twofold protection against BTB, on average [25]. Sun et al. [26] investigated seven SNPs in 
the Toll-Like Receptor (TLR) 1 and 9 genes in Chinese Holstein cattle, and found that 
polymorphism TLR-G1596A exhibited a significant association with M. bovis infection. In a 
Chadian breed of cattle, microsatellite polymorphisms in the Natural Resistance Associated 
Macrophage Protein 1 (NRAMP1/SLC11A1) gene, specifically alleles 211, 215 and 217, 
were significantly associated with lower incidence of infection of BTB [27].  
In African buffalo, an association study done by le Roex et al. [28] tested 69 SNPs in 
immune-related genes for association with BTB infection status, and found three positive 
associations. These SNPs were located in the Solute Carrier Family 7 Member A13 
(SLC7A13) gene, Deleted in Malignant Brain Tumour 1 (DMBT1) gene and Interleukin 1 
alpha (IL1α) gene. SLC7A13 is a heteromeric amino acid transporter (HAT), and although 
relatively uncharacterised, other transporters, such as SLC11A1 (NRAMP1), have been 
associated with TB infection in humans [29]. DMBT1 is regarded as a pattern recognition 
receptor (PRR), which forms part of the human host defence system against invading 
organisms such as M. tuberculosis [30]. The IL1α protein is a pro-inflammatory cytokine, 
and plays a role in the activation of T-lymphocytes, and the recruitment of leucocytes to sites 
of inflammation [31]. These SNPs are promising candidates for the selective breeding of 
buffalo with increased BTB resistance. In addition to these SNPs associated with BTB in 
African buffalo, the high sequence homology between African buffalo and bovine genes, 
such as SLC11A1 (N. le Roex, unpubl.), suggests that SNPs identified in the cattle BTB 




studies may be potentially useful additions to the set of candidate genes that could be utilized 
for screening for resistant African buffalo for breeding programs. 
 
3.3 Genomic Selection 
Genomic selection refers to the selection of individuals based on marker or haplotype 
information obtained from a dense array of markers that cover the entire genome, thus 
theoretically incorporating all the loci that contribute to a particular trait [22]. This 
information is compiled to calculate a genomic breeding value (GEBV), which can then be 
used to predict the breeding value of individuals in the absence of phenotype data [19]. 
Genomic selection is highly applicable in livestock species where uniformity of phenotype is 
desired and lack of trait diversity is considered beneficial (excluding stud farms). In order to 
generate the marker information required for genomic selection, a large reference population 
with phenotype data is required. This is one of the biggest challenges facing genomic 
selection, but if such a population can be established, all measurable traits of interest can be 
phenotyped in this same population, and thus GEBVs for all phenotypes can be calculated 
[19]. This is an enormous amount of invaluable data, and has the potential to dramatically 
alter the future of breeding programs. Success has already been achieved - studies in 
Holstein-Friesan cattle have shown up to a 71% concordance between GEBVs and true 
breeding values, averaged across a number of traits [32], and studies in broiler chickens 
showed a fourfold increase in the accuracy of prediction of a food conversion rate phenotype 
[33]. 
The African buffalo genome has not been assembled as yet, and no commercial SNP chip for 
the buffalo is available. Without the existence of a genome-wide marker map, a genomic 
selection approach is impossible, and the cost of generating a customised array based on the 
sequencing that has been done on the African buffalo genome thus far, as well as the time and 
cost of validating the SNPs identified, is likely to be prohibitive. In terms of BTB, genomic 
selection for resistance to the disease may increase resistance to other intracellular bacterial 
pathogens, such as Brucella abortus and Mycobacterium avium paratuberculosis, which 
would be an additional benefit [34]. However, variation within the immune response provides 
population resilience. A population with diverse immune responses to a novel pathogen has a 
greater chance of survival and increased adaptability. Thus care must be taken when selecting 
for BTB resistance that susceptibility to other types of pathogens is not increased [35]. 
 




4. Conclusions and future directions 
African buffalo are a species of great importance in southern Africa, particularly in the 
tourism, hunting and commercial game farming industries. This creates a constant demand 
for buffalo, and prices have continued to increase accordingly. The market value of buffalo 
within South Africa varies according to disease status, with „disease-free‟ buffalo fetching 
approximately 10 times that of their counterparts at auction. However, bovine TB is prevalent 
in a large proportion of the country, and the maintenance of the disease by buffalo has 
implications for biodiversity, ecotourism and public health. The BCG vaccine has no 
significant effect on BTB infection in buffalo, and as such, it would be enormously beneficial 
to breed buffalo with increased resistance to BTB. These buffalo could then be used to re-
stock reserves where BTB is endemic, and establish new herds in private game farms. 
Selective breeding programmes have been successfully applied to improve numerous traits in 
livestock species. Advances in DNA technologies have allowed the incorporation of genetic 
information into the estimated breeding values of individuals, thus greatly increasing the 
scope for improvement and the success of these strategies. To the best of our knowledge, no 
selective breeding programmes for BTB resistance in buffalo have been implemented, and as 
such, the incorporation of any genetic information into a marker-assisted breeding strategy 
would be enormously advantageous.  While genomic selection may ultimately be more 
beneficial, or provide a larger increase in genetic improvement, until such time as there is a 
sufficiently large reference population and/or commercial SNP chip available for the African 
buffalo, marker-assisted selection may be the best strategy. As the cost of genotyping and 
custom SNP arrays continue to decline, genomic selection may become more feasible. Future 
plans should look to the accurate phenotyping of a large reference population of buffalo for 
multiple traits, including BTB resistance. 
While the breeding for BTB resistance in African buffalo offers many positive outcomes, 
there are some considerations which must be taken into account. As M. bovis is capable of 
infecting numerous species other than cattle and buffalo, which act as reservoir hosts, an 
increase in tolerance to BTB in cattle or buffalo populations is not an optimal solution to 
control of the disease in an ecosystem. However, it may make a considerable difference to 
spill-over hosts, such as greater kudu, particularly if the increased tolerance is associated with 
a reduction in M. bovis shedding and thus transmission. If a dual selection strategy that 
selects for both resistant and tolerant genotypes is not possible, it would be important to 




consider the resulting effect on tolerant genotypes within both the breeding program 
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The work presented in this thesis addresses the issue of Mycobacterium bovis infection in 
African buffalo, the genetic underpinnings of host susceptibility to this disease, and the 
applicability of this information to the commercial and farming sectors. African buffalo are of 
particular interest as hosts of BTB because they functions as wildlife reservoirs of M. bovis 
within free-range game reserve settings, and it is believed that without this reservoir, spill-
over hosts would not be sufficient to sustain this alien disease in the environment. 
An initial investigation into the extent of the BTB epidemic in African buffalo was 
undertaken using data collected from Hluhluwe iMfolozi Park, South Africa (Chapter 2). 
BTB was first diagnosed in buffalo in HiP in 1986, and surveys in 1998 identified regions of 
particularly high BTB prevalence within the park. Since 1999, there has been a limited test 
and cull policy in operation in the park, involving the mass capture and testing of between 
250-900 buffalo annually, and the destruction of BTB positive individuals. Test and cull 
policies have traditionally met with mixed success, and as such it is important to quantify 
changes in BTB prevalence that may be attributed to this management strategy. Data 
collected over a seven year period from 1999-2006 was analysed to estimate BTB prevalence 
at both the area and herd level within the park. Brand and capture information was used to 
support the validity of the area-based classifications, and prevalence changes over time were 
analysed with respect to the original aims of the operation, which were to reduce BTB 
prevalence in high prevalence areas, and to prevent the increase of disease in the more 
moderately affected areas. Area level prevalence for the different regions ranged from 2.3% 
to 54.7%, but was most commonly in the region of 10-15%. A decrease and subsequent 
stabilisation in the high prevalence areas suggested that a high initial prevalence may take 
longer to be affected by the culling of BTB positive individuals, but once a sufficient 
proportion had been removed, prevalence may decrease. The number of individuals captured 
(capture effort) and the time interval between capture events (capture interval) were 
significantly correlated with change in BTB prevalence – i.e. the more individuals are tested 
and culled, the less increase in BTB prevalence, and the greater the time period between 
capture events, the larger the increase in BTB prevalence. This data suggests that the test and 
cull programme is working in its current capacity, and that the way this programme is 
managed in the future might be crucial to its continued success: it may be of little benefit to 
perform test and cull events in a particular area if the time between events is longer than three 
years; likewise, a certain number of animals may need to be tested at each event in order to 




effect a change. These factors should be included in the management plans for this 
programme in the future, in order to maximise the benefits of this strategy. 
The role that host genetic variation may play in susceptibility to disease has been investigated 
in many different diseases and species. Tuberculosis in humans, caused by Mycobacterium 
tuberculosis, has been extensively studied, and there are many reviews regarding the role of 
host genetics in susceptibility to TB. Bovine tuberculosis, by comparison, has received far 
less attention in the genetics field, particularly in wildlife species. Before undertaking a 
disease association study, it is important to review what has previously been attempted in 
other studies, in related species or environments, and identify candidate genes that may be 
involved in the development of resistance/susceptibility. For this purpose, a review of the 
genetic susceptibility to BTB in cattle and wildlife was prepared, incorporating both 
heritability and association studies (Chapter 3). Collating both heritability and association 
studies of BTB in livestock and wildlife highlighted the need for further research in these 
areas in wildlife. Considerations that must be taken into account when undertaking genetic 
studies - such as phenotype classification, statistical power and population stratification – ere 
addressed, and suggestions made as to how these obstacles may be overcome. Finally, 
recommendations for future work in this area were proposed, including genome-wide 
association studies and investigations into more complex mechanisms such as gene-gene 
interactions. This review assembled the body of genetic work in BTB, and provided a 
foundation on which to base this research. 
One of the biggest hurdles to overcome in animal genetic work is the lack of sufficient 
genetic data available. Model organisms, such as the mouse or cow, have fully sequenced and 
assembled genomes, but this is not the case for many animal species. The African buffalo is 
one of these species; while researchers have investigated population genetics and 
phylogeography in African buffalo, these studies predominantly utilised microsatellite 
markers and mitochondrial loci, and to date, large-scale or whole-genome information has not 
been available. To this end, next generation sequencing was performed on nine buffalo, in 
order to generate a wealth of genetic sequence information, and identify single nucleotide 
polymorphisms throughout the genome (Chapter 4). The sequencing was performed on the 
ABI SOLiD4 platform, and Bowtie and BWA software packages were used to map the 
buffalo sequence reads to the UMD3.1 domestic cow (Bos taurus) reference genome. The 
Bowtie and BWA packages identified a maximum of 2,222,665 and 276,847 SNPs within the 




buffalo genome respectively, depending on the analysis method used. The BWA package 
combined with the Genome Analysis Tool Kit 1.1-3 (GATK) identified 76,615 SNPs within 
gene regions, 56,054 of which could be associated with possible consequence data using 
information from Ensembl. A panel of 173 SNPs were selected for validation, and BWA + 
GATK SNPs showed a validation rate of approximately 57%. The SNPs making up the 
validation panel were selected specifically with the view to utilise them in the subsequent 
BTB association study. This study allowed the generation of sufficient sequence information 
to make informed choices about candidate genes for BTB association work in African 
buffalo, and will serve to inform any future genetic studies across a wide range of fields. 
There are many factors involved in the outcome of infection by a pathogen, one of which it 
the genetic make-up of the host. The host genome plays an important role in determining 
whether an exposed individual will remain uninfected, become infected but remain 
asymptomatic, or become infected and progress to active disease. In order to investigate 
genetic susceptibility to BTB, 69 SNPs with predicted functional consequences in genes 
related to the immune system were selected from those previously identified and validated in 
the next-generation sequencing. These SNPs were fluorescently genotyped in 868 African 
buffalo samples, collected from the Kruger National Park and Hluhluwe iMfolozi Park, and 
tested for association with BTB status (Chapter 5). Case-control association testing and 
statistical analyses identified three SNPs associated with BTB status in buffalo. These SNPs - 
SNP41, SNP137 and SNP144 - were found in the SLC7A13, DMBT1 and IL1α genes, 
respectively. The SLC7A13 gene forms part of the family of heteromeric amino acid 
transporters (HATs), and although this particular transporter is relatively uncharacterised, 
other related transporters have been associated with TB infection in humans. SNP137 is 
located in the coding region of the Deleted in Malignant Brain Tumour-1 (DMBT1) gene. 
DMBT1 is one of the pattern recognition receptors (PRRs), which recognize the conserved 
structures in bacterial and yeast cell walls that are vital to the survival of the invading 
organism. This SNP remained significantly associated after permutation testing, and was the 
most robust of the associations identified. SNP144 is located in the Interleukin 1 alpha (IL1α) 
gene, which belongs to the IL1 family of pro-inflammatory cytokines, and plays a role in 
mediating local and systemic inflammation. These three polymorphisms and genes are 
promising candidates for further exploration into genetic susceptibility to BTB, and may also 
hold potential for marker-assisted breeding programmes in African buffalo. There will, of 




course, be many other genes and variants that contribute to the host genetic component of 
BTB susceptibility, and should be investigated as time and finances allow.  
Despite the numerous benefits of next-generation sequencing, there are a few notable 
limitations, particularly when mapping to the reference genome of a different species. One of 
these limitations is that only a percentage of the sequenced genome is represented in the final 
data. There are a number of reasons why a particular region might not map correctly or have 
sufficient coverage – regions containing many repeats are difficult to map unequivocally, and 
there may be too many differences in the sequence identity of the reference and sequenced 
genomes at a particular locus for correct alignment to take place. As such, there may be little 
or no sequence information obtained on specific regions or genes of interest. One of the most 
commonly investigated genes in bacterial disease susceptibility is NRAMP1 (SLC11A1), and 
it has been associated with susceptibility to salmonella, brucellosis, and paratuberculosis in 
numerous animal species. Very little informative sequence data was obtained from the 
SOLiD4 next-generation sequencing of the buffalo for this gene. To compensate for this lack 
of data, Sanger sequencing was performed to more thoroughly characterise the sequence, 
structure and variation of the NRAMP1 gene in African buffalo (Chapter 6), with the 
intention of utilising the identified polymorphisms in future BTB susceptibility work. Fifteen 
novel single nucleotide polymorphisms and three microsatellites were identified within the 
NRAMP1 gene. The predicted protein structure was similar to that of the cow, and displayed 
the conserved elements characteristic of this family of proteins. Phylogenetic analysis of the 
amino acid sequence of the protein grouped the African buffalo with water buffalo. Of the 
variants identified, 5 SNPs were found in the 5‟ and 3‟ untranslated regions, 9 SNPs were 
intronic, and one was exonic. While the exonic SNP was not predicted to cause an amino acid 
change in the NRAMP1 protein, variants within the 5‟ UTR can have a significant impact on 
gene expression, and thus the variants identified in this region may be excellent candidates 
for future genetic association work.  
Investigations into host genetic susceptibility seek to identify genetic variants that play a role 
in host resistance, in order to utilise these genetic markers either as potential drug targets or 
vaccine candidates, or for selective breeding purposes. While the BCG vaccine is highly 
effective in some animals, no significant protection has been shown in African buffalo after 
experimental challenge with M. bovis. The ineffectiveness of the BCG vaccine, combined 
with the logistical concerns of administering a new drug or vaccine to a free-ranging wildlife 




species such as the African buffalo, suggests that the primary utility of identifying genetic 
variants involved in susceptibility to BTB in African buffalo may lie in the potential for 
selective breeding. Selective breeding has been employed for numerous production traits in 
cattle, such as milk yield and age of first calving, as well as for diseases such as mastitis. 
However, there are many aspects of this type of control program that must be understood and 
taken into account, particularly when performed on a different, wild and free-ranging species. 
To more thoroughly clarify some of these aspects, a review was compiled to address the 
applicability of selective breeding to African buffalo (Chapter 7). Phenotypic and genotypic 
approaches to selective breeding were evaluated, and the role of heritability studies in 
breeding programs and the type of information required were addressed. Consideration of 
these aspects in relation to African buffalo, and what has been achieved in cattle, suggests 
that selective breeding for BTB resistance in African buffalo is a viable strategy. Presently, 
the inclusion of genetic loci in a marker-assisted approach would improve on a traditional 
phenotypic approach, and as the cost of genotyping continues to decrease, the incorporation 
of additional genetic loci or genome-wide information would further enhance the potential of 
breeding BTB resistance in African buffalo. 
In the course of this study, a vast amount of sequence data on the African buffalo genome 
was generated, through next-generation and Sanger sequencing, and has identified upward of 
75 000 SNPs within gene regions. This is the first time that next-generation sequencing 
technology has been applied to the African buffalo, and the data generated can be utilised in 
many future studies across multiple fields. Our candidate SNP set was by no means 
exhaustive – many other genes and SNPs are likely to influence BTB susceptibility in African 
buffalo, and should be investigated further as time and finances allow. Furthermore, it may be 
beneficial to determine the level of success that could be achieved using a commercial cattle 
SNP chip for genotyping African buffalo. As technology progresses and costs decrease, this 
could be the most informative and cost-effective way to investigate the full complement of 
genetic variance involved in BTB susceptibility in African buffalo, provided that sufficient 
data can be obtained using cattle SNPs. And finally, the utility of the information gained from 
genetic association studies must be considered. With the lack of protection conferred to 
buffalo by the BCG vaccine, it seems likely that the primary utility of genetic association 
information will be in the incorporation of this information into breeding values, for selective 
breeding of animals with increased BTB resistance. This strategy has particular application to 
newly established game farms looking to introduce buffalo, or in the re-stocking of farms in 




BTB endemic areas, in order to limit the maintenance and spread of BTB within these 
reserves, and minimise the ecological and economic impacts associated with this disease. 
Bovine TB is a chronic, infectious disease that threatens the welfare of people, livestock and 
wildlife. In countries like South Africa, with vast human-livestock-wildlife interfaces, it is 
imperative that sufficient resources are committed to understanding the different aspects of 
BTB infection, and that new methods of control and management are constantly under 
development. Host genetic studies form a vital part of the research needed to inform a new 
set of wildlife BTB management options, so that the impact and consequences of M. bovis 
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